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Abstract 
The collection of umbilical cord blood (UCB), a source of clinically-useful stem 
cells, has become a highly strategised process known as ‘banking’, with 160 banks 
globally. State-funded public banks rely on unremunerated donations of UCB from 
women. STS scholarship has explored the broader ethical and economic tensions of 
such banks and the private enterprises offering banking for a family’s exclusive 
future use of their own donated tissue. Less focus has been given to public banks’ 
institutional practices and strategic concerns. I address this gap by adopting an 
archival lens popularised by Jacques Derrida (1996). How, I explore, might it help to 
think of these collections not as banks, but as archives? 
Using a number of qualitative data collection approaches, I develop an archival 
anatomy to highlight different elements of these selective collections of biological 
matter. I explore the issues of archival order and the racialised dimension of tissue 
selection criteria that guide UCB collection. I also interrogate the exclusionary 
practices of these collections. Whose donations are excluded, and what does this 
mean for a system reliant on the appeal to communitarian donation? Attention is 
given to how use is made of the archive. How might archivists be making the 
collection more appealing to these users? This leads to an exploration of the risk of 
obsolescence in UCB collections which struggle to sustain relevance alongside 
changing clinical requirement.  
The thesis demonstrates how an archival lens offers the heuristic richness that ‘bank’ 
thinking cannot provide to highlight important aspects of operating and planning the 
future of a collection of biological material. It thus provides a novel contribution to 
the STS literature on regenerative medicine and tissue banking and the growing 
interdisciplinary corpus on the usefulness of the archive in understanding the 
complex aggregations of matter and data facilitated by contemporary technologies. 
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Chapter One: Introduction 
1.1 Introduction 
Imagine finding out that you are probably going to die. But you have a chance, and it 
is in a freezer in Nottingham. Inside this big silver cask (which is probably just 
shorter than you but three times as wide) are lots of little slides. On each slide are 
many thousands of haematopoietic stem cells (HSCs), taken from somebody’s 
umbilical cord just after birth. Maybe they were frozen last month, or five years ago 
(this matters, and I will get to that later). But they were frozen there in anticipation 
that somebody – possibly you – would one day need them. This story is rare, but it 
happens. In 2013, 93 people in the UK were told they had a similar chance in a 
freezer somewhere (Anthony Nolan and National Health Service Blood and 
Transplant, 2014: 25). But what makes all this possible? How did your clinician 
know to look at that particular freezer? Who did s/he have to speak to? How did s/he 
meaningfully decide that it was that slide that was your chance? Why was it those 
HSCs in the freezer and not some others? What networks, based on which 
knowledge, gave you this chance? 
HSCs, which are used to reconstitute the bodies of patients with various blood 
malignancies, were found in the blood of human umbilical cords in 1974. Ten years 
later in the United States, a five year-old boy was given HSCs to cure his blood 
disorder. These had been taken from the umbilical cord that had sustained his new-
born sister through gestation, well before the new personage of the saviour sibling 
had taken cultural root (Hocking and Ryrstedt, 2009). Soon after this, scientists in 
New York set up the first collection of individual umbilical cord blood units. Such 
collections, of which there are now 160 (World Marrow Donor Association, 2013: 2) 
are generally referred to as umbilical cord blood banks. But what strikes me about 
these collections of matter is that for one person to have their life saved relies on 
much more on than the act of depositing a unit in a ‘bank’. The careful management 
of physical matter, the constant alertness to changes in scientific and clinical 
preferences, and the ongoing negotiation of whether a unit remains ‘useful’. These 
themes of anticipation, futurity, resilience, use and so forth are much more readily 
drawn from what I think of as an archival sensibility than any kind of ‘bank’ logic.  
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I will step back first, though, and give some context. Before these collections of UCB 
existed, the only source of this type of stem cell was human bone marrow located via 
one of the established adult donor registries1 that hold information but no physical 
matter from potential donors. It is umbilical cord blood banks and, to an extent, their 
relationship to other sources such as adult donor registries that form the context of 
what follows. More and more, UCB is figuring publically as a viable “weapon” in 
the clinical “arsenal” of “fighting” cancer, familiar language for an illness now as 
mortifying socially as it can be physically (Sontag, 1978). UCB’s prominence is 
particularly apparent in the occasional news articles that address the plight of the 
individuals who require these kinds of treatment. For example, a story for the BBC 
details the case of a toddler who received a UCB transplant: 
‘A 19-month-old boy from Coventry is recovering after receiving 
blood cells from America that could save his life. [He] has a rare 
type of blood cancer and was told by doctors this summer he had 
only six weeks to find a donor. This week suitable blood cells from 
the umbilical cord of a newborn baby in the US were donated… the 
Anthony Nolan Trust … said people from non-white backgrounds 
had a poorer chance of finding a suitable donor. [The patient] is 
mixed race and the cells he received were an 80% match rather than 
the 100% ideal. His family hopes to meet the donor when her 
identity is revealed. In the meantime they are campaigning to get 
more non-white donors on the bone marrow register’. (BBC News, 
2014a) 
In this news article about a young, ‘mixed race’ patient, the journalist explains that 
non-white individuals have ‘a poorer chance’ of finding a match. I could have chosen 
any number of examples for this. In the last year there have been numerous human 
                                                 
1 Adult donor registry is the term that I use throughout this thesis although across the 
scientific and sociological literature it is used interchangeably with bone marrow registries 
or registers. 
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interest stories about this very issue: A women with a Jewish-Hungarian father and a 
Croatian mother describes in The Independent how, because of her mixed-ethnicity 
background ‘the outlook was less encouraging’ (Partos, 2014). A Beijing 
correspondent for the BBC writes about a young British boy of ‘Chinese heritage’ 
who could not locate a match in the UK and found his donor on a registry in 
Shanghai instead (Hatton, 2015). The Telegraph features a British Pakistani girl who 
could not find a match on the registry, and felt ‘disappointed and angry’ at other 
Pakistanis for not having more of a presence on the UK’s bone marrow registries 
(Hoyle, 2014). A story in The Mirror introduces us to a young Londoner whose 
attempt to find a match has been made ‘even more difficult because of his Indian 
background’ (Manger, 2015).  
These stories of disappointment, obligation, requirement and desperation all circulate 
around some configuration of race or ethnicity. When I read these stories, I feel a 
fundamental dissatisfaction. This is not dissatisfaction with the perceived 
‘inequality’, but at the black boxed nature of these claims. Why is there thought to be 
a relationship between ethnicity and the chance of finding a match? In what realm of 
probabilities does this claim emerge, and how is it quantified? Is data collection 
really so fine-tuned that claims like this can really speak to the reality of stem cell 
provision? Let me return one final time to a news story. This one is about a man from 
Manchester. 
‘A man who was given 18 months to live after being diagnosed with 
leukaemia has said his life has been saved by stem cells taken from 
umbilical cords …The treatment for patients with cancers such as 
leukaemia uses donated blood stem cells, usually from adult donors, 
to replace damaged ones.… No suitable matches were found … 
through a search of his family and a database of other donors. The 
grandfather … said he “had never heard of getting stem cells from 
umbilical cords”…’ (BBC News, 2014b) 
This grandfather from Manchester had not known that stem cells can be taken out of 
umbilical cord. It seems that he only knows about it because he could not find 
suitable tissue in his family or ‘a database of other donors’. It was, therefore, lower 
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down on the list of his clinician’s preferences, only checked because the preferred 
sources were not available in this instance. Of course, it once was the case that 
umbilical cord blood would never have been considered at all. These technologies, of 
course, have not always been around. How, as a treatment option, did it transition 
into being on his clinician’s list of treatment options? Would it always have been 
there as an option for him? In ten years’ time would this man’s clinician even bother 
to look through the adult database or would the clinician search for cord blood first? 
This story also highlights the requirement of needing interconnected, searchable 
collections of these sorts of tissues. There is a sense, even simply in knowing 
somebody was searching through these databases and collections that – at a given 
time – one of them held suitable tissue. These are, it seems, managed spaces with 
practices akin to curated, retrievable collections in which matter and data are 
thoughtfully archived away for a future time. 
News stories like the ones above tend to focus on the individual trials of patients. A 
Mancunian grandfather, a mixed-race toddler. These are, of course, important and 
influential narratives. They help not only to engage audiences but steer public 
understanding in how these kinds of illnesses (and their possible cures) work 
(Henderson and Kitzinger, 1999). But there is not much more in the way of patient 
stories in this thesis. In part, this is because I am interested in the availability of 
HSCs and patients actually have little to do with the search for tissue. They do not 
ask for a particular treatment, but “place their faith” in the practitioner to make 
informed choices on behalf of them. Nor is there any data from the actual or potential 
UCB donors as my interest is focused more on those who collect, rather than who 
they collect from. These decisions, made early on in the research, were informed by 
Healy’s contention that we are best thinking of these sorts of systems as systems of 
procurement instead of systems of donation. He writes that human tissues are  
‘…collected and distributed by complex organizations … The co-
ordinating organizations work to elicit donations from donors, to 
elaborate the meaning of the donation, and to specify the nature of 
the gift and the obligations that flow from it. This work involves 
both logistical and cultural effort. The result is a practical system of 
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procurement and distribution, but also a moral order of exchange.’ 
(2006: 17) 
Healy’s work focuses on procurement of blood and organs, not blood stem cells. But 
I take important guidance from Healy. What I am looking at is a complex system of 
procurement that cannot be reduced down to many singular acts of donation. Each 
unit of cord blood, each saliva sample at an adult donor drive, can only be donated 
because a system makes it possible. Part of my general interest has been in trying 
simply to understand that system. How does it operate? What knowledge and 
motivations guide it? What practices sustain it? 
In the UK, the two main British umbilical cord blood banks are run by independent 
organisations: the National Health Service Blood and Transplant (NHSBT) agency 
and a charitable trust called Anthony Nolan (AN). In 2010, a government minister 
announced the production of a unified national UCB banking strategy as part of a 
plan to produce recommendations for managing and developing the UK’s own 
supply of publically available blood stem cells (Hansard HC Deb., 2010). The UK’s 
Department of Health oversaw this forum, which was called the Stem Cell Strategic 
Forum (SCSF). It was made up of different parties including representatives of AN 
and NHSBT, along with senior practitioners working with stem cells and generally 
attached also to Universities and actively publishing academic work, and patient 
charity activists involved in this area of transplantation. This manifested in a report 
(UK Stem Cell Strategic Forum, 2010a, 2010b). But why would the collection of 
tissue into a freezer require so much planning?  
In 2012, a few months before my project began, the SCSF report recommendations 
were taken up by the All-Party Parliamentary Group on Stem Cell Transplantation 
(APPG) which hosts SCSF members to discuss points of the collaborative 
governance arrangement as it develops. The APPG produced its own report (2012) 
that re-asserted the requirements and recommendations laid out initially by the 
SCSF. It reasserted there was a need for practitioners (in the clinic) and scientists (in 
the bank) to be in dialogue. Why would it be that a bank of UCB stem cells would 
need a “strategy”? What makes the scenario so challenging that it demands such 
regular reconsideration, and from so many parties?  
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This thesis addresses these themes, arguing primarily that the most comprehensive 
understanding of these public collections of UCB comes through trying to reconceive 
them not as banks, but as ‘archives’. This is done through laying out what I call an 
archival anatomy, which I then use to explore how these collections are understood, 
managed, and used. How, I explore, can archival thinking help us to understand the 
ways in which collections of cord blood are ordered? This draws in an exploration of 
race as a complex and contested ordering mechanism in contemporary collections of 
human tissue. The thesis also asks how these public collections of cord blood can be 
seen, like all archival collections, as exclusionary. Here, new issues about the 
validity of the extant public/private binary of banking are raised. The archival 
anatomy also gives rise to questions of use. How clinicians’ affective and rational 
repertoires of decision-making combine to make a collection more or less useful 
becomes central here, as well as how those working in such collections respond to 
shifts in these preferences. Finally, the thesis explores how the element of risk, 
central to the longevity and relevance of all archives, plays out in public collections 
of umbilical cord blood. What different risks confront those charged with 
maintaining and sustaining these gatherings of matter, and what is done to efface 
such issues? 
Before this, however, the following chapter plots out the history that made the asking 
of all these questions possible. It provides an introduction to the varied 
understandings that scientists have had about how bodies come to be “compatible”, 
and how our molecular constitutions are framed within the language of ethnicity and 
race. I also plot out the emergence firstly of collected data about adult stem cell 
donors, and secondly of UCB matter, before contextualising the UK’s provision of 
these sources. I do this to introduce the suggestion that what is at work within the 
strategic management of such collections is an archival practice of sorts. Before all 
of this, though, it is important to note that the provenance of UCB lies, perhaps a 
little surprisingly, in the tumultuous beginnings of nuclear science. Bomb making 
seems far away from the stories mentioned above. However, this context helps to 
frame the technology I write about in the chapters that follow, as well as the careful, 
selective, archival practices that I discuss within them. 
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1.2 From Military Research to Treatment Paradigm 
Writing about the convergence of military interests and scientific development, 
Naomi Oreskes warns that ‘any account of knowledge that does not include its 
cultural origins is at best incomplete, and at worse misleading in intellectually and 
politically significant ways’ (2014: 1). Laying out a definitive teleology of historical 
events is, perhaps, impossible. In attempts to do so, we must posit even more 
questions than we perhaps can answer. The stories I tap into now come both from the 
scientists themselves, and comprehensive accounts of the intellectual emergence of 
the theory and practice of haematopoietic stem cell transplantation that have been 
laid out by others (Kraft, 2009; Kutcher, 2003, 2009). It is necessary to explore, if 
only fairly briefly, some of the ‘cultural origins’ of the ‘account of knowledge’ (to 
borrow from Oreskes again). This is because to understand the contingencies and 
anticipations that I want to illuminate in the chapters that follow, the reader must 
recognise that things were never certain, never known.  
To really emphasise the unsettled foundations of a science that is now one of the 
mainstays of the regenerative medicine repertoire, it is worth noting that early 
iterations of this kind of health intervention, particular bone marrow transplantation, 
a cancer treatment, ‘was not developed by clinicians for the treatment of cancer’ 
(Kraft, 2009: 173). Bone marrow transplantation, which preceded the banks of 
umbilical cord tissue that join it as a treatment option in contemporary cancer patient 
experiences, was developed purely to address underlying concerns for the welfare of 
military personnel working directly with nuclear material (Kutcher, 2003). It was 
also intended to remedy the increasingly frequent incidents of lethal radiation 
amongst clinicians given the increased use of x-rays (Kraft, 2009). Indeed, in their 
history of the radiography professional, Thomas and Banerjee suggest that concerns 
about dose reduction in diagnostic radiology emerged because ‘many of the early 
generation of X-ray workers’ (2013: 14) actually died from using the equipment. 
These were some of the many ‘radiation martyrs’, as the authors call them, of early 
radiology.  
More broadly, as nuclear fear began to emerge in the wake of the Japanese atomic 
bomb attacks (Weart, 2009) a need for effective treatment for radiation became even 
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more pressing. As Kutcher notes, ‘In the period immediately following … Hiroshima 
and Nagasaki, a new type of illness was identified’ (2003: 109). Depicted in 
contemporaneous journalism as the ‘atomic plague’ (Lindee, 1994: 11), such events 
highlighted the risk to civilians in addition to the existing concern for military and 
medical personnel. Based upon such accounts, it makes sense that E. Donnall 
Thomas, one of the leading early bone morrow transplantation researchers, felt it was 
out of concern ‘for the atomic disaster of tomorrow’ that medical interventions for 
irradiation should be developed without delay. The following came from one of the 
early papers he authored with colleagues. Its importance is perhaps evidenced by his 
own re-iteration of the same tract in his 1990 Nobel Prize lecture where he framed 
the history for which he had won the award.  
‘In an atomic age, with reactor accidents not to mention stupidities 
with bombs, somebody is going to get more radiation than is good 
for him. If infusion of marrow can induce recovery in a mouse or 
monkey after lethal radiation, one had best be prepared with this 
form of treatment in man. The leukemic patient who needs radiation 
and bone marrow ... From helping them one will be preparing for the 
atomic disaster of tomorrow and it is high time one did.’ (Thomas et 
al., 1957: 496 ) 
Perhaps unsurprisingly, this ‘military face of leukaemia therapy was made to vanish 
from the history of medicine’ (Kutcher, 2003: 117). It is only in critical histories of 
the technologies written later and in some very brief reflective moments later on by 
those involved in the technology at the time (Thomas, 1994) that we see such stories 
told. Indeed, it is unlikely that most people receiving this kind of treatment (and 
probably plenty of the people facilitating it) are even aware that most of the early 
research on this kind of treatment, almost exclusively happening to mice and dog 
models, was catalysed and funded by state military institutions such as the U.S. 
Atomic Energy Commission and the U.K. Atomic Energy Research Establishment. 
And just as it is difficult to give the teleology of a technology, it would be hard to 
know what kind of impact, if any, this knowledge of the past might have on a stem 
cell recipient today. 
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As I have already noted, bar a few historical accounts of the emergence of stem cell 
technology, there is not much to draw from in trying to give some historical context 
to the chapters that follow. As such, I want to consider a few of the original studies 
by what are now considered to be some of the most significant groups according to 
these accounts. In particular, the group that was led by E. Donnall Thomas who 
features prominently in the academic accounts mentioned above. But in telling 
histories we are at risks of obscuring or reducing the multiple processes that bring the 
present into being. Readers might notice the androcentrism of the chapter that 
follows. Indeed, it was a highly masculine environment where research teams 
comprised only men. In January 2015, when E. Donnall Thomas’s widow Dorothy 
“Dottie” Thomas passed away, the New York Times obituary noted a comment once 
made by her husband: 
‘In the laboratory days, my sometime friends pointed out that Dottie, 
who had the library experience, would go to the library and look up 
all the background information for a study that we were going to do, 
and then she would go into the laboratory and do the work and get 
the data, and then with her writing skills, she’d write the paper and 
complete the bibliography. And all I would do is sign the letter to the 
editor.’ (Roberts, 2015) 
Sure enough, Dottie Thomas is not on the list of authors of these papers, and it is 
arguably only because of the professional success of her husband that we can glean 
this knowledge of her story. Thus, we must proceed with caution that in the context I 
now explicate there are unavoidable omissions, not least about the roles of the many 
women who doubtless brought this science into being without any of the scientific 
credit granted to their male counterparts. 
In the 1950s, the uncredited Dottie, her husband, and his team attempted to 
demonstrate that bone marrow contained cellular entities that might act as the seed 
for further cell production. Kraft argues that this research period constituted an 
attempt to reinforce the existing ‘cellular’ hypothesis that one cell could seed the 
repopulation of the body with its various kinds of cells. This theory was gaining 
traction against the ‘humoral’ hypothesis that a hormone might promote cell 
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production. The cellular hypothesis would – as Warwick Anderson and Ian MacKay 
(2014) have since pointed out about the duelling theories – only reinforce the case 
for the construction of the body as a defensive space that could fold in on itself and 
ultimately breakdown from within.  
Thomas et al. (1957) reported results of allogeneic marrow grafts in a series of six 
human patients with different forms of immunitary illness. The marrow that patients 
received had been taken from living and cadaveric donors, aborted foetal tissue and, 
in one case, a human rib removed during an operation to open up their chest. There is 
perhaps some biblical irony that it was the only woman in this series of six patients 
that received the rib marrow. Several patients died soon after treatment, whilst others 
became ‘ambulatory’. Beyond this, the success of the treatment was not detailed 
though it has since been noted in a piece to commemorate the 50th anniversary of the 
paper that all the patient treatments were unsuccessful (Forbes, 2007).  
Human patients were used for these ‘experiments’ when opportunities to do so 
presented themselves. However, as Thomas would point out in his Nobel Prize 
lecture (1994), researchers could be more systematic in their efforts by using animal 
models. Perhaps unsurprisingly, his account does not reflect on some of the ethical 
tensions engendered in this reliance on animals, or even how the research in this 
period was vital in standardising animal models for the biomedical research that 
would follow (see Rader, 2004). The potential ethical tensions that might beset such 
studies today notwithstanding, the most revealing early research on HSCs came from 
research on dogs and mice. Thomas and his colleagues were making direct causal 
links between clinical success and the donor and recipient being genetically related 
litter-mates (Ferrebee et al., 1958; Thomas et al., 1959).  
Their studies also made reference to work early in the decade by Barnes and 
colleagues, a team based between Paris and London. In this study, the authors had 
induced leukaemia in mice from one strain through whole body irradiation. The 
researchers then injected the irradiated mice with marrow from other, healthy mice. 
Some would receive this marrow from another mouse from within their strain, and 
others would receive marrow from unrelated strains. Grafts from these latter 
unrelated strains were less successful in the mice. The authors noted that, as of 1956, 
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the failure could not be explained. ‘The detailed pathological processes,’ they wrote, 
‘are not yet understood’ (Barnes et al., 1956: 627). But they were more optimistic 
about the grafts that were successful. Mainly these successes occurred when the 
source of tissue came from a healthy mouse of the same ‘strain’, i.e. genetically 
related animals. 
Thomas would later point out the importance of this link in his Nobel Prize 
recipient’s lecture. He would note that allogeneic transplantation (that is, tissue taken 
one dog and grafted into another) mainly resulted in either immediate failure or a 
successful engraftment proceeded by a deadly wave of illness. This was what 
clinicians now understand to be graft-versus-host disease (GVHD). GVHD was 
conceived of as the ‘secondary syndrome’ and began to be understood, as it still is 
now, as a situation where the cells seeded by the transplanted marrow attack the 
recipient’s body (Kutcher, 2003). But Thomas did find some encouragement in ‘the 
fact that an occasional dog, usually with a littermate donor, went through the grafting 
procedure successfully’ (Thomas, 1994: 341). Results presented in the 1959 study 
also gave some suggestion that there was the capacity for unrelated canine marrow 
transplants too. The 1959 paper concluded that ‘marrow transplants between 
unrelated animals appeared more difficult but not impossible’ (Thomas et al., 1959: 
734). With encouragement from successful related engraftments in a few dogs and a 
sense of the possibility of unrelated engraftment, researchers in the field were 
moving towards an understanding simultaneously emerging more widely in the 
nascent profession of immunology that it was possible for two beings to have some 
gradient of ‘compatibility’. 
1.3 Molecular Individuality and Race 
As Warwick Anderson and Ian MacKay note, 1950s immunology saw the suggestion 
that a human might have a particular expression of antigens across all their cells that 
could be either more or less compatible with another person’s. But short of the 
breakthrough success of extended patient survival post-graft, it would not be until the 
1970s that a link would emerge between these ‘transplant antigens’, and 
immunological responses between donors and recipients. Importantly, this meant that 
a single human could then have one expression or ‘type’ common across their cells. 
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This, as Anderson and MacKay put it, compelled ‘a deeper understanding of the 
molecular meaning of individuality’ (2014: 117) which speaks to the dominant logic 
of tissue transplantation as it emerged in the 20th century, and as it develops today.  
This logic operates on an immunitary distinction between the allogeneic and the 
autologous derived from the Greek autós (self) and állos (other). An autologous 
transplant (or ‘autograft’) is therefore one in which the patient is the recipient of their 
own tissue, taken from and then re-placed into, the self. An allogeneic transplant (or 
‘allograft’) describes the opposite, any scenario in which a patient receives tissue 
from somebody else, an ‘other’ – be they a stranger, a friend, or a relative. 
Transplantation technology is thus held together by a fundamental understanding of 
self/other distinction and that some bodies are, corporeally, more or less compatible 
than others. In the dominant model of immunological understanding, transplant 
compatibility between a donor and a recipient is determined by their Human 
Leukocyte Antigen (HLA) type. Using molecular analysis, tissues can be ‘typed’ for 
their HLA composition. According to the current consensus, the formation of ‘a 
unique protein sequence’ (Hollenbach et al., 2011: 336) on the surface of individual 
cells is guided by a particular set of genes. These genes can be analysed to determine 
(referring back to Anderson and MacKay’s compelling term) a person’s molecular 
individuality.  
Guided by an understanding that it is a small section of genes that determine a 
person’s cell surfaces, this technology is used to establish a tissue type. In a bone 
marrow transplant, up to five genes are looked at. These are the genes currently 
called HLA-A, HLA-B, HLA-C, HLA-DRB1 and HLA-DQ (Howard et al., 2015; 
Shaw et al., 2009). As per the current consensus in the field, all individuals ‘inherit 
both a maternal and a paternal HLA allele, co-dominantly expressed in the cell’ 
(Erlich, 2012: 2). Accordingly, two versions of each of these five genes must be 
looked at. A tissue type must therefore offer an analysis of 10 genes (the maternal 
and paternal versions of the HLA antigens deemed important to compatibility). Both 
recipient and donor are typed in this way, and their compatibility can be measured by 
how closely matched these genes are. Two people could conceivably be compatible 
at each antigen, and thus be a 10 out of 10 match. This is, of course, just an account 
of the current model of understanding. This account has changed as more research 
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has highlighted the relevance of hitherto unconsidered factors. As a recent consensus 
status notes, ‘typing resolution terms have the potential to change over time as new 
alleles are identified’ (Hollenbach et al., 2011: 339). As such, one of the questions 
that must be asked is how the model and the wider field contend with these changes 
as they happen. 
The 1950s- and 1960s-era research on HLA typology took place in a highly 
competitive environment. In his history of the profession of immunology, Leslie 
Brent notes that HLA research was being undertaken by ‘powerful personalities’ in a 
professional world with a ‘strong competitive edge’ (Brent, 1996: 141). In the 1960s, 
the leaders in the field were searching for assent to their own systems that would 
adequately describe these antigens and their molecular variability. To do so, they 
‘arranged annual international histocompatibility workshops to bring some order to 
the research enterprise and to standardize classification’ (Anderson and MacKay, 
2014: 128).  
The bringing of order, then, was central to the historical emergence of the 
immunological individual. The individuated body’s identity in immunological terms, 
was (and is) ‘still in formation, still learning, shaped by its continuing history 
(Anderson and MacKay, 2014: 132). It was, the authors note, out of such meetings 
that a consensus developed by the end of the sixties that there was one major 
histocompatibility complex in the human body, the overarching HLA framework. 
Discussions over standardisation and the controversies that surround them are 
germane to this field. As STS scholars have noted, the clinical application of nascent 
technologies requires the setting of standards, workflows and nomenclatures (Berg 
and Timmermans, 2000). To refer back to Anderson and MacKay, the compunction 
to ‘bring some order’ is inscribed in the field of immunology. As such, it is important 
to ask how the endeavour for standardisation and order informs the practices of 
contemporary stem cell transplantation. 
As Thomas would reflect in his Nobel Prize lecture, after a number of allograft (self-
to-other) failures in human patients, researchers abandoned further study of the area. 
It was work beyond the field of marrow cell transplantation, namely by 
immunologists exploring the HLA framework, that would bridge that gap between 
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knowing that tissue transplantation could be done, and learning more about how it 
was done: 
‘As we developed our knowledge of DLA [Dog Leukocyte Antigen] 
matching, we followed closely the work of Dausset (Nobel Laureate, 
1980), van Rood, Payne, Bodmer and Amos in the human, the HL-A 
system. By 1967, we thought that the time was right to return to 
allogeneic marrow grafting in humans.’ (1994: 341) 
These antigen discoveries of the fifties joined the ABO antigen group as another 
means of locating and articulating molecular differences between bodies. The ABO 
group meant that people (anybody donating or receiving blood) could be divided up. 
For example, I can say I am “O rhesus positive” which distinguishes me and fellow 
group members from anybody who is not. So too did the ABO conception allow 
people to be divided up, as Lawrence Hill (2014) has noted, into racial groups even 
though two people from anywhere, of any skin tone, who have the same blood type 
can share blood in a transfusion safely. Blood, as Hill adeptly demonstrates, has a 
racialised history that precedes all the advances of the 18th, 19th and 20th century in 
the laboratory.  
Race is tenacious and so, perhaps unsurprisingly, it emerged as a meaningful 
category around which a lot of the immunology profession’s early work would 
coalesce, particularly in their work with geneticists. For example, Dausset (whom 
Thomas cites above as an important influence in his own understanding of bodily 
compatibility) became ‘obsessed with mapping patterns of HLA expression around 
the world’. He was joined by geneticist Luca Cavalli-Sforza known (in)famously for 
the ill-fated Human Genome Diversity Project (Reardon, 2005) where indigenous 
activists’ accusations of ‘biocolonialism’ stymied any further research in that vein. 
Dausset and Cavalli-Sforza attempted ‘to trace the global distribution of human 
polymorphism, or genome diversity’ (Anderson and MacKay, 2014: 129). Walter 
Bodmer, whom Thomas credits too, also engaged in research about human 
polymorphism with Cavalli-Sforza. 
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This involvement of population geneticists and immunologists had repercussions that 
emerge in a racialised way. I have already noted that, as the dominant immunological 
model would have it, half of any cell’s surface in a given human body is ‘maternal’. 
The other half, by this logic, is ‘paternal’. The gendered dynamics of this language 
aside, it is understood that the surfaces of cells are dependent on one’s parentage 
(Erlich, 2012). Population geneticists such as Bodmer, it could be argued, extrapolate 
out from this basic tenet. They suggest that different ‘populations’ have different 
‘frequencies’ of HLA types. In the literature, notions of populations often transmute 
into racialised language. Race, the tenacious category, thus re-emerges in this 
conception of bodily difference as it did in the organisation of tissue matter in light 
of the discovery of the ABO antigen system (Hill, 2014). ‘White’, for example, could 
have several near-synonyms. If you are white in one instance, you could be 
‘Caucasian’, ‘European’, or ‘Caucasoid’. Though each permutation might have 
different meanings, they are used in the literature interchangeably, something that 
Catherine Bliss (2011) calls a conceptual ‘slippage’ in her systematic literature 
review of the use of racialised language in genomic research. 
In 1971, Bodmer co-authored a book with Luca Cavalli-Sforza, the Italian geneticist 
who had worked with Dausset. The Genetics of Human Populations (1971) explored 
the methodological and theoretical underpinnings of global studies of genetic 
difference, including HLA-type differences, around the world. The work remains a 
reference point for studies of the HLA frequencies in different marrow donor groups 
around the world (for example, see Mori et al., 1997; Schipper et al., 1997). In 1994, 
Cavalli-Sforza and colleagues published The History and Geography of Human 
Genes. This is now a much celebrated milestone title in human genetics, its most 
recent citation being in a paper on ‘racial and ethnic differences’ in drug disposition 
and response by Ramamoorthy et al. (2015) demonstrating that the echoes of its 
publication over forty years ago can still be heard. 
In the field, the pervasiveness of the immunological thinking set out in these key 
texts became manifestly apparent during a conversation with a scientist. Just after 
they had signed their informed consent form, and I had turned on the voice recorder, 
they queried my interest in the research topic. I explained that I had been very 
interested in the work of population geneticists, and the controversy surrounding 
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Luca Cavalli-Sforza. Hearing this, the interviewee stood up from their chair to 
consider their book shelf, full of large folders and a handful of textbooks. They 
pulled out a copy of The History and Geography of Human Genes as if to evidence 
our shared interest. They explained: 
I’ve got his book. It just happens to be one of my interests as well. 
The front cover of this book displays a world map colour-coded to depict what the 
authors believe to be four major ‘ethnic groups’. They are keen to avoid the term 
race, laying out in the book how the term has suffered ‘scientific failure’ at the hands 
of ‘modern taxonomists’ whose seemingly classification-happy work had produced 
‘3 to 60 or more races’. Cavalli-Sforza et al. explain that ‘this latitude depends on the 
personal preference of taxonomists, who may choose to be ‘lumpers’ or ‘splitters’ 
(1994: 19). Cavalli-Sforza and his colleagues thus prefer the term ‘ethnic group’ by 
which they refer to places on the globe where they had data to evidence that people 
living there were more likely to present particular antigens on their cell surfaces (that 
is, HLA tissue types). Of course, this could be read as their personal preference for 
lumping and splitting. In Carter and Dyson’s discussion of the apparently benign 
language of ethnicity, they argue that the term is ‘a clever contrivance to allow 
researchers to talk about the fixity of social character without using disreputable 
notions of race’ (2011: 966). Similarly, we might argue that the term ‘ethnic group’ 
seems to allow the authors of The History and Geography of Human Genes to talk 
about race without actually having to say the word. 
Colour means something when we talk about race. Since the start of the 20th century 
we have witnessed the theoretical proposition of a ‘color line’ (Du Bois, 1903) and a 
‘color complex’ (Russell-Cole et al., 2013). Colour has a lot of weight given its 
political centrality to the project of race equality. Therefore it seems at best 
problematic that the front page of a book that at once extolls the ‘scientific failure of 
race’ whilst arguing for the ontological facticity of ethnic grouping, should so 
prominently feature a colour coded world map. Each colour represents an ethnic 
group. Yellow for ‘Africans’, red for ‘Australians’, blue for ‘Mongoloids’ and green 
for ‘Caucasoids.’  
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Jonathan Marks argues that Cavalli-Sforza exemplifies the unreflexive use of race 
(2010: 266). The lack of reflexive engagement with the terminology used in studies 
such as these could, it has been argued, mean that scientists are potentially 
unproductively delimiting public understandings about what genetic differences 
between individuals actually mean (Lee, 2009). A sustained awareness of the use of 
these terms is vital because uncritical employment of them might ‘serve to produce 
and reproduce wider forms of essentialism, stereotyping and racism’ (Gunaratnam, 
2003: 19). It would indeed be helpful for scientists or, as Anderson calls them, 
‘nature’s interlocutors’ (2006: 253), to explain their adoption of specific taxonomies. 
This is because, as Bliss points out, one might be reifying race as a genetic fixity 
whenever one uses it to produce and disseminate genomic research. Such categories, 
which are ‘imported from the social sphere must be carefully explained and defined’ 
(2011: 1026). 
It is in this critical context that Jonathan Marks (2010) draws comparisons of Cavalli-
Sforza and colleagues’ contention with the work of Carl Linnaeus, ‘the grandfather 
of modern taxonomy’ (Bowker, 2005: 129). In particular, his effort to taxonomise the 
world’s population into four races (white Europeans, red Americans, brown Asians 
and black Africans) as the below table, reproduced from Sundquist (2008),  plots out. 
Table 1: The world’s races according to Carl Linnaeus’ “Systema Naturae” 
Europeaus 
Skin (white); build (muscular); hair (long, flowing), eyes (blue); 
disposition (gentle, and inventive) 
Americanus 
Skin (reddish); build (erect); hair (black, straight, thick); distinct 
facial features (wide nostrils); disposition (stubborn and angered 
easily) 
Asiaticus 
Skin (sallow; yellow); hair (black); eyes (dark); disposition 
(avaricious and easily distracted) 
Africanus 
Skin (black); hair (black; frizzled); skin texture (silky); distinct 
facial features (nose flat, lips tumid); disposition (relaxed and 
negligent) 
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In this thesis, I do not attempt to evaluate the facticity of the race-based claims made 
in the field. Putting this simply, I do not want to make any attempt to question race’s 
(in)existence. Brett St. Louis writes that sociological critiques of race category usage 
‘have arrived at the following conclusions: race does/does not exist and we 
should/should not use the concept’ (2005: 30). We might therefore take on board 
Rogers Brubaker’s understanding of races as ‘practical categories, situated actions … 
organizational routines, institutional forms, political projects, and contingent events’ 
(2004: 11). This is borne of an understanding of racialisation as, primarily, a political 
practice. He argues that we must take ‘as a basic analytic category not the “group” as 
an entity but groupness as a contextually fluctuating conceptual variable’ (ibid.). 
Brubaker’s argument engages with overt political groupings based around ethnicities, 
but its logic can be extrapolated into the arena of public stem cell banking, wherein 
processes of ‘groupness’ can be located in the mobilisation of organisations. Perhaps 
most importantly, Brubaker argues that to understand race ‘does not require us to 
posit the existence of race’. Rather, to borrow from the same writer again, I am 
interested in considering the means and processes through which ‘people – and 
organizations – do things with categories’ (ibid.: 13). Thinking back to the story of 
the mixed raced toddler at the beginning of this chapter, it is crucial that we ask what 
work race is being put to in this context. How do these categories emerge, and to 
what end? 
1.4 Saving It for Later 
Thus far, we have explored the emergence of HSC technology in the form of bone 
marrow transplantation. Its early iterations were a response to concerns for military 
personnel, then clinicians, and finally the public. But HSC technology is now, as 
Kraft notes, a firmly clinical intervention with cancer treatment at its centre. This 
transition, as we have seen, has been informed by the development of a framework of 
understanding in which different bodies can be seen as more (or less) compatible. 
This framework is articulated through the language of racial difference, and offers a 
context for understanding how contemporary HSC technology is enrolled. However, 
Thomas and colleagues’ animal models, yet another tale of ‘men and their 
organisms’ (Rader, 1999: 319), are an interesting point of discussion. Here was the 
first suggestion that it might be possible (and indeed prudent, a rhetoric we see re-
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emerge in the literature of many private tissue banks today (Fannin, 2013)) to store 
tissue into repositories in anticipation of some future requirement. As we know, such 
ideas have (in a sense) been realised though probably not in any way that would have 
been recognisable to Thomas and his colleagues. 
Back with Thomas’ team of researchers, another paper in 1960 again raised the 
feasibility of storing tissue. Mannick and colleagues’ study on autologous marrow 
grafts in dogs – went so far as to suggest that it would be useful to consider ‘the 
establishment of autologous marrow banks for personnel potentially exposed to 
radiation and for patients about to receive consequential radiation or chemotherapy’ 
(Mannick et al., 1960: 264). The fact that the authors described it as a ‘bank’ echoes 
a trend of describing collections of human tissue with this word. As Kara Swanson 
(2014) notes, in the United States sperm was being systematically “banked” by 1953, 
human blood from 1937 and, before all of this, breast milk in 1910. I will take up my 
issue with the term bank in chapter two, suffice for now to repeat Swanson’s position 
that using the bank metaphor this way fundamentally shapes the way we ‘think about 
body products’ (2014: 4). This is the point of a metaphor – to help us understand an 
instance or an entity in a particular way. This is something to which I will shortly 
return.  
For now, it is important to note that Mannick et al.’s suggestion was one of a ‘bank’ 
of tissue for people working with hazardous radiation material, and for patients about 
to be irradiated in curative procedures. These would be autologous banks because the 
tissue would be saved with the purposes of being injected back into the self in case 
that self should become irradiated. This could be a kind of prudential storage of 
matter for those people most likely to need it. As we will see, this imagined scenario 
would not play out with bone marrow, but some forty years later with a different 
source of HSCs: umbilical cord blood. At the time, however, the researchers were 
still pondering a scenario in which repositories of adult-derived tissue could become 
a reality. This historical context makes plain that requirement was the guiding force 
behind these early (imagined) banks. Need was anticipated, and the banks were 
posited in response. So to what extent are requirements and anticipation still at the 
core of contemporary practices?  
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The autologous marrow bank that Mannick and his colleagues described was perhaps 
prohibited by the slow development of the science that would determine it to be a 
worthwhile investment. Perhaps the banks were never developed because of the 
likely high cost of the endeavour. Based on the original motivations for the initial 
studies, it might even have been an assuaging fear of atomic power. Perhaps it was 
because, for the military personnel, unless leukaemia had already been clinically 
indicated, an invasive procedure requiring surgical extraction would seem 
unnecessary. As it turns out, post-indication of leukaemia, harvesting stem cells 
would probably not have been much use anyway, given that leukaemic cells might 
have resided in whatever was sequestered (Kurtzberg et al., 2005).  
The explanations are unavailable to us now, but perhaps, as Kraft argues about the 
general dispersal of interest in the field after its active beginnings, ‘the moment had 
passed, the cohort had dispersed, and new research agendas emerged’ (2009: 175). 
By the 1970s, autologous banks had lost all priority and the first transplants from 
allogeneic, sibling donors were taking place (Bortin and Rimm, 1978; Speck et al., 
1973). Even more momentously, in 1973 a transplant of allogeneic HSCs from a 
completely unrelated donor into a three year-old boy, Simon Bostic, was successful 
(Foroozonfar et al., 1977). Bostic would be the first recipient of allogeneic HSCs 
derived from an individual not from within their own family (Hughes-Jones et al., 
1991), a procedure now simply called an “unrelated transplant”. 
It was because of this newsworthy success that the mother of another young boy 
requiring similar treatment sought out the same intervention received by Bostic. 
Shirley Nolan would travel from Australia to London, where Bostic’s treatment took 
place, to see if it was possible for her son, Anthony, to receive it. In 1974, on 
discovery that she and her family were not sufficiently compatible as tissue donors 
and she would have to find an unrelated donor she founded the Anthony Nolan Trust. 
As the organisation’s 40th Anniversary retrospective (2014) tells it, the Nolan family 
faced such a challenge in trying to find a match that they began compiling a list of 
potential donors and their tissue types. In other words, a bone marrow registry. 
Creating a solution for the requirement for allogeneic tissue was pressing by the 
1970s given that it was now required for a proven medical intervention that had the 
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capacity to save lives. The notion of requirement was central. Interestingly, the 
pressure was compounded by concerns that family sizes (and thus, related donor 
options) were decreasing (Pavlů et al., 2011). Her son Anthony died, having never 
found a compatible donor. Despite this or, perhaps, because of it, Nolan remained 
active at the Trust. As one of her obituaries would note, after Anthony Nolan’s death, 
Shirley Nolan ‘resolved to continue campaigning’, eventually setting up the charity 
in its official quarters in London. Shirley Nolan died in 2002. John Goldman, the 
London-based clinician who would work with her to tissue type volunteers willing to 
donate to Anthony, reflected on Shirley Nolan’s legacy in her obituary in the 
international journal Bone Marrow Transplantation. 
‘Most haematologists at the time were not immediately enamoured 
of the idea of HLA-typing large numbers of volunteers from the 
general public in the hope of finding just one suitable donor, but 
Shirley’s enthusiasm and commitment were persuasive. The project 
was publicised by every available route and more than 300000 
potential donors were tissue-typed in the next few years.’ (Goldman, 
2002: 627) 
The Anthony Nolan Trust’s list of tissue-typed volunteers is now used as the first 
example of a bone marrow registry (Pavlů et al., 2011). Other developed countries 
would follow suit with bone marrow registries being established in Australia, North 
America, and across Europe. Such registries are databases of volunteers (usually 
referred to as donors, although most will never actually donate), each having given a 
sample of blood or saliva that has been tissue typed. The database holds the donor’s 
personal information and their tissue type, but none of their physical matter.  
As clinician Effie Petersdorf noted in 2010, many of these registries would 
eventually unite under the efforts of Thomas (the Nobel Prize-winning clinician who 
had worked on the dog models), Goldman (who had worked with Shirley Nolan to 
develop the first register) and others to establish the ‘Cooperative Marrow Donor 
Program’. This group aimed to produce guidelines for the nascent practice of tissue 
exchanges between donors and recipients living in different countries. It was this 
initial group, Petersdorf notes, which gave impetus for the later establishment of the 
32 
 
World Marrow Donor Association (WMDA). In 1995, the WMDA was founded to 
both promote and formalise the international exchange of donor HSCs: 
‘It is in this spirit that the mission of the WMDA - to work towards 
making high quality and secure hematopoietic stem cell products 
available for all patients worldwide while maintaining the health and 
welfare of the stem cell donors – has led to a global effort.’ 
(Petersdorf, 2010: 807) 
Bone marrow registries are now also called ‘adult donor registries’, partly because 
since the establishment of the first registries, bone marrow is no longer the primary 
means of sourcing HSCs from the adult body. Adult stem cells are now much more 
frequently sourced from “peripheral blood”. That is, the blood which flows around 
the body. The donor is given a regimen of drugs that augments the number of HSCs 
entering into the blood, and then is connected to an extracorporeal machine that 
separates the HSCs from the blood before returning it to the donor’s body. The donor 
can expect to return to the hospital over the course of several days to complete the 
process. In 2009, out of the 812 stem cell donations sourced in the UK, only 13% 
were directly drawn from bone marrow, whilst 74% came from peripheral blood (UK 
Stem Cell Strategic Forum, 2010b: 15). Another reason why the nomenclature has 
changed to adult donation has been the emergence of a non-adult source: the 
umbilical cord. As of 2013, the WMDA connected 71 adult donor registries and 160 
collections of umbilical cord blood (World Marrow Donor Association, 2013: 2). 
1.5 Umbilical Cord Blood as an Alternative HSC Source 
It was out of this historical context that umbilical cord was first found to be a source 
of HSCs (Knudtzon, 1974). As I mentioned briefly at the start of the chapter, it was 
in 1988 that cord blood was used to treat a blood malignancy, Fanconi’s Anaemia. 
The cells, taken from the umbilical cord of the young patient’s sister, grafted 
successfully and the treatment details were published the next year by Eliane 
Gluckman and colleagues (1989). It was, noted a leading cord blood clinician in the 
US in the mid-nineties, because of these first successes with transplantation of UCB 
sourced from sibling donors that the first initial programs for the collection of 
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unrelated UCB began (Wagner, 1995). But what need was there if a source already 
existed? Around this period, authors with a professional interest in cord blood were 
amassing lists of issues with the state of bone marrow provision as it stood at the end 
of the 20th century (see, for example, Rubinstein et al., 1993). For instance, as 
Wagner and his colleagues asserted: 
‘…there are several important obstacles that limit the successful use 
of unrelated donor marrow; these include, (1) the long length of the 
donor search process which is currently a median of 3.5 months 
(range 1 month to 6 years,) (2) limited numbers of donors in certain 
racial and ethnic subpopulations, (3) donor unavailability at the time 
of request, and (4) an increased risk of graft rejection, severe graft-
versus-host disease (GVHD) and opportunistic infection after the 
transplant procedure. Various strategies for ameliorating these 
problems are currently being investigated.’ (Wagner et al., 1996: 
795) 
The lengthy wait for an adult donor and the risk of unavailability or attrition of 
donors in the meanwhile, the persistence of GVHD, and an apparent dearth of 
particular ‘racial and ethnic subpopulations’. These coalesce in these mid-nineties 
accounts as sufficient motivation to look further afield. One of the strategies of 
amelioration was thought to be umbilical cord blood. As members of the team behind 
the first UCB transplant explained, UCB blood ‘has the potential to overcome some 
of the limitations of the current system of registries’ (Socié et al., 1994: 340). The 
same argument was taken up by the team involved in setting up the first umbilical 
cord blood collection, based in New York. They wrote that ‘“banks” of 
cryopreserved placental bloods would not depend, for example, on the recruitment 
and continued collaboration of large numbers of volunteer potential donors and on 
compensating for the unavoidable attrition caused by retired volunteers’ (Rubinstein 
et al., 1993: 1679). 
In such accounts, there is an implication that there are a number of advantages in 
utilising umbilical cord blood extraction in lieu of other methods of isolating HSCs. 
Extraction does not, it is argued, necessitate obvious physical pain or discomfort (see 
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Brown, 2013 for a sociological examination of the claim of safety in CB banking), 
whilst the extraction of bone marrow-sourced stem cells and peripheral blood 
donation is invasive and requires repeated hospital visits on the part of the donor. 
One of the most attractive qualities of UCB is that the tissue is already there in the 
repository and immediately available for the ordering clinician. Adult donor 
registries require donor correspondence information to be continually updated, and 
rely on the potential donor remaining willing to donate and physically available to do 
so. 
These images were taken during a visit to a public UCB bank in Madrid that I 
contextualise in chapter three. These visual data are used to illustrate how umbilical 
cord blood units can be immediately removed from the freezer, placed in a travel 
freezer and swiftly couriered worldwide. The travel canister in these images had just 
returned to the Madrid bank from a clinic in New Zealand. The visit to this cord 
blood bank, and more detail about the heavily-stickered travel canister is recounted 
elsewhere (Brown and Williams, 2015). 
Figure 1: An open cryogenic freezer in Madrid  
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Figure 2: (below) An umbilical cord blood unit being draw out of the cryogenic 
freezer in Madrid 
 
 
 
 
 
 
 
Figure 3: (below) Travel canisters in Madrid for sending units out to hospitals 
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Along with this, UCB-derived stem cells offer a solution to what is considered to be 
one of the most significant issues regarding the current configuration of adult donor 
registries. Established registries, for example in Australia (Samuel et al., 2007) the 
United States (Johansen et al., 2008) and the United Kingdom (Brown et al., 2000), 
are mainly populated with data from donors who identify as white. Because of the 
understanding of a link between ethnicity and HLA typing that I touched upon earlier 
in the chapter, this is construed as an over-representation of white donors and a 
dearth of minority donors which, it has been noted, has evident consequences for 
minority ethnicity would-be tissue recipients for whom a match cannot be found. I 
have given further critical exploration of this point elsewhere (Williams, 2015) but 
other questions concern me here. The notion of over-representation implies a 
normative point of representativeness from which banks and registers can deviate. 
Why is representativeness thought to be a good thing in the first place? Furthermore, 
how is representativeness measured in contexts such as this? When we see racialised 
language appear, it is important to explore, in Rogers Brubaker’s (2002, 2004) terms, 
what interests these invocations of groupness serve. 
We have seen, then, that UCB collection practices emerge out of a particular history. 
The situation we have now, of 160 allogeneic umbilical cord blood banks (World 
Marrow Donor Association, 2013), was not quite what Mannick and colleagues had 
earlier imagined with their autologous bank for military personnel and cancer 
patients. This thesis is interested specifically in the contemporary UK context of 
UCB collection, which exists today far removed from its militaristic roots. In the 
next, final section of this chapter, I plot out this context in a little more detail to 
contextualise the proceeding chapters. 
1.6 Umbilical Cord Blood in a UK Context 
Not too far behind the first collections of UCB in the early nineties, by 1995 the 
UK’s National Blood Service had established its own umbilical cord blood repository 
which they called a umbilical cord blood “bank” (National Blood Service, 1997: 12). 
In 2010 the Anthony Nolan Trust, rebranded simply as Anthony Nolan, established a 
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UCB repository in the UK again named a “bank”, a linguistic trend that is now 
pervasive internationally. Historically, these two organisations (the former, now 
called the NHS Blood and Transplant authority, or NHSBT) have operated 
separately, managing their own individual adult donor registries and umbilical cord 
blood collections. However, in 2010 the UK’s Parliamentary Under-Secretary of 
State for Health, Anne Milton announced the production of a unified national UCB 
banking strategy: 
‘A properly developed infrastructure for the collection and storage of 
cord blood will do much to alleviate the severe shortage of life-
saving stem cells needed for transplantation and to facilitate research 
… it would be neglectful for the UK not to embrace to the full this 
exciting option.’ (Hansard HC Deb., 2010) 
The UK’s Department of Health, oversaw this forum, which was called the Stem Cell 
Strategic Forum (SCSF) made up of different parties including representatives of 
Anthony Nolan and NHSBT, along with practitioners working with stem cells and 
patient activists involved in the area of transplant. The Department of Health 
requested information on the current state of publically available blood stem cells in 
the UK and recommendations for its development which appeared in a report (UK 
Stem Cell Strategic Forum, 2010a, 2010b). It was in this initial forum that the seeds 
of the current collaborative arrangement were sown. In 2011, it was announced that 
£4m was to be given to AN and NSHBT to realise the various recommendations of 
the SCSF, which included the alignment of data from both institutions’ blood stem 
cell inventories, including their individual adult donor registries and UCB banks 
(NHS Blood and Transplant, 2011). The SCSF report recommendations are now a 
point of interest for the All-Party Parliamentary Group on Stem Cell Transplantation 
(APPG) which hosts SCSF members to discuss points of the collaborative 
governance arrangement as it develops. The APPG produced its own report (2012) 
that re-asserted the requirements and recommendations laid out initially by the 
SCSF:  
‘Stem cell transplantation already transforms many lives, curing 
otherwise untreatable blood diseases. Yet finding a match is a 
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painstaking process and – tragically – matches are not available for 
all patients … we must not forget the lives that can be transformed 
by getting this right … It is an investment for today’s patients as 
well as those in the future.’ (All Party Parliamentary Group on Stem 
Cell Transplantation, 2012: 3) 
However, based upon the reflections from earlier in this chapter (particularly those of 
Anderson and MacKay (2014) who draw attention to the contingency of consensus in 
this field), a static list of recommendations prompts important questions. What use 
might the field have in a singular list of recommendations produced in 2010 when 
scientific consensus and medical practice has inevitably moved forward? Whilst 
these questions are amongst those that I explore more broadly in the following 
chapters, it is important at this stage to situate this study as one regarding the 
strategic management of the UK’s two public collections of UCB. Readers will note 
that I treat these two collections as if they are managed as one united inventory. This 
decision has been made mainly because their collection practices (explored later in 
the thesis) and much of their funding has been aligned since 2013 (Anthony Nolan 
and National Health Service Blood and Transplant, 2014) when this project began. 
Importantly, I have not undertaken a comparative study between the two separate 
collections here, which would have required a different approach. Rather, it is a 
study of how these two collections, working together, are managed strategically. 
Before I move on to explain how I collected data for this thesis, it would be useful to 
foreground how I have approached the project theoretically. Broadly speaking, as I 
lay out in the next chapter, the theoretical approach I undertake here is one that 
implicitly takes a critical stance at the notion of the umbilical cord blood collection 
as a “bank”, whilst more explicitly advocating an understanding of the UCB 
collections as managed through a more selective, ordered, considered approach that 
can be described as an archival sensibility. 
 
  
39 
 
Chapter Two: From Bank to Archive 
2.1 Introduction 
Out of the context provided in the first chapter, this second chapter offers a critical 
overview of the existing conceptualisation of umbilical cord blood collections as 
“banks”, dividing into public and private models of practice. Here, I introduce the 
readers to a number of STS scholars who have already been working in the area of 
UCB collection through the language of banking. Although this thesis is indebted to 
their scholarship, the first part of this chapter is interested in highlighting the 
shortcomings of ‘bank’ thinking as a means of understanding the past, present and 
futures of UCB collections. 
With this critical engagement as its foreground, the rest of the chapter sets the scene 
for a different way of understanding how these collections might be conceived. The 
understanding, which I adopt through the rest of the thesis, is based on the notion of 
the archive, a once easily-defined word that has transitioned more recently into a 
theoretical tool of protean capabilities. The chapter explains what I mean by the 
“archive”, offering examples of its previous use and critical exploration of the 
thoughts of scholars that span a diversity of disciplines. The chapter ends by plotting 
out how each of the remaining chapters of the thesis unfolds. 
2.2 The Bank Logic 
Much of the literature that already exists in the area of umbilical cord blood banking 
is concerned with the binary of public and private models of banking. For those who 
elect to bank privately, a growing number of enterprises offer the collection, banking 
and exclusive use of units. Customers pay from £1500 to £3000. Perhaps 
unsurprisingly, critical attention has been drawn to the private UCB banking 
enterprise, not least the use of a health insurance rhetoric (Appleby-Arnold, 2012) 
which is perhaps not dissimilar from the radiation-personnel autologous banks that 
Mannick and colleagues were imagining in 1960. What distinguishes the imagined 
autologous marrow banks of 1960s and the existing service of private umbilical cord 
blood banks is that Mannick’s banks had a specific use – personnel more likely to 
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need it, and chemotherapy patients anticipatorily banking their tissue for use on the 
‘other side’ of their treatment. In contrast, as Brown (2005) puts it, private UCB 
banks engender a ‘regime of hope’ because the enterprise produces its market by 
bringing attention to highly contingent, potential future outcomes so far not 
evidenced in either the clinic or the laboratory.  
More recently, this binary of public and private has been complicated. In practice, 
so-called ‘hybrid’ models (in which a private donation can also be made available on 
a public registry) have emerged. Public models, which follow the same logic of 
unremunerated donation and international accessibility as adult donor registries, are 
the main point of focus of this thesis. It has been suggested that public banks might 
offer a window of opportunity to ‘recreate the commons’ (Dickenson, 2007: 102) 
shifting attention away from for-profit private banking models, whilst umbilical cord 
blood technology has been seen to renegotiate the limits of the female body’s 
reproductivity (Waldby and Cooper, 2010) and engage these bodies in tissue 
economies that imbricate women’s bodily capacities for reproduction within broader 
institutional and national interests. In opposition to private banks, public banking has 
also been conceptualised as a ‘regime of truth’ (Martin et al., 2008), as such models 
do not capitalise on future-based contingent claims, but instead highlight currently 
used therapeutic options. Out of this context it is important to ask what ‘public’ 
might mean in practice. 
Significant flaws in private UCB collection procedures and possibilities belie the 
promissory marketing claims used by the sector. The promise, for instance, that a 
child might utilise the stem cells that were banked when they were born should they 
later present leukaemia, ignores the possibility that leukaemic cells might reside 
within the initially banked stem cell unit (Kurtzberg et al., 2005). There are further 
concerns about the viability of privately banked units. Whilst publically banked units 
are tested to see whether there are sufficient stem cells within the retrieved tissue, 
privately banked cord blood is not generally subjected to the same testing. This 
results in all samples being stored, including those with insufficient stem cells to ever 
be used in the clinic (Sun et al., 2010). This has been a point of critique for private 
banks given that parents pay for a service that is, perhaps even at the point of 
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collection, redundant and never going to amount to a viable treatment option (Brown 
and Kraft, 2006).  
But although there might be less of a negative moral inflection, similar issues around 
redundancy have become apparent in public banking. Tissues collected in the early 
period of banking were saved because they met different (and generally less 
stringent) criteria, a point I pick up in some depth in the chapters that follow. In STS, 
the transience of standards and criteria (Berg and Timmermans, 2000) and the more 
and less pliable classificatory frameworks enrolled in standard-setting (Bowker and 
Star, 1999; Mackenzie et al., 2013) are central themes. The emergence of private 
banking, and its moral economy wherein the promise of technology is harnessed for 
capital accumulation, has perhaps taken attention away from how these standards 
play out in the public banking context, an issue I address in the chapters ahead.  
2.3 Leaving the Bank Behind 
I have already drawn attention to the use of the term ‘bank’ in describing a collection 
of umbilical cord blood units. Before Thomas and his colleagues proposed 
tentatively ‘the establishment of autologous marrow banks’ (Mannick et al., 1960: 
264) there was an established pattern of describing human tissue collections as banks 
(Swanson, 2014). Since then, “bank” appears to have become the accepted moniker 
but not without prompting lively debate. The use of the term has been particularly 
prominent in the collection of biological materials for research. The term biobanking, 
often enrolled to describe such practices, is used to ‘emphasize the ability to use 
biological materials for extraction of DNA and link it to other data about the person 
from whom the sample was taken’ (Ratto and Beaulieu, 2007: 177). For example UK 
Biobank is a government-funded institution which studies the relationship between 
genetics, environment, and disease development (see Busby and Martin, 2006). But 
as Alan Petersen notes, the invocation of the term bank does more than this. It draws 
particular attention to the notion that the information collected ‘will prove to be an 
‘investment’ or ‘asset’, benefiting individual ‘investors’ and the community as a 
whole’ (2005: 279). It is perhaps telling that, as Petersen goes on to note, the UK 
Biobank was initially called the UK Population Biomedical Collection and, as such, a 
conscious decision was made to rename it. Beyond the UCB bank, then, there has 
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been discussion about what the term “bank” does. But what might it do in the UCB 
context? 
A particularly vocal strand of discussion on this point emerged amongst bioethicists 
in response to an article authored by Hofmann, Solbakk and Holm (2006) where the 
authors argue that we need a more coherent understanding of ‘the prominent role that 
analogies play’ (2006: 49) in reference to UCB. The authors unpack what terms such 
as “waste” do in this context. This word has also received attention in the STS 
literature as a discursive means of positioning the non-donor as actively wasteful to 
the extent that to call UCB “waste” might be seen in itself as a moral injunction 
(Brown, 2013; Waldby and Cooper, 2010). Hofmann, Solbakk and Holm, however, 
spend less time thinking through the notion of “bank” itself. Thanks to an active 
forum feature in the American Journal of Bioethics, responses to the article were 
numerous and quickly took to unpacking what the analogy might be doing.  
Holland (2006), for example, notes that the term “banking” is suggestive of a ‘save 
for a rainy day’ ethos whilst López’s response cites a French Committee Consultatif 
National d’Ethique (CCNE) report on the notion of the ‘biobank’ as an overemphasis 
of ‘the market and proprietary dimensions of the deposited biological material’ 
which the CCNE argued could be counterbalanced by the term ‘biolibrary’ (López, 
2006: 62). Another report that I would add to López’s interjection, with similar 
conclusions to the CCNE, came from Organisation of European Cancer Institutes, 
which proposed in the original Italian report to use the term ‘bio-teca’, a biological 
repository, which was felt to be more appropriate. The terminology of bank ‘recalls a 
lucrative scope,’ the report contends, whilst ‘the word ‘teca’ gives an idea of 
sacredness’ (Organisation of European Cancer Institutes, 2010: 1). 
Perhaps the most important response to Hofmann, Solbakk and Holm came from 
bioethicists in Australia. Their main point is not only salient, but helps to frame the 
approach I have taken with this thesis. They write that Hoffman, Solbakk and Holm’s 
piece neglected consideration of the types of storage that exist in reference to UCB 
banks. They argue that the traction and validity of metaphors in the umbilical cord 
blood context can be determined by the ethos behind the collection. From their 
position, different language befits a public collection wherein tissue is accessible by 
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anybody who should need it, than suits the act of retention for personal use through 
the use of a private storage provider. 
‘…storage of UCB within a public institution should be referred to 
as just that—storage—and not by the term banking, which should be 
used only in relation to private UCB storage as it implies an 
investment—the retention of tissue for one’s own benefit at some 
point in the future … The adoption of this language will allow 
researchers and readers alike to make a clear distinction as to the 
nature of UCB storage under discussion … Public and private banks 
are different in almost every respect and must therefore be examined 
using different language and different philosophical concepts.’ 
(Samuel et al., 2006: 58-59) 
Private banks and public banks are predicated on very different, though sometimes 
hybrid, logics that I have mapped out elsewhere (Brown and Williams, 2015) and as 
such I am inclined to agree with Samuel, Anken and Kerridge’s response. The 
language of ‘banks’ does not fit well with the public model. However I would argue 
that critiques like those I have set out above all coagulate around the problematic 
inflections of a term like bank. The bank suggests investment, perhaps even atomistic 
self-interest and asset management. In these arguments, ‘bank’ emphasises a 
particular ethos behind collection. To the extent that these critiques engage with the 
problematic omissions created by what the term ‘bank’ fails to capture, the concern 
is about the ethos behind collection. According to this particular bioethical discourse, 
‘bank’ conceals the gift relationship (Samuel et al., 2006), and does not confer the 
sacredness that befits human tissue (Organisation of European Cancer Institutes, 
2010). There is scope, therefore, to develop the foundations of this critique of bank 
language on the grounds that it is not just the abstract motivations of donors that is 
lost in this terminology. We have to ask, what practices, purposes and meanings 
might be concealed by what is framed by bioethicists as potentially limiting 
language? What language might help us to better unpack these elements? 
To capture the future-orientated practices of collection establishment and the 
variegated, dynamic practices of collection management, I offer a different 
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suggestion. That we can think of these collections as archives. Archive, as I will 
explore shortly, is a complex notion that (thanks to the work of a great many writers 
whom I will introduce) has emerged over the last two decades as a viable 
paradigmatic entity, a lens through which collections and their practices can be 
considered more comprehensively. It is out of the context that I have laid down in 
this chapter that I argue that the complexity enfolded into the practice of UCB 
banking today needs to be thought of as more than a collection of matter or data. 
These collections are inflected with a profession’s view of what constitutes 
requirement, representativeness and usefulness. They are not stagnant gatherings, but 
inherently temporal. They are informed by past technological innovation, present 
scientific consensus, and the manifold unknown demands of a future always on the 
precipice of becoming. 
2.4 The Archival Lens 
Umbilical cord blood collections, then, are almost always referred to as ‘banks’. In 
the last section, I laid out the arguments of bioethicists who highlight the various 
issues of such language, asking what practices and purposes might be obscured by 
such a notion. I also suggested that the heuristic paradigm of the ‘archive’ could be a 
useful way of understanding the publically-available collection of umbilical cord 
blood. In the rest of this chapter, I want to lay out what I mean by the archive-as-
paradigm approach. 
For many historians, writes Laura Ann Stoler, the archive is simply a collection of 
documents and the institution that keeps them. In the cultural theory domain, 
however, it becomes ‘a metaphoric invocation for any corpus of selective 
collections’ (2009: 45). In the chapters that follow, I use the archive as a kind of 
paradigmatic lens to bring to light features of the public UCB bank, a selective 
collection of biological matter. As Mike Featherstone argues, the “archive” can be 
thought of ‘as a paradigmatic entity as well as a concrete institution’ (2006: 596). In 
what follows, I plot out how the paradigmatic “archive” came to be understood as 
such through the work of Jacques Derrida, Michel Foucault, and a number of writers 
(professional archivists, anthropologists, historians, social and cultural theorists, and 
STS scholars) who have been influenced by these philosophers, particularly Derrida. 
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By doing this, I offer a kind of archival ‘anatomy’ upon which the rest of this thesis 
builds, highlighting avenues of exploration that I take up in the rest of the thesis. The 
chapter finishes with the exploratory starting points of the four empirical chapters 
that follow. 
I wrote a lot of this section of my thesis in a library just outside Stoke-on-Trent. To 
the left of the desk I am sat at today are shelves full of manila files, themselves full 
of manila envelopes, again full of something. I do not know what is in them because 
the files are numbered, and the numbers mean nothing to me without a reference 
guide. A lot of people will think of this scene when they think of an archive. They 
might even find the imagined scene a little uninspiring. That is, before becoming 
aware of the integral role played by filing stationery in the transformation of modern 
recording keeping and office management (see Yates, 1993). But, the revolutionary 
manila file notwithstanding, Verne Harris argues that the theoretical literature 
produced by professional archivists is ‘one of the dullest bodies of written work 
imaginable’ (2005: 141). However the 1990s, he contends, saw a shift, with the ‘the 
emergence of a new generation of archivists … willing to allow imagination space’ 
(ibid.) with several practising archivists publishing work with significant postmodern 
influence including Brien Brothman and Terry Cook. Their work, along with other 
contemporaries, features in this chapter and those that follow. Broadly, though, this 
chapter asks the reader to do what Harris advocates, and allow some imagination 
space. 
What, then, do I mean when I use the word archive? As I have said, Stoler notes that 
the archive for historians and the archive for cultural theorists are very different 
objects of analysis. The archive of cultural theory ‘is figurative, and leads elsewhere’ 
(2002: 94). The point here is that taken out of its traditional domain, the archive is 
heuristic, prompting questions about the various selective collections we might be 
interested in. A similar point is made by Thomas Osborne who asserts that the 
archive is useful because of its elasticity, that ‘it enables us to oscillate between 
literalism and idealism’ (1999: 51). STS scholar Geoffrey Bowker similarly 
describes this as folding the archive ‘into our set of actions in the present and in the 
built and shaped environment’ (2005: 21). 
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One can speak of archives as physical spaces, but they do not have to be visible, or 
even touchable. The archive can refer to ‘an ideal, or generalized, place’ (ibid.: 52). 
We might argue that the archive is therefore an ideal type of sorts, its heuristic 
qualities formed by the ‘synthesis of a great many diffuse, discrete, more or less 
present and occasionally absent concrete individual phenomena, which are arranged 
according to those one-sidedly emphasized viewpoints into a unified analytic 
construct’ (Weber, 1949: 90). The archival paradigm is thus a starting point through 
which a given area of research can come to be known in a particular way, by 
allowing certain questions to be asked. The archive itself is a kind of theoretical 
framework. 
Before moving towards this, though, a quick note on language is in order. In this 
chapter, there are many references to “the archive” and “the archival”, but 
throughout the chapters after it I have generally avoided doing this. In part, this is 
because I will be talking about particular collections of matter (umbilical cord blood 
collections) in a particular context (that is, the UK). As will become clear, though, I 
do suggest in a modest way that certain features I have located in my study context 
may have some (or a lot of) semblance to other similar collections around the world. 
In this current chapter, though, I – and the authors I have quoted here – employ “the 
archive” to propose features that are perhaps common across the diversity of archives 
that have been, are being, and may one day be, constructed. This lexical diversion 
hopefully gives the reader some sense of the direction of both this chapter and the 
thesis as a whole. 
2.5 How the Archive Has Been Used 
To understand the archive as a heuristic tool, I now turn to look at how others have 
used it. The elevation of the archive to a ‘new theoretical status, with enough cachet 
to warrant distinct billing, worthy of scrutiny on its own’ (Stoler, 2002: 92) tends to 
be pinpointed in the work of Foucault and Derrida whose writings have helped to 
form the landscape on which people are now thinking with the archive. In The 
Archaeology of Knowledge, Foucault employs a notion of the archive in which it is 
not an institution and cannot be ‘seen’. Instead, he uses it to describe all of those 
discursive practices through which statements are established as events and objects 
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(an act, a personage and so forth). Foucault develops this definition in reference to 
the idea that all discourse is based on the ‘already-said’ (1972: 27). His claim is that 
an object can only exist in reference to an externality of complex relations that allow 
it to appear with, be compared to, and situated against, other objects, and ‘be placed 
in a field of exteriority’ (1972: 50). He prefaces his point, noting that any book is, 
‘…beyond the title, the first lines, and the last full stop, beyond its 
internal configuration and its autonomous form … caught up in a 
system of references to other books, other texts, other sentences: it is 
a node within a network.’ (ibid.) 
It is thus in reference to the ‘archive’ – not simply a canon of literature, but of texts 
(in its literary theory valence, i.e. any object that might be ‘read’), and of sentences 
(language, syntax, grammar) – which encircles us and brings meaning to every 
enunciation that things are made meaningful. Foucault’s archive makes a case for 
thinking as much of context as text, of the ‘system of references’ in which an 
utterance occurs. This point, that the infrastructure brings meaning to its content, is 
broadly one that I take forward in the discussion that follows. But whilst Foucault’s 
work is often mentioned in reference to the archive, it is Jacques Derrida who has 
been more widely credited with, to borrow from Osborne, elasticising the archive.  
Derrida is considered ‘a key mover in what has been recognised by many as an 
archival turn in intellectual work’ (Harris, 2005: 131). This is due in large part to his 
lecture-turned-monograph, Archive Fever. The book has been formative to many 
explorations of the archive in different settings, from biodiversity databases 
(Waterton et al., 2013) to YouTube and Facebook (Beer, 2013). It is also quite 
foundational to the chapters that follow. Most of it, however, is not really about 
archives. Mainly, Archive Fever explores Jewish scholar Yerushalmi’s (1991) 
analysis of Freud’s Moses and Monotheism (1939). During the book, Derrida argues 
that Freud’s work is a platform on which we can begin to think of the mind’s 
requirement to archive. There are also a number of moments where we see Freud and 
the archive overlap in Derrida’s discussion. However, as Carolyn Steedman notes, 
the bulk of the book feels ‘curiously dislocated’ (1998: 66) from the Greek 
etymology of the word ‘archive’ that Derrida offers at the beginning of the 
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manuscript. He notes that the originary Greek term arkheion specifically denotes the 
domicile of the archons – the individuals in command, guarding the archive. The 
archive was initially found in the environment of those with a publically recognised 
authority and it was here that documents pertaining to, or perhaps of interest to, the 
polity were housed. As custodians of documentation, these first archivists ensured 
that documents were secured.  
Derrida having made these important steps, one of the most effective uses of the term 
“archive” beyond its traditional mainstay can be found in recent analyses of 
contemporary cultural consumption. This is particularly apparent in the theoretical 
ground work of Mike Featherstone who argues that culture can increasingly only be 
understood in terms of the archive (Featherstone, 2000, 2006) and Dave Beer, whose 
work (2013) puts Featherstone’s conceptual configuration into practice. It is worth 
briefly considering this scholarship because it elucidates how the archival paradigm 
can illuminate important facets of the researched subject, particularly around the 
themes of issues of political participation, organisational infrastructure, and 
selectivity that make frequent appearances in the following chapters. 
Featherstone builds on the work on Georg Simmel and Walter Benjamin to consider 
how theorists have looked at organisation and ordering in the wake of commodity 
capitalism’s ‘overload of cultural production’ (2000: 163). Beer takes up 
Featherstone’s suggestion that the paradigmatic archive would throw up ‘new 
agendas for sociology’ (Featherstone, 2000: 173) arguing in his monograph Popular 
Culture and New Media that ‘the history of cultural production and consumption can 
be seen as a history of archiving’ (Beer, 2013: 49). In particular, he argues that using 
the concept of archiving elucidates contemporary processes of organisation, 
structuring and ordering of (particularly) digital data. There is a value of thinking 
about selective accumulations of data, as Beer puts it, ‘in terms of archives and 
archiving’ because ‘it forces us to consider how they are organised, structured and 
ordered’ (2013: 49). 
In the archives Beer discusses, the amassing of digital content compels individual 
gatekeepers to archive data in personal archives. Importantly, Beer’s contemporary 
archives hold content produced by the people using it. Thus, they are ‘based upon 
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some form of participation’ (2013: 51). His concern is with how we understand this 
participatory landscape. Archives of this kind may be ‘infrastructures of 
participation’, but they must also be understood as ‘infrastructures of participative 
organisation’ (ibid.: 53). He explores this in reference to the act of “tagging” digital 
data, which highlights the role of users in the organisation, as well as consumption 
of, content. ‘It is not just the content that is open’ notes Beer, ‘but often also the 
classificatory system underpinning it’ (ibid.: 54). Beer’s point, however, is that the 
new archives, like the older archives, ‘are deeply political spaces that cannot be 
simplified with terms like decentralised, democratised or participatory’ (ibid.: 55). 
The normality of these archives in our lives means that political issues can be 
obscured and we may assume that they are empowering spaces. Beer cautions against 
this, noting that whilst they ‘might be less visible … it does not mean that these 
hierarchies and structural systems of power do not reside within them’. 
For Beer, then, we can see how assuming the archival lens opens up particular 
aggregations of data to questions of politics and propriety. Take, for example, Arjun 
Appadurai’s point that we are witnessing the archive becoming ‘gradually freed of 
the orbit of the state and its official networks’ (2003: 17). An important point raised 
by Beer is that these personal archives – such as Facebook – are often corporately 
owned. He is wary of rose-tinted visions of democratised space, echoing the concern 
evident in Featherstone’s aporetic question, ‘who will archive cultures in the future – 
the state, or the corporations, or the public?’ (2000: 167). As a heuristic, the archive 
lends itself to asking questions about inclusion and exclusion. In a given collection, 
who has access to use the archive? Who is included or represented in it?  
Another side of this point is illustrated by Featherstone’s argument that technological 
innovation allows massive data to be produced and consumed ‘at a rate that defies 
organization’ (2006: 595). A seemingly trivial example of popular culture 
consumption in late 2014 brings Featherstone’s 2006 suggestion into relief. User-
content video archive YouTube’s individual video view counter had been coded such 
that the largest view count that could be recorded was 2,147,483,647. As the 
popularity of South-Korean musician Psy’s record Gangnam Style pushed the video 
ever-further over the brink of two billion views, YouTube’s programmers then had to 
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recode the website’s view counter in anticipation of viewing numbers that the current 
organisational arrangement would not have allowed (Griggs, 2014).  
This has very obvious implications for particular interests given the commercial 
gains of measurably high video views and as such, the ‘new number should give viral 
video artists something to shoot for’ (Selcke, 2014). But more generally, this 
demonstrates that the archive’s infrastructure is at constant risk, to use Featherstone’s 
parlance, of being defied. Featherstone argues that the drive to archive ‘runs up 
against the speed and flexibility of the technologies which undermine stable 
classification and indexing’ (2006: 595). In this sense, the use of the archive as a 
means of understanding cultural consumption brings attention to the technologies on 
which the archive’s metrics, measurements and, ultimately, its order rests. 
Accordingly, this prompts us to ask how, when, and why those technologies may (or 
may not) fail and may (or may not) change? 
For Featherstone, there is another important element in the archive. That is, the 
amassing material of contemporary cultural practices presents us with a peculiar 
archival problem of ‘not what to put into the archive, but what one dare leave out’ 
(2000: 170). This question is an important one, because it highlights the ‘problem of 
selectivity’ (ibid.: 162) in the construction of archives where more and more of 
everything can potentially be archived. Featherstone’s piece considers the work of 
the Internet Archive which was, at the time, a new organisation confronting the 
‘daunting task’ of archiving the internet, ‘collecting public materials on the internet 
in order to construct a public library’ (ibid.: 178). Recent events speak to the political 
salience of these kinds of archives’ practices of selectivity, such as the MH17 
passenger flight shot down in July 2014 near Donetsk Oblast in Ukraine, during the 
ongoing Russia-Ukraine conflict. Somebody (importantly, an unknown person with 
unknown motives) captured a Ukrainian separatist fighter’s social media post soon 
before it was deleted and entered it, via the ‘Wayback Machine’ interface, into the 
Internet Archive. In the post, the author claimed that they had been party to shooting 
down the plane. As a digital archivist at the US Library Congress would later point 
out:  
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‘An important dimension of the smaller web archiving story is that 
the blog post didn’t make it into the Wayback Machine by the 
serendipity of Internet Archive’s web-wide crawlers; an unknown 
but apparently well-informed individual identified it as important 
and explicitly designated it for archiving.’ (Taylor, 2014) 
The issue of selectivity once the archive becomes an actuality, rather than a plan, is 
clearly apparent. Who, then, chooses what to save (and, what not to save), by what 
criteria, and to what ends?  
2.6 Towards an Archival Anatomy 
Representation, inclusion and exclusion become central features of analysis when the 
archive is used to explore cultural consumption. There are also important issues 
surrounding how selective collections are ordered – what their infrastructures look 
like, how they might be at risk of failure, or subject to change – that come to light. In 
addition, we are also prompted to think about the selectivity of the archive. What is 
permitted entrance? Of equal importance, why are certain things placed in the 
archive? These are issues that I want take up now more broadly. In what follows, I 
offer the archival anatomy that informs how I analyse the UK’s publically available 
collection of umbilical cord blood. In highlighting these different avenues of 
exploration I draw on a diverse selection of scholars who span the disciplines of 
cultural and social theory, anthropology, history, archival practice, science and 
technology studies (STS) and philosophy. The intention of doing so is to offer an 
intellectual context to the explorative starting points for the four empirical chapters 
that lie ahead. 
It is important to explore how archival material finds its way into the archive. Is it via 
the collusion of the viewer’s encoded eye and the reflexive knowledge that produces 
and surrounds that individual (Foucault, 1966: xxii)? Perhaps it is when the matter is 
viewed through a particular lens of cultural intelligibility which reifies particular 
assets of that matter with particular worth, power or sentiment (Butler, 1990). These 
are means of understanding the ‘multiple grammars of worth’ (Lamont, 2012: 9) 
brought to bear on the matter we interact with and witness. The vital point here, 
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regardless of the terminology we use to understand it, is that we recognise the 
importance of the archivist in locating worth in, and bringing meaning to, the matter 
they choose to place in the archive. For an archive to exist, one must select things to 
put into it.  
As Featherstone notes, ‘the archivist’s gaze depends on an aesthetics of perception, a 
discriminating gaze.’ It is through this gaze, he goes on to argue, that events are 
isolated ‘out of the mass of detail and accorded significance’ (2006: 594). Here, 
Featherstone is building on Osborne’s argument that the archive can be understood 
as a ‘centre of interpretation’ (1999: 52) wherein there is a ‘whole process of 
scrutiny, interpretation and, one is tempted to say … divination’ (ibid.: 58). The user 
must accord meaning to what is already in the archive, but the archivist must choose 
what goes into the archive first. Those managing the archive must therefore develop 
what Osborne calls ‘an aesthetic of perception’ that can isolate ‘significance out of a 
mass of detail’ (ibid.). 
As such, we begin to see that the ‘archive is never raw’ (Lynch, 1999: 69). It is 
selectively put together, its omissions and inclusions determining the pathway 
walked by future users. As Terry Cook reminds us, the users of archives are only 
able to access what is there, in the archive. They have no knowledge of ‘what 
archivists saw before the appraisal decisions were made to give researchers what 
they get’ (2001: 35). This is an important point that takes centrality in Lynch’s 
argument. He notes that the archive must not be understood as a space of rawness, or 
the home of the primary datum:  
‘…the prior consignation of documents to the archive limits what 
visitors can find in it, and in cases in which the archive is tightly 
constructed to enhance the reputation of an author or to cast an event 
in a way that supports a partisan cause, the archive can be said to 
embody an intentional design.’ (1999: 79) 
This point is echoed in Achille Mbembe’s consideration of the archive, where he 
argues that archives are ‘primarily the product of a judgement … which involves 
placing certain documents in an archive at the same time as others are discarded’ 
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(2002: 20). The archivist must select, must discriminate. Mbembe argues that, 
because matter in the archive must pass this test of selection, being in the archive is 
itself a status, a point that Derrida made similarly. Things in the ‘uncommon place’ 
of the archive are there ‘by virtue of a privileged topology’ (Derrida, 1996: 3, 
original italics). As Mbembe notes, in ‘any given cultural system, only some 
documents fulfil the criteria of “archivability”’ (2002: 19). If we take this point one 
step further, some documents necessarily must not fulfil those criteria. The 
selectivity of archiving, its intentional design, as Lynch called it, is taken up by Boris 
Groys. To decide that something should not be relevant, to not give it the privileged 
status of archivable, is to say that it ‘is unimportant, irrelevant and, so, should be left 
out’ (2003: 179). But what constitutes relevance? What grammars of worth, or lens 
of valuation, operates within the archive? What metrics or orders inform such 
decisions?  
We can also ask whether relevance is a stable quality. Does something always 
remain relevant? Obviously, relevance pertains to the context. A wooden spoon is 
relevant to baking, but would be of little relevance in this conceptual discussion 
(excepting my use of it here as an example). But context has a temporal dimension 
too. What is relevant today may not have relevance tomorrow. Therefore, no content 
has guaranteed permanence because archival status is contingent on the changing 
values to which the archive responds. Accordingly, archival matter ‘travels 
backwards and forwards … between rubbish, junk and sacred’ (Featherstone, 2000: 
593). It might be considered of worth at one point. It might transition into 
worthlessness at another. As Groys explains, importance is ‘usually defined as all 
that which is important for life, for history, for human beings. And things of such 
importance must necessarily be incorporated into the archive’ (2003: 179). Brouwer 
and Mulder argue that value is determined in how information can be used, or ‘its 
operationality’ (2003: 5). 
Not everything in the archive is being used in the present moment. Rather, most 
archival content waits for its time to be used at some point to come. As Elisabeth 
Kaplan puts it, those in charge of an archive ‘do what they do so that others ... now 
or in the distant future, can do what they do’ (2002: 217). Similarly, Appadurai 
argues that an archive’s design and intention are based upon ‘the uses we make of the 
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archive, not from the archive itself’ (2003: 14). The future is therefore an important 
element in how the archive is managed and even why it exists. Because of this 
centrality on potential use, the archive stands as ‘an irreducible experience of the 
future’ (Derrida, 1996: 68). It awaits the use of its material, and is designed to 
maximise the likelihood of this use, be it imminent or latent. As Hilary Jenkinson 
(the archivist widely credited with professionalising archival practice in England) 
explained in 1938, archiving is a career of service, ‘to make other people’s work 
possible, unknown people for the most part and working very possibly on lines 
equally unknown to [the archivist], some of them in the quite distant future and upon 
lines as yet unpredictable’ (cited in Evans, 1975: 153). Future, as Jenkinson made 
clear in the thirties, is a key facet of this discussion. How is the future anticipated, 
though? How is the archive managed in accordance with this anticipation? 
An added vector that we should keep in mind when talking about archives is that 
they can be a referent in how we think about ourselves and the world around us. 
Many archives form an important element of identity construction, be it of ourselves, 
the ‘other’, or perhaps the nation state. As Brien Brothman puts it, through archiving, 
people have ‘the power to generate and share meaning and to establish, amongst 
themselves, the identities of all things within the world’ (1999: 65). Derrida similarly 
notes that ‘[t]here is no political power without control of the archive, if not of 
memory’ (1996: 4). He argues that the level of a polity’s democratization can be 
measured by ‘the participating in and the access to the archive, its constitution, and 
its interpretation’. If groups are excluded from participating in what constitutes the 
archive – if they are not, as Joyce above suggests, ‘represented’, the archive is not as 
democratic as it can be. This is because, as Steedman puts it, in the archive, ‘a whole 
world, a social order, may be imagined by the recurrence of a name in a register, 
through a scrap of paper, or some other little piece of flotsam’ (1998: 76). What we 
see in the whole is not the whole of reality, but an aggregation of ‘disaggregated 
classifications that can at will be reassembled to take the form of facts about the 
world’ (Bowker, 2005: 17). 
If we are to believe Schwartz and Cook, that archives form ‘the basis for and 
validation of the stories we tell ourselves, the story-telling narratives that give 
cohesion and meaning to individuals, groups, and societies’ (2002: 13) then the 
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archive is necessarily a political space. This argument is similarly present in Stoler’s 
book Along the Archival Grain (2009), building upon ideas initially presented in an 
earlier paper (2002), where she contends that archives were directly involved in the 
‘emotional economy’ of colonialism, and a referent for the construction of identities 
of the imperial self and the colonised (and racialized) other: 
‘Managed hearts were critical to colonialism’s political grammar. 
Imperial projects called upon specific sentiments, and assessed racial 
membership, in part by locating appropriate carriers and recipients of 
those feelings… Colonial statecraft required the calibration of 
sympathies and attachments, managing different degrees of 
subjugation both among its agents and those colonized … Archival 
documents participate in this emotional economy.’ (2009: 40-41) 
Featherstone seems to agree, highlighting the multiplicity of historical purposes for 
archives. Archives, he argues, engender a ‘whole epistemological complex’ of 
information-gathering by a central administration to manage its imperial interests 
(2006: 591). Some archives had the capacity to assist in regulating domestic as well 
as colonial populations. As well as having a role in the global interests of Empire 
building, archives could also be seen as ‘a crucial site for national memory’, the safe 
place for storing the pivotal artefacts and writings used in the generation of social 
solidarity. In this way, argues Featherstone, archives could also be instruments with 
which national identity could be cultivated by housing the referents with which the 
imagined community could manifest itself (ibid.: 592).  
Building more explicitly on Benedict Anderson’s notion of imagined community 
(1983), Brown and Davis-Brown argue that modern, national archives can be 
understood as depositories of state history that, along with libraries and museums, 
‘help to preserve a collective national memory and thence to constitute a collective 
national identity’ (1998: 19). They argue that along with national curricula, 
publically displayed monuments, national ceremonies and even Olympic teams, 
archives are enrolled in the construction of ‘narratives of nationality’. We can push 
this a little further into the present from the modern archive of Brown and Davis-
Brown. Contemporary instances of collecting data and matter – which the later 
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chapters of this thesis explore ‘can be seen as a relatively straightforward progression 
from an imperial impulse to a desire to archive knowledge in the service of the state 
and Empire’ (Waterton, 2002: 178) in the sense that they engender a desire to 
produce useable aggregations of information for some kind of public or state service. 
As such, Osborne’s description of the archive as ever ‘oriented towards a space of 
public contestation, towards a never-ceasing politics’ (1999: 56) is surely true. Public 
archives have always bred a concern over the stories told, and the futures thereby 
made possible by the quiet, yet heavily mediated decision made about archival 
content. Why might some people be able to provide matter to the space, whilst others 
are denied? The beginning of the answer to this question, which is explored in more 
depth in later chapters, lies in Featherstone’s point that ‘the archive should be as 
exhaustive as possible’ (2006: 593). Archivists should consign to archives a diversity 
of matter, as if to make it ready for the unknown future. The archival process 
demands a level of selectivity as we have seen, but ‘the mandate for completeness’ 
obliges the archive to be composed under a rubric of ‘formal dissimilarity’ (Groys, 
2003: 182).  
Mbembe makes a similar argument, that through archives – an assembly of pieces 
that formulate a story – are no more than ‘a montage of fragments [that] creates an 
illusion of totality and continuity’ (Mbembe, 2002: 21). This is perhaps what Derrida 
argues, in his suggestion that those working in the archive aim ‘to coordinate a single 
corpus, in a system or a synchrony in which all the elements articulate the unity of an 
ideal configuration’ (1996: 3). The point he works towards here is that this ideal 
configuration comes at a cost. The gathering together of ‘the figure of a totalizing 
assemblage … is never without violence’ (ibid.). This is the violence of exclusion. 
Therefore the archive, because it is a composite of selected things, is necessarily 
exclusionary. The US National Archive demonstrates this. They state, for example, 
that ‘[o]f all documents and materials created in the course of business conducted by 
the United States Federal government, only 1%-3% are so important for legal or 
historical reasons that they are kept by us forever’ (National Archives, 2015). 
Meanwhile, as Groys writes, ‘unimportant, irrelevant, worthless things remain in the 
profane realm, beyond the archive’ (2003: 179). The many irrelevant 
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correspondences are lost from the totality of the archive, excluded through the 
implicit political violence of selection.  
By way of Derrida, Bowker argues that this is what constitutes the archive as a 
jussive space that permits certain things to be remembered and commits certain other 
things to the oblivion of forgetting. This, as Bowker puts it, is the ‘exclusionary 
principle’ of the archive (2005: 12). Given the importance of the archive in the 
construction of identities, it is perhaps unsurprising that we see archives designed to 
address this exclusion of material from other archives (see, for example, Nestle, 
1998). Archives are inherently exclusionary spaces, but they can be harnessed to 
address that exclusion. The focus of an archive can be adapted to ensure a re-
weighting of its contents, but it can never include everything. What, then, is 
excluded? What are the implications of this? How is exclusion challenged, and what 
new exclusions emerge in the process? 
In this context, it is worth noting that race is often involved in how the archive is 
ordered and constituted. Stoler (2009), for example, discusses how it was through 
colonial archives that the otherness of non-whiteness was (re)affirmed. The 
bureaucratic technologies that begat the collation of data on ever-larger scales, 
argues Ian Hacking (2005) ran parallel to the imperial projects that reified racialised 
difference. The exclusive presence of racialised bodies in colonial registers through 
to their over-representation in police DNA databases (Skinner, 2013) speaks to the 
resonance of race in the archival setting. As a primary social category in the world, it 
is hardly surprising that it slips so easily in the ordering of archives. But there is, as 
Bowker suggests, another dimension to the presence of the exotic or the other, which 
I consciously group with the ‘ethnic minority’ that so often constitutes our archives. 
He argues that there is something about the mundanity behind the Western drive to 
aggregate information that makes it unattractive in the archive. There is, he suggests, 
the perception of… 
‘…a great divide between our knowledge, which is timeless and 
without a past trajectory (it is always already there) and other folks’ 
knowing, which is tied oh-so-closely to their environment and their 
traditions. We need to preserve their memories and their diversity 
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precisely because we are the ethnos without memory: particularity is 
always already other.’ (Bowker, 2005: 225) 
In the case of the selective collection explored in this thesis race is also central, as 
might have been assumed by its thematic prevalence in the last chapter. It is therefore 
an interesting point of exploration to think about how the archive can operate in 
relation to race. How are decisions of inclusion shaped around race? How is the 
archive’s order informed by race? 
This speaks to an important point that merits its own exploration here. Order is at the 
heart of the archive. Classificatory systems, argues Beer, ‘order the content, make it 
retrievable and searchable, place it, categorise it, and give it meaning’ (2013: 41). It 
is through naming, and classifying, that ‘we bring order to chaos. We tame the 
wilderness, place everything in boxes’ (Duff and Harris, 2002: 282). Accordingly, 
where there is something deemed unworthy of the archive, there is a framework that 
must at some point have excluded that something. Archives, then, rely on criteria of 
classification, ‘grids of specification’ (Foucault, 1972: 46). As Derrida puts it, there 
can ‘be no archiving without titles … without names … without criteria of 
classification and of hierarchization, without order’ (1996: 40). 
Importantly, though, the technical structure of an archive is the overriding 
determinant of what can go in it. Derrida ponders, in an example of the two 
overlapping concerns of his work Archive Fever (Freud, and the protean notion of 
“the archive”), what the psychoanalytic archive (see Appadurai, 1996; Marcus, 
1998)2 would have looked like if Freud and his contemporaries had used computers, 
                                                 
2 Marcus notes that those working in an academic discipline can view the literary corpus of 
their discipline as an archive, suggesting that anthropologists all produce ‘personal 
ethnographic archives’ due to the accumulation of material from the field. An anthropologist 
himself, he notes that each of his colleagues in one way or another ‘is an archivist of his or 
her own career’ (1998: 53). Appadurai’s introduction to Modernity at Large (1996) similarly 
makes continual reference to the anthropological corpus as an archive, whilst a similar point 
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teleconferencing and email instead of letter writing. The ‘geo-techno-logical shocks’ 
of these novel communication forms would, he contends, have altered 
psychoanalysis unrecognisably.3 More broadly, he notes that archives are not simply: 
 ‘…the place for stocking and for conserving an archivable content 
of the past which would exist in any case, … the technical structure 
of the archiving archive also determines the structure of the 
archivable content even in its very coming into existence and in its 
relationship to the future. The archivization produces as much as it 
records the event.’ (1996: 16-17) 
Here, Derrida is arguing that the archive is not some passive container that holds 
whatever people at the time think is worth retaining. The archive is a product of 
technological context as much as the archived content. Derrida’s point here is vital. 
Conceivably, anything might be archived if the technological conditions facilitate 
and merit it. Accordingly, archival strategies and methods ‘over the past centuries, 
and from here on into future centuries’ are ‘constantly evolving, ever mutating, 
continually adapting’. Cook explains that this is because of the often radical changes 
not only in small institutional shifts, but ‘the wider cultural, legal, technological, 
social, and philosophical trends in society’ (1997: 20). Similarly, Bowker notes that 
every novel medium ‘imprints its own special flavor to the memories of that epoch’ 
(2005: 26). The medium thus produces a qualitative change in the archive. The 
                                                                                                                                          
is made by Foucault in The Archaeology of Knowledge in the chapter ‘The Unities of 
Discourse’ where he unpicks the notion of an author’s œuvre, to wit, self-referential archive. 
3 It is also worth qualifying Derrida’s remarks in the light of Joanne Yates’ monograph on 
the transition into modern bureaucratic practice in American business. Given the 
‘weaknesses of the pen’ (1993: 36), the emergence of the typewriter ‘transformed the 
production and use of documents’ (ibid.: 44). It is therefore very likely that a typewriter 
would have produced a geo-techno-logical shock all of its own for the early psychoanalysts 
even without the advent of email. 
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identity of the record is produced by way being stored in, saved on, and recorded via, 
the given medium. 
Instability, it has been argued by Cook and co-author Schwartz, is an inevitability of 
any endeavour of record keeping, which is a pursuit facilitated by technology and 
‘moulded by organization culture’ (Schwartz and Cook, 2002: 13). Elsewhere, the 
same authors argue that the nature of archives themselves – spaces that require 
content that necessitate subjective, interpretative knowledge – impose seemingly 
rational, stable systems of record management that are ‘inherently chaotic’ (Cook 
and Schwartz, 2002: 176). They argue that novel technologies or discoveries (indeed, 
we might include any kind of change) can be the catalyst of disassembly for entire 
archival strategies and methodologies.  
It becomes apparent, then, that what Brothman calls an ‘Edenic order’ in a piece in 
which he imagines the archive as a tended garden with a particular ‘archival ecology’ 
(1991: 80) is not a naturally occurring thing. Records do not have, he argues, a 
natural place in the archive. It is instead an ‘imposed socio-historical order’ (ibid.: 
85). It makes sense to look at STS scholarship on classification and ordering at this 
point, particularly that of Geoffrey Bowker and Susan Leigh Star. The basic point 
made by the authors is that there is much to be learnt from infrastructures. By 
performing what they authors call an ‘infrastructural inversion’ (Bowker and Star, 
1999), it is possible to ‘unearth the dramas inherent in system design creating, to 
restore narrative to what appears to be dead lists’ (Star, 1999: 377). We might, then, 
spend time looking at the ‘practices that make up [an archive’s] unspoken order, its 
rubrics of organisation, its rules of placement and reference’ (Stoler, 2002: 94). How 
are those orders developed, and do they ever change? If so, how and why?  
As Bowker notes, ‘any information infrastructure … aims by its nature to contain all 
and only the information that is needed’ (1997: 126). But there is, Bowker adds 
elsewhere, ‘no foretelling what information will be relevant’ (Bowker and Star, 
1999: 116). Any and all information could be useful, but one cannot know until it 
starts being used. As he puts it, ‘you won’t know what makes a difference until you 
have built up a body of knowledge that relies, for its units of data, on the 
classification scheme that you have not yet developed’ (Bowker, 1997: 131). This is 
61 
 
because, as Waterton reminds us, knowledge itself is ‘chronically performative, 
contingent, and emergent, interacting with a world which itself is in an eternal 
process of becoming’ (2010: 654) which speaks to Bowker’s claim some years 
earlier that, in light of this quality, ‘naming mechanisms tend to break down’ (2000: 
654) in archives. To the extent that a classification system and the matter that fits 
within it can be open to determinations of outdatedness, irrelevance or insufficiency, 
an infrastructure (or, at least, those to be of future use) cannot be finished. Star 
argues that though infrastructural revisions may have been made speedier in the 
contemporary moment, the ‘heated, but invisible, discussions’ persist, their shapes 
and arenas simply having changed (2002: 111). Energised discussion about the form 
and operation of classifications within archival spaces has not disappeared with the 
advent of new technologies.  
For this reason, ‘a perfect archival system is a chimera’ (Bowker, 2000: 670). 
Classificatory systems are incredibly unstable, shifting with professional and 
technological preference. Archivists, we know, engage with material through 
evaluative lenses peculiar to the archival field of interest. But, given Bowker’s point, 
these lenses must be forever liable to tiny or, occasionally, seismic recalibration. In 
respect of this, Bearman argues that archivists might better think of themselves as 
managers of a ‘process that sets known benefits and current costs against future, 
long-term and unknown risks’ (2002: 326). Notions of order change, and so archives 
must be pliant with this. Archives must contend with the possibility that something 
within the archive may no longer be required. To maintain order is a big job, and it 
requires the identification and removal of things that ‘no longer “fit” within a 
preordained social/ archival order’ (Brothman, 1991: 81). Once such items are 
removed, they no longer enjoy the “status” of the archive (Mbembe, 2002).  
Order, then, ‘is constantly threatened with disruption’ (Brothman, 1991: 80). The 
borders of the archive (that which it will receive, and that which it refrains from 
collecting) and the classificatory frameworks used to manage the matter within those 
limits, are always potential ‘sites of disagreement’ (Beer, 2013: 43). Without the 
capacity for these conversations, though, ‘archival credibility will suffer … 
Irrelevance will loom’ (Cook and Schwartz, 2002: 179). With this in mind, 
obsolescence (a term that brings to life the temporal quality of irrelevance) is a risk 
62 
 
that cannot be effaced. However, it can be managed. What happens, then, when the 
archive becomes irrelevant, or when some of the matter within it loses applicability 
to future users? An important question emerging from this is how such risks are 
managed. 
Risk, of course, presents itself in myriad ways. Derrida argues that there is ‘no 
archive without outside’ (1996: 11). One cannot archive without consigning the 
archived thing to an external place which, by way of its exteriority and vulnerability, 
‘menaces with destruction’. Dramatically, he closes his idea by suggesting that the 
archive ‘always works, and a priori, against itself’ (ibid.: 12). He makes the point 
again in a paper some time later: 
‘You need the exteriority of the place in order to get something 
archived. Now, because of this exteriority, what is kept in the 
archive, of course can be erased, can be lost, and the very gesture 
which consists in keeping safe – in a safe, so to speak – is always, 
and from the beginning, threatened by the possibility of destruction.’ 
(2002: 42) 
Featherstone argues that discussions about the archive are usually interested in how it 
changes over a period of time, even though ‘the archive has a spatial history too’. In 
drawing attention to the spatiality of the archive, he describes how archives 
developed in one space could be transferred to another space, such that Haiti’s 
national archive resides in France. Archives can physically ‘be destroyed, stolen, 
purchased and relocated’ (2006: 592). It is worth keeping this in mind. Whilst 
Derrida is not referring to literally quaking earth when he said that deconstruction 
would cause the archive concept to be ‘shaken by an earthquake’ (1996: 5), archives 
dealing with physical material are, like the rest of the physical world, vulnerable to 
the world’s proclivities. Floods, fires and earthquakes could literally destroy the 
archive. To return to Derrida’s etymology from earlier in the chapter where he raised 
the issue of the archive as a guarded space, we can begin to ask questions about how 
the archive protects itself from such material risks as destruction. More broadly, we 
might combine these issues of risk (obsolescence, physical destruction) to ask how 
the archive can sustain itself, in light of the diverse risks it faces. 
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2.7 Blood in the Archive 
In the next chapter, chapter three, I explore the methods employed in the data 
collection and analysis, and reflect on the intertwined experience of producing a 
conceptual understanding alongside the production of empirical data. I treat this 
methodological exploration as a kind of audit of the different elements that occurred 
on the way to producing the thesis. Accordingly, I explain how I became familiar 
with the scientific underpinnings of umbilical cord blood, and how I initially orbited 
towards the All Party Parliamentary Group that acted as a useful means of locating 
the relevant participants who I went on to interview. In this chapter, then, I also 
explain why and how I undertook qualitative interviewing, and how I then analysed 
the data emerging from these encounters alongside the various documents – policy 
documents, reports, and so forth – that I also used as data. 
The fourth chapter, which is the first of four empirical chapters, adopts an archival 
lens to consider the empirical data in reference to the issues of order in the archive. I 
explain how the archive in question – the UK’s publically available collection of 
umbilical cord – is ordered along explicitly racialised lines. I explore here how the 
archival goal of representativeness is worked towards in this instance by encouraging 
stem cell donation from Black and minority ethnicity donors. One of the key 
elements of this chapter is thinking through how race is used to bring order, but is 
itself a chaotic classification that proves challenging to wrangle into a classificatory 
schema that makes sense universally. The actual use of ethnicity data by those who 
use the bank – practitioners – is minimal, as they instead rely on the molecular tool 
of Human Leukocyte Antigen (HLA) typing. 
Chapter five explores the archive as an exclusionary space, plotting out the dualism 
of public/private that has come to define projects of UCB collection. Public, as I 
touch upon in this chapter, implies particular communitarian sentiments of access to 
donation whilst in practice, the capacity to donate to this public archive has a variety 
of limits in terms of resources and geographies. This chapter, then, explores the 
tension between the moral admonishment of ‘waste’ avoidance through UCB 
donation and the privation of access to donation faced by so many in the UK. In 
addition to this it also explores the racialised differentiation of bodies through 
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encouragement of particular communities to help others from within the same group. 
How does the appeal to community spirit have the potential to invert itself such that 
people will donate only for particular recipients? 
The focus of the sixth chapter is around use in the archive. Here I am interested in 
exploring how the clinical standards that determine what stem cell source might be 
selected inform how the archive comes to be managed. An important caveat I 
highlight here is that use in the archive cannot be fully understood without 
comprehending how the archive comes to be used. For that reason, I explore the 
different registers of judgment (the rational and affective strata insofar as they can be 
divided) that bring the archive into play for clinicians. Here I focus on one feature of 
the umbilical cord blood stem cell unit – its Total Nucleated Cell (TNC) count – to 
highlight the responsive shifts in archival practice in accordance with user 
preferences. The chapter is concerned with how and why these archivists respond to 
their users’ preferences. 
The final empirical chapter, chapter seven, is broadly engaged with the various risks 
faced by the archive. Its first concern is the way in which archivists come to think of 
their collections as different ‘generations’, as if learning from previous iterations of 
practice. What, I explore, does this reveal about the archive as an inherently dynamic 
space? In addition to this, the chapter engages with what happens when users’ 
selection criteria and preferences shift. Matter stands to travel out of relevance, and 
the archive – without addressing this – faces the death knell of obsolescence. How is 
such risk dealt with? Risk, though, takes on other guises. What physical challenges 
does the archive come up against? How might we come to understand the industry’s 
concern with ‘resilience’ within an archival framework? Finally, how do archivists 
anticipate future challenges and absorb those within their strategic project of 
development? 
Finally, the concluding eighth chapter lays out the arguments made throughout 
preceding chapters. Rather than just a summary, the chapter draws out something of 
these critical threads to frame some of the key problematics that the thesis brings into 
relief. This chapter also offers an opportunity to reflect on the methodological and 
theoretical limitations of the doctoral research presented here. Finally, I use this last 
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chapter as an opportunity to put forward some future pathways of enquiry that can 
begin to address these limits and also build upon the critical offering provided in this 
thesis. 
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Chapter Three: Methodology 
3.1 Introduction 
In this chapter, I set out to explore the methods employed in collecting and 
considering the data I offer in the following chapters. In a way, the chapter acts as an 
account of the coiled relationship between the theoretical and empirical work in this 
thesis. Far from a linear process, data collection, analysis, and the production of a 
theoretical understanding were intertwined. This chapter, then, acts like an audit of 
the various tasks I undertook on my way to writing the thesis. 
I begin by explaining some of my early familiarisation with the scientific literature. I 
then explain my early interest in the All Party Parliamentary Group (APPG) on Stem 
Cell Transplantation, and the UK Stem Cell Strategic Forum (SCSF), which are 
names that appear fairly regularly in chapters to come. I describe my early intentions 
to observe APPG meetings, before introducing the body of policy documents I 
analysed. After this, I describe why I approached particular people for qualitative 
interviewing and how I undertook this part of my data collection. Here, I reflect on 
my own experience of developing fluency in expert knowledge. I also describe the 
ethical approval process and, in particular, the issue of maintaining participant 
anonymity in a field where many participants seemed to know one another.  
3.2 Before Data Collection 
In an effort to prepare myself for data collection (particularly to develop the 
beginnings of a literacy, if not fluency, in the scientific nomenclature of the field I 
had anticipated needing to know about), I undertook a review of the scientific 
literature that relates to UCB. I reflect later on in the chapter on the issue of 
developing this kind of expert fluency but it is worth explaining here how I benefited 
from this early exercise. Firstly, I read through the most widely-cited journal articles 
on umbilical cord blood stem cell storage and transplant in the leading journals of the 
field (‘Blood’, ‘Bone Marrow Transplantation’, ‘Transfusion’, ‘New England 
Journal of Medicine’). Reading these through gave me a sense of the shifting 
landscape of UCB storage and transplantation, and familiarised me with some of the 
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terms that I would later come across in data collection. At this stage, I also 
familiarised myself with undergraduate immunology material. This was useful not 
least because it allowed me to see how the field of immunology (and tissue 
transplantation science) conceptualises and visualises the theories it relies upon. 
Then, I undertook an internet search for UCB studies that made reference in some 
way to either the ‘race’ or ‘ethnicity’ of donor/recipients using key word searches.  
Ethnicity classifications usually appeared in tables of data and were generally only 
discussed beyond any tabulated appearance to specify statistical significance in the 
given research. Often ethnicity was not mentioned at all in this way and its presence 
in the table was unquestioned even though it often held no statistical significance in 
research findings, implicitly re-inscribing the ‘variable’ of ethnicity as a necessary, 
yet silent, point of data collection. I was interested here in how these categories 
shifted, unfolded, got reduced and magnified. A number of ethnicities might appear 
in one graph only to be reduced to a white/non-white binary in another (see, for 
example, Ballen et al., 2006). It interested me that race could be reduced like this, as 
I had understood race to have use only when used for specificity.  
These slippages, to refer back to Bliss’s (2011) term, were interesting, though, and 
highlighted for me the difficulty of pinning down durable classificatory frameworks. 
This issue came to the fore during data collection and analysis. An Australia-based 
study includes ‘Australian aboriginals’ and ‘pacific islanders’ (Samuel et al., 2007) 
in order to correlate with the Australian bureau of statistics, whilst these categories 
are unsurprisingly absent in other studies, where different specificities emerge. In a 
Singapore-based study, for instance, “Malay” and “Asian Indian” categories are used 
(Tang et al., 2007). It became apparent here that race categories had to have some 
local meaning, perhaps even had to fit into political classificatory frameworks like 
censuses, which themselves have an interesting locality and history (Hacking, 2005), 
to be useful. 
This exercise was invaluable in developing my methodological approach because it 
produced a more articulated awareness that race had use, but that it was a very 
difficult thing to classify consistently. To that extent, I also realised that I had to have 
some consistency myself. Through this exercise I decided a few things. Firstly, I 
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have chosen not to use the term ‘non-white’. To me, it infers a lack of ‘white’. It also 
positions the non-white identity around whiteness, a point that resonates with Dyer’s 
(1997) suggestion that white people are somehow free of colour, the point in 
reference to which all ‘othered’ bodies should be understood. I use terms like Asian, 
Black or minority ethnicity in this thesis to describe a group or a body racialised as 
such. I do this in the main because these are terms used by minority activist groups 
working in the field (see National BAME Transplant Alliance, 2012). They are 
imperfect terms as they do not fully capture the heterogeneity of the bodies that are 
minoritised by way of their racialisation (see St. Louis, 2005). But I want to 
understand why and how race is enrolled, and talking about race cannot be done 
without race (Warmington, 2009).  
As the famous post-racialist Gilroy noted in 1998, it is important to ask ‘what that 
trope “race” lodged in the body might mean in the age defined by … molecular 
biology’ (1998: 843). So too is it important, I think, to keep asking what this ‘trope’ 
might mean more broadly across contemporary scientific discourses related to human 
bodies and populations. But for the sake of consistency, I do not use the word ‘race’ 
a great deal in the thesis that follows. I use the word ‘ethnicity’, which I freely agree 
with Murji and Solomos is used here ‘as an inference of race’ (2005: 4). I hope 
though, that Carter and Dyson would appreciate that although I recognise their 
argument that the seemingly benign term ‘ethnicity’ might allow some to talk about 
‘race’ without having to actually say such a ‘disreputable’ word (2011: 966), they 
would recognise that I choose to use the word, whilst conscious of its variable 
meanings, for consistency and clarity. 
3.3 Observation and Documentary Analysis 
In this section, I consider the inclusion of particular data sources into my analysis. 
The first of these, and the most minor, are parliamentary meeting observation notes. 
In September 2013, I attended an APPG at the Houses of Parliament. Although this 
meeting was open to the public, I requested to the secretariat that my name and 
affiliation were published on the minutes. The APPG report has been an active space 
for political discussion about the establishment of HSC usage in the UK and its 
potential both for clinical, industry, and research purposes. The topic of the meeting I 
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attended was the needs of patients from ethnic minority backgrounds. I took 
observation notes in which I wrote down, with as much speed as possible, the 
relevant points of presentations and discussion. The determination of relevance of 
course represented my own positionality (Mulhall, 2003), but data collection by this 
means was cut short. One meeting was postponed at short notice, and because of the 
room size for the following two meetings, the APPG was closed to public audience. 
Another opportunity arose for observation, this time in Madrid. This occasion was of 
a different nature, and involved a visit to a public umbilical cord blood processing 
unit and bank. The access negotiated by the European Commission action, Bio-
objects, permitted access through the entire complex of the municipal blood centre, 
where regular donors give blood, and where an entire district of Spain’s blood 
supplies are stored in their separate components to retain their use for as long as 
possible. Behind all of this lay a much quieter laboratory, where a single man and 
two female operatives oversaw several freezers full of stem cells from Spanish 
donations of umbilical cord blood. This visit included a small group of STS scholars 
including myself and Nik Brown, with whom I have since co-authored an article 
exploring our observations here amongst other things (Brown and Williams, 2015). 
On this visit, I was able to collect a significant amount of visual data (some of which 
I offered as context in chapter one). During this trip, I spent time in industrial cold 
storage units, observed the careful work of scientists fractionating and measuring 
bloods, and processing UCB units ready for storage. It is important to note that 
whilst this visit took place abroad as part of a European network and so may not 
appear to have direct relevance, it was particularly useful in drawing my attention to 
the physical aspects of resilience engendered in the design and management of these 
spaces, not only in Spain and the UK but globally. This is a significant concern of 
chapter seven. 
As Ball (2011) notes, the unobtrusive nature of locating public domain literature 
makes them a particularly useful source of data. As will be seen in the chapters that 
follow, use is made of these different sources as I explore the data. They offer a 
peculiar insight into what the secretary found fitting to document, or what a presenter 
found the most useful way of visualising their point for an audience. Fortunately, 
minutes and presentations from the two APPG meetings that preceding my project, 
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the set from the meeting I attended, and the two that took place after this, were made 
available in the public domain on the APPG website for anybody with an interest. 
These documents were incorporated into data analysis (n=5). Where made publically 
available on the APPG website, I have also incorporated presentations into analysis 
which includes both PowerPoint presentations and verbatim scripts provided by 
speakers (n=16). Some interviewees were also APPG speakers, and I make this clear 
in the following chapters wherever I think it will be useful for the reader.  
Most bureaucratic institutions ‘are awash with … forms, memos, monthly, quarterly 
and annual reports, procedure manuals, spreadsheets and records, as well as policy 
and mission statements’ (Prior, 2011: 98). Accordingly, policy documents were also 
included in data analysis. This was, again, another means of unobtrusive data 
collection that permitted great insight into the rationales, aims, and rhetoric used by 
the various institutions I was interested in. Importantly, though, these data were not 
used to ‘supplement’ that collected from interviews as a means of validating them. 
Rather, the documents analysed as part of this project themselves formed a rich, 
invaluable source of readily available data that complement, rather than simply ‘prop 
up’, the other data appearing in the following chapters. Appendix C outlines those 
documents (n=12) included in the data analysis. Covering a wide range of sources, 
these are government policy documents, incident reports, and operation/classification 
guidelines. I came across these various documents at different points. Some were 
found well before interviews began, some were considered in response to the 
recommendation of interviewees. More still came to my attention during data 
analysis and were incorporated at this point.  
Along with this, I also included parliamentary discussion in my data analysis. The 
reason for this is because the establishment of the Stem Cell Strategic Forum was 
mandated in parliament by a government minister. A number of other MPs have also 
raised motions about UCB’s role alongside adult volunteer donation in parliament. 
Though all these individuals have all been involved in the APPG in some way, it was 
apposite that the parliamentary discussion itself be incorporated into data analysis 
because they demonstrate an official, transcribed documentation of the political 
emergence of the issue of umbilical cord blood in the UK. Using the online archive 
of the UK parliamentary record of what was said in parliament, Hansard, which 
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thematically indexes discussions in the House, I selected all instances of the 
discussion of UCB in parliament. The extracts (n=4) from Hansard include all 
statements, questions and answers made in reference to the initial speaker’s motion 
or bill. The first discussion of umbilical cord blood in the House is in 2008, and is 
followed by further instances in 2010 and 2011. Hansard extracts, downloaded 
verbatim from the Parliamentary publications website, include a first and a second 
reading of a bill regarding the donation of umbilical cord blood, and two motions 
regarding umbilical cord blood banking facilities in the UK. 
3.4 Why Qualitative Interviews? 
So far, I have described the foundational work I undertook in preparation to begin 
data collection. I have also outlined the various documents and materials included in 
data analysis. At this point, then, I want to consider the role of qualitative interviews 
in this study. It was recognised from the beginning of the project that I would need to 
speak to those involved in the production of policy. Talking to the individuals would 
allow me to complement my other data collection, not least because interviewing is 
an ‘interactive, situational and generative approach to the acquisition of data’ 
(Mason, cited in May, 2002: 225). Generativity points to something beyond the fact 
that interviews yield data. They also generate new pathways of exploration that 
analysis of documents alone cannot provide. Writing about their methodologies in 
studies on biotechnology regulation, Prainsack and Wahlberg (2013) note the same. 
Assuming there was no coherent order, they sought to move beyond the tailored 
policy documents to see the messiness behind the order. Qualitative interviews stand 
to shade in the tidy policy with the dominant voices, receded suggestions, the 
consensus (and lack thereof) that could have shifted an entire policy strategy in a 
different direction.  
Interviews, of course, will never ‘unearth the relevant data … because the 
phenomenon under research does not have a static decontextual … existence’ 
(Mason, cited in May, 2002: 227, original italics). But as a generative tool, the 
interview encounter stands to reveal complexity, enriching data analysis and key 
findings. To this end, much of the data in the chapters ahead were the product of a 
semi-structured approach to interviewing. This entailed the development of a brief 
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list of headings that were prepared in advance, and tailored to the participant’s 
position and access. In Appendix D, I provide a list of general themes and example 
questions related to these that are indicative of what interviewees were asked. This is 
by no means an exhaustive list. Questions were highly dependent on a participant’s 
previous responses and varied depending upon that own person’s involvement in the 
broader area. A briefer indicative list of thematic avenues for questioning is outlined 
below. 
Table 2: A list of thematic avenues for qualitative semi-structured interviews 
The individual 
participant's involvement 
in the APPG, SCSF, 
and/or the WMDA 
Particularities of the role 
of the APPG, SCSF, 
and/or the WMDA 
The collection and use of 
ethnicity data in the UK 
and internationally 
The development and 
current state of Total 
Nucleated Cell (TNC) 
count thresholds 
The development and 
current state of HLA 
typing resolution 
consensus 
The economic 
dimensions of UCB 
banking and clinical 
application 
Particularities of the role 
of the individual 
participant’s charity 
The individual 
participant's knowledge 
of UCB technology 
The consensus on a 
relationship between 
HLA and ethnicity 
The historical and current 
relationship between 
UCB and adult HSCs 
The recommendations of 
the Stem Cell Strategic 
Forum’s 2010 report 
Specific queries related to 
particular documents with 
which the individual 
participant has been 
involved in producing 
The clinical emergence 
and uptake of UCB 
The choice of UCB 
collection sites across the 
UK 
The role of private 
banking in the UK 
 
When undertaking interviews, I found that considering what themes to discuss in 
advance ensured that key bases of inquiry were touched upon in such a way that 
participants were still able to etch the conversational flow. Structure, then, was 
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useful. But too much structure in the interview would not lend itself to the 
‘sensitivity to context and particularity required’ (Mason, cited in May, 2002: 231) in 
this research setting. A more inflexible method such as the structured interview, 
usually invoked because of the researcher’s ‘need to standardize the way in which an 
interviewee is dealt with’ (Bryman, 2008: 437) would be at odds with this need for 
unanticipated avenues of exploration. Of course, though I had decided how I wanted 
to interview, deciding who to talk to would require its own consideration. 
3.5 Who is an Expert? 
In this section, I want to consider how I decided who to approach as a participant. I 
would, on reflection, call this one of those dilemmas of trying determine ‘expertise’, 
a debate that many STS and Science Studies scholars have engaged in (see Rip, 
2003). I describe here how I began by searching for the ‘core set’ of scientists 
involved before extending my search into the broader sphere of policy production to 
include those speaking or involved in chairing parliamentary meetings, those 
contributing to the key policy documents. Developed by Harry Collins (1981), the 
core set approach is a means of determining who to involve in the participant group 
in those communities involved in the production or use of generally emergent 
technological or scientific processes. The overarching determination of whether 
something can be considered a core set comes through considering whether the 
common interest of the ground is defined by controversy, disagreement, and potential 
upheaval. The core set, then, is that ‘small group of experienced and qualified 
persons who actively contribute to scientific debate’ (1988: 740). Controversial 
science, in Collins’ formulation, is an important element in determining the existence 
of a given core set. 
From its instantiation, umbilical cord blood has been involved in controversy. 
Significant concern has been raised about the claim that UCB donation is harmless 
for the woman and baby involved. This discussion tends to coalesce around the 
potential problematics of early clamping, particularly for neonates who may stand to 
benefit from late clamping of the umbilical cord, rather than the early clamping 
required to sequester stem cells for storage (American College of Obstetricians and 
Gynecologists, 2012). Consequently, this controversy stands to have an impact on 
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whether parents decide to store stem cells or delay clamping for other potential 
benefits for their own neonate (Brown, 2013).  
UCB also takes a place in those discussions about the morality of scientific 
interventions that use stem cells. As a potential point of political controversy, those 
working with cord stem cells have taken pains to ensure UCB stem cells’ definitional 
differentiation from controversy-ridden embryonic stem cells. In scientific research 
literature they described as having ‘embryonic characteristics’ (McGuckin et al., 
2005) or being ‘embryonic-like stem cells’ (Alvarez-Gonzalez et al., 2013). In New 
Scientist magazine, it was similarly asserted that UCB contained ‘“ethical” 
embryonic stem cells’ (Coghlan, 2005). This hints, perhaps, to ‘moral pathfinding’ in 
which ‘a number of negotiations and an amount of reconceptualisation work’ take 
place around potentially controversial, perceivably embryonic, tissue (Svendsen and 
Koch, 2008: 95). By way of explaining how the controversy was managed by 
interviewees, consider the quote below from one of the interview transcripts. 
There was this business of what was embryonic and what was 
adult? And of course, cord blood often gets mistaken as being 
embryonic and it isn’t. It’s adult stem cells. Well actually it isn’t 
either … the cells in cord blood are derived from foetal stem cells. 
… But it’s not embryos and the ethics and all the rest of it around 
that. And so it’s quite easy to see how people get confused. So, in 
terms of ethics, cord blood is adult stem cells.  
But public controversy – the ‘people’ who ‘get confused’ – is not the only kind of 
controversy that has come to define this domain. Some members of the ‘core set’, 
argues Collins, ‘will not necessarily interact frequently with one another, for some 
members may be enemies’ (1981: 8). A dramatic description perhaps, but it does ring 
true with some of the sentiments expressed by interviewees, such as in this quote 
from a participant. Here, they describe a conference attended by those involved in 
producing professional guidelines, including several people I interviewed: 
It was funny because it wasn’t a discussion. It was an argument, a 
total argument. About “it was better for the mortality, the TRM 
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[tissue-resident memory cell count]”, “it’s better if there is a 
mismatch.”… It was an argument between two different groups … 
fighting about what was wrong.  
As Collins notes, a core set can be determined by asking individual participants ‘who 
else they think has made a significant contribution to the debate’ (1981: 9). Frequent 
mention of important names signals inclusion in the core set, argues Collins. Not 
unlike the much more commonly found approach of snowball sampling, all 
interviewees were asked to recommend other people I might be able to speak to. 
Those I interviewed also occasionally mentioned other individuals during our 
discussions as in these examples, which are taken from transcriptions with 
participants. 
So xx would be your man because he has the criteria now that 
people use and he’ll be able to tell you exactly what different 
people are doing.  
Have you spoken to xx yet? ... I’ll send your email to him. He’s 
really spending his whole life now in building these models in 
costing and all that. 
However, the challenge here, as Collins and Evans have termed it, is one of 
‘extension’ (2002). The core set approach makes space for the possibility that it 
might have to make space for more than the few qualified scientists undertaking 
esoteric work. The core set should only include those who are ‘reasonably 
scientifically qualified and/or experienced’, but Collins explains himself here: 
‘This is only to say that on matters scientific … we prefer our 
technical opinions … to be formed by the outcome of debates among 
the wise (whether these outcomes turn out to be correct or not) rather 
than by the first impressions of John Doe or “the man on the 
Clapham omnibus”.’ (Collins, 1988: 740) 
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If indeed a fairly well defined group of scientists could be approached, was that 
enough? How far beyond that, if at all, might I extend? And in what direction? As 
Rip puts it, ‘the state-of-the-art (i.e. our knowledge) in a domain derives from the 
state-of-the-debate’ (2003: 374). My conviction from the start of this process was 
that I wanted to talk with those people involved in the discussion about the role of 
umbilical cord blood in the UK’s stem cell provision services. Though this included 
scientists, it did not end with them. As such, invites were extended to those who had 
been involved in APPGs and those who had contributed to particular policy 
documents. I use the word ‘contributed’ rather than ‘authored’ as in some cases, 
authorship was credited institutionally whilst all contributors are listed within the 
document. The policy documents I used were reports produced by the SCSF (UK 
Stem Cell Oversight Committee, 2015; UK Stem Cell Strategic Forum, 2010a, 
2010b) and the APPG (2012). 
For this study 28 potential participants were contacted via email which included an 
information sheet and informed consent form (see appendix). In total, 18 were 
interviewed. Of the ten who were not, two felt that their expertise was not relevant to 
the research because they had moved away from working in the area of umbilical 
cord blood. One told me they were too busy to meet with me (although I did clarify 
that I was able to visit them at any time over the months I was collecting data). One 
had retired and no longer felt they were in the position to talk to me, one had moved 
into a different role and helped to organise a meeting with the colleague who had 
taken over their job. One email address had become inactive presumably because 
they had left the institution, and a search for their replacement was fruitless. Three 
were entirely unresponsive to emails, and one agreed to a telephone interview but 
eventually became unresponsive, presumably because other commitments had taken 
precedence.  
Data saturation, of course, is never an easy thing to determine (Francis et al., 2009). 
As Collins notes, the core set’s ‘exact membership is not a thing to be agonized over’ 
(1981: 9). However, participants (unaware of who I had already interviewed) started 
to recommend those who I had already approached. As such, by the end of data 
collection all of those recommended to me (and who I then checked were 
appropriately involved in the study context) had been approached. Along with this, 
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there was also the issue of relevance. Was it worth ‘swelling the numbers’ to ensure 
validity, or would validity have suffered? Should I have invited those who were not 
suggested to me, or who were perhaps ‘less’ involved in the field? The answer to this 
question, I decided, was no. This was particularly apparent when I began to analyse 
interviews and found the data thematically rich and conceptually fertile. I expand on 
the process of data analysis shortly, but it is worth firstly giving some detail about 
the interview data I collected for this project. 
3.6 The Participants in This Study 
To contact participants, email addresses were found through an internet search. I also 
arranged meetings at the APPG, and at the annual conference of the World Marrow 
Donor Association (WMDA) in London where I met with two participants. A 
standard template explaining the project and tailored to their particular involvement 
was emailed to them all individually, and was sent out to a few participants at a time. 
As most of these individuals were based in London, I had hoped for practical 
purposes to combine as many interviews into each visit as possible. Inevitably, 
practicality was not on my side and I was soon quite familiar with the National Rail 
advance train booking process. Indeed, on one occasion I was halfway down to 
London when I received an email from the participant telling me they could were ill 
and could not meet. Interviews took place between October 2013 and November 
2014.  
The table below presents information about those who were interviewed. In total, I 
undertook 21 interviews with 18 participants. Some interviews (n=4) were done over 
the telephone, and in 2 of these cases I followed up the telephone interview with a 
further face-to-face interview as phone interviews tended to be shorter (~40 minutes) 
whilst the average face-to-face interview lasted around an hour and a half. In one of 
the cases, the telephone conversation was a ‘follow up’ after undertaking some initial 
data analysis as I outline later in the chapter. In the column below where I describe 
their relevance to the study, I refer to their membership to different groups or forums. 
These are the UK Stem Cell Strategic Forum (SCSF), the All-Party Parliamentary 
Group on Stem Cell Transplantation (APPG), the World Marrow Donor Association 
(WMDA), the Cord Blood Working Group of the British Society of Blood and 
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Marrow Transplantation (BSBMT) and NetCord, an international cord blood bank 
accreditation and advisory group. 
Table 3: A list of individual participants interviewed for this study 
Means of 
communication 
for interview 
Participant’s 
anonymised 
identifier 
The participant’s relevance to this 
study 
In person Participant 1 
Involved in APPG, SCSF and BSMBT 
Cord Blood Working Group 
In person 
Participant 2 Involved in APPG 
By telephone 
By telephone 
Participant 3 Involved in APPG 
In person 
In person Participant 4 Involved in APPG and SCSF 
In person Participant 5 
Involved in APPG, SCSF and BSMBT 
Cord Blood Working Group 
In person Participant 6 
Involved in BSBMT Cord Blood 
Working Group and WMDA 
By telephone 
Participant 7 
Co-author of recommendations for 
international best practice; also involved 
in SCSF In person 
In person Participant 8 
Involved in APPG, SCSF, BSBMT Cord 
Blood Working Group and WMDA 
In person Participant 9 
Co-author of recommendations for 
international best practice;  also involved 
in NetCord and WMDA 
In person Participant 10 Involved in APPG and SCSF 
In person Participant 11 Involved in APPG 
In person Participant 12 Involved in APPG 
In person Participant 13 Involved in APPG and SCSF 
In person Participant 14 Involved in APPG 
In person Participant 15 Involved in APPG 
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In person Participant 16 
Co-author of recommendations for 
international best practice; also involved 
in NetCord, SCSF, and WMDA 
In person Participant 17 Involved in WMDA 
By telephone Participant 18 Involved in APPG and SCSF 
 
During the course of interviewing participants, I came across an issue that I had – to 
an extent – anticipated. This was the development of fluency in expert knowledge, 
which others have tackled by assuming the role of a status subordinate (Delaney, 
2007) who can essentially perform a lack of knowledge that prompts elongated 
answers from participants. Elsewhere, this has been described as the exploitation of 
outsider status (Herod, 1999), or playing the role of unthreatening supplicant 
(Desmond, 2004). As Morris (2009) notes, these methods permit deception and 
manipulation in the interview encounter. Before I began interviews, I had – as I have 
outlined above – spent a considerable amount of time familiarising myself with the 
scientific literature. I studied undergraduate texts on basic immunology, and learnt a 
great deal from the initial science literature review. These were revealing exercises in 
that they familiarised me with concepts, methods and measures commonly employed 
during collecting, processing, measuring and freezing UCB. Nonetheless, terms came 
up during interviews that I had not come across. For example, a participant said 
GIAS (pronounced guy-uss) several times during our discussion. They felt it relevant 
enough to say it, so I asked them what GIAS stood for.  
Graft Identification Advisory Service … the hospital will send us 
the [patient] details and we will then make the decision on who 
[which volunteer donor] to do the extended typing on… and as 
much as telling you who it’s good to tissue type, it will also tell you 
who you should definitely not further type because they’ll say “this 
person, no they’re not going to be nearly what we want” … So it’s 
really good. It helps to unlock the part of our register that, 
beforehand, was locked basically … it means that we can reduce 
the number of people that people have to do confirmatory typing 
on which will … hopefully speed up transplant as well. 
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This clarification uncovered something vital. The above quote illustrates the idea that 
older data could somehow be ‘locked’. In this case, tissue typed in the past at a lower 
resolution of molecular specificity must now undergo ‘confirmatory typing’. It was 
only through asking for clarification that a thread that runs through the final 
empirical chapter, obsolescence, really started to come alive in my mind as an 
important point in the practice of storing and registering HSCs. 
In Welch et al.’s discussion of interviewing those in senior positions in business, 
they advocate knowing abbreviations (2002: 624). This point resonates with my own 
experience. When working with scientists and those who come into contact with the 
scientific language they use, it was effective to practice what I have started to call 
acronym awareness. I mean this on two levels. Firstly, acronym awareness can be 
thought of as the preparation of knowing terms, abbreviations and basic ideas 
beforehand so the interview’s flow is less frequently hindered by requests for 
clarification. It has been argued that preparation can ‘establish trust with the 
interviewees’ (Mikecz, 2012: 487). Perhaps it also allows for interaction that can 
only take place when the interlocutors are talking in the same “language”. Secondly, 
it advocates alertness for acronyms and abbreviations. If I did not know one, it was 
worth finding out what it stood for. Put simply, terms are not abbreviated unless they 
are being used a lot. If somebody abbreviates a term, it must be in fairly frequent use 
and therefore have some relevance to the day-to-day practices I am interested in. 
Considering this diverse assembly of data sources, I would suggest that the project 
rests on what Prainsack and Wahlberg call an ethnographic sensibility. Not an 
ethnography, but not reliant only on interviews or on policy documentation, I have 
tried to move past analysis only of ‘tailored narratives found in policy documents and 
policy-makers’ accounts,’ instead paying attention ‘to the practices and narratives 
“on the ground”’ (Prainsack and Wahlberg, 2013: 340). In their respective studies of 
Israeli stem cells and Vietnamese complementary medicine, the authors collected 
data by a variety of methods. 
‘Spending time in our respective countries of study, interviewing 
experts, being in laboratories, gathering and analysing policy papers, 
discussions from e-mail lists, and other relevant documents, 
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speaking to lay persons, ‘hanging out’, and reading newspapers was 
what brought insight…’ (ibid.: 341) 
In this thesis, I have sought data through an array of methods to bring insight to a 
system that, on reflection, I would argue cannot be appreciated without some attempt 
to ‘broaden methodological scope’ (ibid.) beyond a single approach. As I have 
described here, I undertook qualitative interviews, analysis of a diversity of 
documents, meeting observation, spending time in a UCB and blood processing unit, 
and following published updates in clinical and scientific consensus. Data and 
reflections from all of these sources appear in the empirical chapters that follow the 
current one, offering what is intended to be a rich and dynamic exposition of the 
complexity that underwrites the context of interest here. 
3.7 Ethical Considerations 
In light of the data collection methods I decided to use for this study it was necessary 
to secure ethical approval from the ELMPS (Economics, Law, Management, Politics 
and Sociology) sub-committee of the University of York’s Ethics Committee. In 
application for approval, I laid out the rationale behind, and good practice for, data 
collection. I explained, for example, how I would undertake observations at APPG 
meetings (which, as I explained above, became less integral as a data collection point 
as the research progressed). To do this ethically, I would notify the secretariat that I 
was attending and ask them to ensure that my name and affiliation were written 
down in minutes. Because of my decision to focus on the production of policy and 
not look specifically at the treatment of NHS patients, I did not require NHS ethics 
approval. Similarly, my research did not set out to explore work undertaken by NHS-
employed staff members in the course of contracted employment duties. 
Accordingly, NHS research and development approval was not required. 
I outlined my approach to qualitative interviewing which centred mainly on the issue 
of anonymity. Anonymity has been termed the operationalisation of research 
confidentiality  and is a central facet in the production of social research (Wiles et 
al., 2008). One of the largest challenges I had anticipated in this study was 
maintaining confidentiality of participants both during, as well as after, my data 
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collection. As Collins notes of many involved in a core set, individuals are ‘linked 
biographically and occasionally bibliographically’ (1974: 171). In short, they often 
know one another. Those involved in policy discussion, scientifically trained or 
experienced in the field outside of the laboratory (for example, charity leaders who 
were au fait with the science though not themselves ‘scientists’) did tend to know 
one another, having met many times before. Collins’ point resonates with my own 
experience, as people I had already spoken to would be suggested by others as 
potential participants. Here I was faced with a decision. On the one hand, I could 
reveal one participant’s identity to another. On the other, I could prevaricate, jot 
down the suggested name and feign an intention to pursue it further. I found the 
second option to be the only choice.  
In this context it is perhaps unsurprising that one of the biggest decisions made in 
writing this thesis was made to maintain the anonymity of participants. I am talking 
here about the omission of information about their locality, their gender and – as best 
as possible – the specificities of their role beyond their involvement and membership 
in the groups that have come to constitute this core set. Consider this hypothetical 
participant who exemplifies the plurality of interests, expertise and capacities that 
defined my various participants.  
A trained immunologist who used to work in an adult donor 
registry in Europe but who now works for a UK-based charity 
encouraging cord blood donation in the Jewish community. 
This would probably be a recognisable descriptor to the rest of the core set. As such, 
I offer biographical or professional context beyond core set affiliations at junctures in 
the chapters that follow. But I only do so when I feel it enriches data analysis. 
Though every effort has been taken to anonymise these individuals who have kindly 
offered their time to be involved in the study, all were provided with the information 
sheet and signed informed consent forms to confirm their recognition of the potential 
that, even after this anonymisation, there was still the possibility of identification. 
Being explicit about the issue and thus allowing the participant to decide if they still 
wished to take part was, as the Research Ethics Committee agreed, the only option 
available for this research with the core set. 
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3.8 Data Analysis and Theoretical Framework 
I transcribed all the audio recordings of interviews myself using transcription 
software made available by the University of York. I did so as a means of 
familiarising myself with the collected data ahead of analysis (Bird, 2005). I 
undertook each transcription once I had finished the interview and had returned to 
my office. I then listened to the audio and read the transcribed document 
simultaneously so as to ensure consistency between the two sources and remove 
errors. I selected to transcribe all audio data verbatim, and removed conversational 
pauses and fillers. I did this to maximise clarity of the transcribed data, both for me 
during analysis and for the reader in the upcoming chapters. It is also worth noting 
that in the data used in the following chapters, there are often recollections of 
conversations. This is particularly so when I ask participants to reflect on the 
production of a particular policy document or a discussion in a particular meeting. Of 
course, ‘accounts of accounts’ and ‘versions of versions’ are a quotidian feature of 
everyday life (Potter and Wetherell, 1987: 4). As such, I use grammatical 
conventions to clarify where the interviewee is referring to somebody else’s speech 
or a statement they made in the past in their own account in the present. 
To analyse the data, I used the QSR NVivo qualitative data software package and 
‘coded’ all interview transcripts, policy documents, APPG minutes and observation 
notes, and Hansard excerpts. I grouped relevant portions of data into ‘nodes’ which 
represented various themes. I did this without a pre-existing thematic schema, 
permitting the data to ‘speak for itself’ given the semi-structured nature of interviews 
to allow expansion into new conversational terrain, and the broad array of data 
sources. It is worth noting, though, that I did not depart on theoretical analysis from 
the purely inductive starting point of grounded theory. Rather, by the time that this 
phase of research began I had already started thinking about the economic and 
geographic tensions within the field of research which I explore elsewhere 
(Williams, 2015). My analysis was also inflected by the historical context that I lay 
out in chapter one. Along with this, my awareness for the enrolment of ethnicity in 
this context also played a role in selecting what I found to be ‘node-worthy’ in the 
initial analysis stage. 
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Figure 4: Bryman's steps of qualitative research projects 
 
Although I had already become familiar with the key policy documents from the 
SCSF and the APPG, I began data analysis after I had undertaken 10 interviews. This 
is because during transcription, which is one of the first interpretative interactions 
with interview data (Bird, 2005), I had started to notice emerging issues of selectivity 
in collecting umbilical cord blood tissue, and in deciding what best to include in 
UCB collections. In analysing these first interviews and the bulk of the other 
documents listed above, I was making an attempt to engage with the data in a 
recursive manner as demonstrated in the image above, which I have recreated based 
upon Bryman’s (2008: 384) depiction of the qualitative research process. Notice 
further down the diagram that the interaction with earlier-collected data can be useful 
in collecting later data. 
Through the initial data analysis, I developed a fairly thematic framework built 
around notions emerging in my theoretical explorations. These were, broadly 
speaking, the themes of risk, materiality, order, classification, standardisation, use, 
Selection of relevant site(s) and subjects 
General research questions 
Writing up finding and conclusions 
Collection of relevant data 
Interpretation of data 
Conceptual and theoretical work 
Tighter specification of 
the research question(s) 
Collection of 
further data 
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race/ethnicity, identity, inclusion, exclusion, selectivity, rarity and usefulness. For 
example, ‘classification’ became a key node, with sub-nodes emerging from it that 
included ‘inter-institutional data collection alignment’ and ‘difficulty of mixed-race 
classification’, the latter of which related back to another key node: ‘race/ethnicity’. 
In a bid to try and understand these various key nodes and how they fitted together, I 
came upon the literature on the archival paradigm that I elucidated in chapter two. It 
was in this phase of ‘conceptual and theoretical work’ from the diagram above that 
the archival lens began to take shape. From this point, I returned to the field to 
undertake the remaining interviews. The questions did not diverge much from the 
thematic matrix outlined earlier in the chapter. However, my lines of enquiry around 
particular issues became more prominent, including my interest in the selectivity 
over inclusion in the banks (around HLA types, a UCB unit’s cell count, a donor’s 
qualities, and the geographic limitation of collection sites), and the difficulty of 
stabilising classifications in the management of the UCB collection (for example, 
HLA typology which, as I noted in chapter one, is subject to frequent update). 
3.9 Conclusion 
In this chapter I have outlined the methodological considerations that underwrite this 
thesis. I began by plotting out some of the preparatory work I undertook before 
collecting data. Doing this kind of ground work, I noted, was useful in both situating 
myself moving forward but also in developing a familiarity with the language of 
HSC transplantation. In this chapter I also introduced the documents I analysed, 
along with APPG meeting minutes and Hansard extracts. These, I explained, 
complement the other element of my data collection which is qualitative semi-
structured interviewing. An interesting aspect of this facet of data collection was 
deciding who I should approach to participate. For this, I turned to the work of Harry 
Collins (1981, 1988) whose conceptualisation of the core set guided me in trying to 
select those experienced and/or qualified individuals who are engaged in the 
discussion about UCB in the UK setting. It is in the context of this discussion that I 
move into the first empirical chapter where the data takes a central stage. 
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Chapter Four: Order in the Archive 
4.1 Introduction 
So far, we have seen a number of questions emerge from the context of HSC banking 
explored in chapter one. In the second chapter, I laid out the theoretical 
underpinnings and thematic structure of how I would approach an empirical 
exposition. The data and analysis of this chapter, then, speak to how we might 
understand order in the UK’s umbilical cord blood collections We have seen that all 
archives are predicated on a particular kind of order (Brothman, 1991). That order 
will be specific to the users and managers of the given collection and, whilst it might 
make little sense to outsiders, it forms the basis of how they understand and 
conceptualise the collected matter.  
Order in the umbilical cord blood banks, as this chapter explores, coalesces around 
donors’ racial identities. If all archival content is selected for inclusion with reference 
to a concern for representativeness (Jimerson, 2009) then it is important also to 
explore how ethnicity – or ‘groupness’, as Brubaker (2004) calls it – is enrolled and 
deployed in decisions about archival inclusion. The chapter begins, then, by 
considering how the goal of archival representativeness is manifested in the context 
of the UK’s umbilical cord blood banks. By unpacking the life-saving purposes of 
the bank, as set out in parliamentary debate and discussion, I offer a foundation out 
of which we can begin to see how a supposed underrepresentation of black and 
minority ethnicity donors in adult donor registries provides the impetus for 
encouraging the collection of UCB within underrepresented demographics. The 
chapter therefore positions ethnicity as a central element in coming to understand the 
issue of archival order as it exists within the UCB bank.  
I consider how archival order, including its technologies of classification, have been 
developed both to conceptualise the bank as it exists now and to develop it for the 
future. Following on from this, the chapter plots out how ethnicity data collection is a 
practice marked by disorder. Drawing on interviews, I demonstrate how ethnicity 
data (if indeed it is even collected) can be a highly inconsistent practice across 
different banks, adult registries and international networks of stem cell exchange. 
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This, I suggest, can be read as an inherently chaotic practice of translating 
classifications used in different contexts that mean different things to different 
constituencies in different spaces and places. The chapter then turns to an important 
division between molar and molecular differentiation of bodies. I focus on the 
assumption that racial differences can be reduced to genetic composition to show that 
the actual use of ethnicity data is not in the clinical decision-making space. Rather, 
the molecular HLA match between donor and recipient becomes the fulcrum of 
clinical selection. Ethnicity is instead found to be useful in determining what should 
be included in the collection in the first instance. 
4.2 Towards a Representative Ideal 
In what follows, I want to explore the notion that, in deciding to include certain 
things in an archive, those doing so work towards some normative point of 
representativeness. By this, I mean simply that those working in archives tend to 
have a sense of what constitutes representativeness in their context that they try to 
build their archive in reference to (Jimerson, 2009). In the UCB bank, I want to 
consider if, and how, this might be the case. To what extent is the decision about 
what to include driven by a concern that the collection should be – in some way – 
representative of something. How might that representativeness be understood?  
The account below is taken from an interview with a policy maker. In it, they offer 
an account of the situation for UK ethnic minority patients requiring stem cell 
transplantation. 
…one area that we’ve certainly looked at is the number of Black 
and ethnic minorities because that’s – it’s a bit better now, but it’s 
still a scandalous situation … just because you happen to be born 
Black or Asian or whatever … you stand what is a massive 
difference in terms of your chances of finding a donor. And then 
there’s the whole mixed raced issue as well which is, if your 
father’s black and your mother’s Chinese, you’ve had it. 
(Participant 15) 
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In this participant’s account, they describe a ‘scandalous situation’ in which ethnic 
minorities writ large (‘black or Asian or whatever’) face a ‘massive difference’ in 
their chance of locating a suitable stem cell donor. This brief statement echoes a 
similar one made in an extract in chapter one, from a news article about a minority 
ethnicity toddler. This ‘massive difference’ is put down to the fact that the bulk of 
adult volunteer donors self-identify as ‘white’ or, as this chapter will shortly 
demonstrate, whichever equivalent category is made available to them when they are 
asked to select an ethnic classification for themselves. As Brown et al. note, this is in 
part because adult registries enjoy ‘strong historical penetration amongst advantaged 
middle class blood donors but recruit less well beyond the mainstream demographic’ 
(2011: 1117). Many groups are excluded from the composition of the adult volunteer 
registry because of this historical penetration in particular demographics. The 
resulting demographic deficit of the adult donor registries in part explains the UK’s 
motivation to collect umbilical cord blood. The quote below comes from a policy 
maker involved in the SCSF. 
Obviously the whole aim of setting up the cord blood banks was to 
address the, redress the balance of underrepresentation of Black, 
Asian and minority ethnic donors on the adult registries. 
(Participant 10) 
Here, they explain that the purpose behind banking in the UK context was 
‘obviously’ to redress a lack of ethnic minority donors in the alternative source of 
HSCs (adult volunteer donor registries). Tellingly, this participant conceptualises this 
in terms of an ‘underrepresentation,’ which necessarily implies a normative point of 
representativeness that the aggregated collections of HSCs (both from UCB banks 
and in adult registries) should strive for. This normative point, or optimum level, of 
representativeness is crucial here. Waterton writes that archives ‘are technologies for 
making representations of the world’ (2010: 649). The idea of finding a resolution 
for ‘underrepresentation’ is important because it demonstrates how this collection, 
like many archives, is expected to be ‘representative’. Take, for example, an extract 
from notes taken at an All-Party Parliamentary Group (APPG) meeting of what was 
said during a presentation on the composition of the UK’s umbilical cord blood 
banks and adult donor registers, and a quote from an interview with an interviewee 
involved in the APPG. 
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There is an element of underrepresentation on the larger registers 
[which] don't necessarily … match the census data [on] the 
percentage of an ethnic minority in the UK population. (APPG 
notes, September 2013) 
…the Nolan and the NHSBT focus collection of cord blood in 
hospitals which have a diverse ethnic mix … So you get cord units 
in that are more reflective of the population … it was part of the 
policy of the Stem Cell Strategic Forum. (Participant 5) 
In the first quote, we again see the notion of ‘underrepresentation.’ The presenter 
implies that underrepresentation comes about because adult registries do not ‘match 
the census data’ available on the ‘percentage of an ethnic minority in the UK 
population.’ From this account we might glean that representativeness is tantamount 
to reproduction of the UK census data. This is even more telling in the practitioner’s 
choice of words in the second quote, above. Here, the participant mentions a 
collection ‘focus’ on particular hospitals, a point that requires separate unpacking 
and one to which I will return in the next chapter. Importantly, though, the reasoning 
behind collecting with a ‘focus’ is to collect units ‘that are more reflective of the 
population.’ The aim to be ‘reflective’ in this way again speaks to the idea that the 
ideal state of representativeness is a mirroring, or a reproduction, of the UK 
population. We see here, then, that those working in and with the different banks and 
registries are informed by the goal of reflecting or representing the ethnic 
composition of the UK population.  
By matching the percentages of the population’s ethnicities, the inventory can be said 
to ‘represent’. Archives are tools of representation. To recall the words of Carolyn 
Steedman, ‘a whole world, a social order, may be imagined by the recurrence of a 
name in a register, through a scrap of paper, or some other little piece of flotsam’ 
(1998: 76). Waterton argues that archives ‘order the world, both in terms of a world 
past … and in terms of future worlds’ (2010: 652). The work of those involved in 
developing UCB in the UK looks towards producing a representative collection. But 
developing a sense of how close or far the collection is to that representative ideal 
requires the given collection to be measurable in some way. That is, to have a metric 
90 
 
by which the collection can be seen as moving towards that state of 
representativeness. What, then, is that metric? If the UCB collection is intended to 
address the lack of adult volunteer donors who identify as anything other than white, 
then the bank must to an extent be understood in terms of – and be measurable by – 
the ethnicities of donors. Order in this archive, then, can be seen to orbit around the 
idea of ethnicity. But how does ethnicity work in practice? How is donor ethnicity 
measured? How, as Bowker and Star (1999) might ask, is the work of classification 
done? And what use, then, might ethnicity data collected through this serve?  
4.3 Producing Useable Ethnicity Data 
We have seen how umbilical cord blood banks in the UK have been developed with 
the aim not only of saving lives, but of saving the lives of people who are more at 
risk of not being able to find a match through existing HSC sourcing avenues. Those 
individuals are defined as ethnic minorities. But how are those working with the 
UCB collection able to tell they are addressing the need they perceive to exist? That 
lies, I suggest, in the order of these archives. Here, then, I want to consider how 
ethnicity can be ‘measured’ in this instance. The quote below comes from a 
practitioner involved in the APPG and the SCSF. Here, they explain the usefulness of 
having information about current volunteer donors’ ethnicities: 
Well it would be useful at the end of the day to tell us where we’re 
not finding donors … But at the end of the day, it tells us what we 
would need to do more of, where we would need to collect, et 
cetera. (Participant 1) 
The quote demonstrates their understanding that ethnicity information about the 
current register would be useful. If it were available, patterns of requirement might 
emerge. If those working to find matches for patients knew – through some metric of 
measurement – that this group struggled to find matches, they could infer that they as 
managers of a collection of UCB ‘need to do more’ in terms of locating suitable stem 
cells for those patients. It is through having information on the ethnicity of volunteer 
donors that those working in the field can be confident in what they ‘would need to 
collect.’ Having ethnicity data is considered useful within the framework of 
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archivists constructing a collection that represents and thereby provides for the 
population adequately, because, as a result of asking individual volunteer donors for 
their ethnicity, the gaps can be more clearly seen. During a presentation to the APPG, 
a UCB bank administrator explains how this kind of information fits into the 
planning about how they are going to compose their collection of UCB. 
It's more difficult to make decisions as to where we need to be in 
terms of percentages … until we know what we’re dealing with. 
(APPG notes, September 2013) 
Decisions about ‘where we need to be in terms of percentages’ – from which we 
might infer, the composition of the UK’s stem cell inventory – are made more 
difficult by the dearth of information about ‘what we’re dealing with’ in terms of the 
current volunteer donor pool. In the minutes from the same meeting, the secretary 
makes note of the ‘questions’ at the end of the discussion where the contributors 
explain to MPs the difficulty of the situation. 
[The presenter] said that NHSBT and Anthony Nolan are working 
with DoH [Department of Health] and the Stem Cell Supply Group 
to review the current inventory needs. [The presenter] stated that 
until the unmet need for BME patients is quantified it would be 
difficult to plan an accurate BAME stem cell provision strategy. 
The British Society of Blood and Marrow Transplantation does 
collect some data but it lacks the resource to do this to the 
standard required for these purposes. [Another presenter] agreed 
and admitted that identifying the best places to recruit can be 
challenging without the data highlighting what the need is. (APPG 
Meeting Minutes, September 2013) 
The ‘unmet need’ has not been ‘quantified,’ and so ‘accurate’ planning for provision 
is challenging. Making decisions about the future rests upon what the requirements 
can be said to be in the present, but without adequate data from the moment a 
volunteer donor was registered at some point in the past makes this difficult. The pie 
chart below is reproduced from a presentation at the same APPG. 
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Figure 5: Anthony Nolan adult donor registry ethnicity composition reproduced from 
APPG presentation 
 
 
As its title notes, the chart offers a particular visualisation of the registry, wherein the 
whole database is represented by the full circle, and the segments represent the 
segmentation of volunteer donors by ethnicity. Over three quarters of this registry is 
composed of data from volunteer donors who self-identify as ‘Northern European’, 
whilst the other categories are congealed into the remainder. Reading along the 
archival grain is what Stoler (2009; 2002) calls those efforts to understand the rubrics 
through which any given archive is organized. In this instance, we can see how this 
archive is thus considered as a singular whole that one can ‘break down by ethnicity’. 
As an archive, the database is informed by a particular order (Brothman, 1991). The 
order in this particular visualisation is an ordering by ethnicity. One can be Northern 
European, Asian, or so forth. The category ‘Other & Unknown’ is home to those 
volunteers with the restive bodies that perhaps do not fit in a single category because 
of their mixed-ness, or because they did not feel at home in a particular category 
when given the options.  
It has been argued that self-identification can offer otherwise-passive biomedical 
research participants some agency. As sociologist Brett St. Louis points out, 
‘voluntaristic modes of self-racialization’ unsettle the argument that biological 
population groups are simply externally ascribed (2005: 43). Of course, it is 
Anthony Nolan register broken down by ethnicity
Northern European
African / African-
Caribbean
Asian
Other & Unknown
Central / Southern / 
Eastern European
Middle Eastern
Hispanic
Jewish
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unavoidable that taxonomies delimit the choices from which the subject may select, 
obliging people to identify within a rigid framework that might not accommodate 
personal preference (see Root, 2003). The ordering system that Anthony Nolan uses 
for adult volunteer donors was presented to the APPG audience. This new 
classificatory framework, reproduced below, was developed for use from October 
2012.  
Figure 6: Anthony Nolan’s ethnicity classification framework reproduced from 
APPG presentation 
 
This table of tick boxes is a means of bringing order to this collection, a technology 
of classification. It is designed to collect data in the most useful way, as I go on to 
explore immediately below. The ‘ethnic group’ classification scheme instructs the 
volunteer donor (who is also the box ticker) to ‘please tick only one.’ The request, 
emphasised with bold letters, confirms that one cannot possibly tick more than one. 
Of course, the extensive ‘Mixed Ethnicity’ options are doubtless intended to capture 
all of those who would feel they could conceivable tick two or more boxes. It asks 
the volunteer donor to ‘give the best description of your ancestors’ origin.’ Let’s give 
it a try. My paternal grandfather was born in Jamaica, whilst all my other 
grandparents come from Bolton in Lancashire (or Greater Manchester, depending on 
your generation). Had I also been born in Jamaica, I could have ticked ‘Caribbean 
Islands,’ but I sit more feasibly in a ‘Mixed Ethnicities’ category. As a consequence, 
I lose specificity. I am ‘Mixed White & Black’ – no longer English and Caribbean. 
94 
 
The specificity of my personal whiteness and my personal blackness is lost. During 
an interview with one participant, I asked about the classification framework. The 
interviewee explains that they were involved in producing it. They describe a 
meeting where it had been a topic of discussion. 
It was [the recruitment team] versus the researchers. We’ve got 
these major categories, and then we’ve got minor categories 
underneath them. So we’ve got mixed within each. British Irish, 
Asian, Northern European, and then mixed within that. So you 
could be Mixed Pakistani and Indian and you come up as Mixed 
Asian. And we also have, like, Mixed British Irish. So if you have a 
Republic of Ireland mother and a Welsh father, you’re Mixed 
British Irish. So we have mixed within those and then we have also 
more major categories! And that was the bit where I was like 
“Look, we’re doing recruitment events here!” … In one of these 
meetings, we were talking about ‘what do you think is far enough 
back to get a true identity?’ and one of our medical people was 
like, “it’s grandparents.” I can’t run recruitment events where I 
say to people “where were your grandparents born?” It’s just not 
feasible. That’s not the way that it works. (Participant 2) 
In this account, the administrator’s adult donor recruitment team stands in contrast to 
their scientific colleagues. The recruiters want to run events where they can 
encourage as much registration as possible. ‘Look,’ they describe having said, ‘we’re 
doing recruitment events here!’ The account makes clear a level of exasperation with 
long lists of ethnicity options produced for the level of specificity required by 
researchers and clinicians. Having an extensive list of major and minor categories, 
with a profusion of ‘mixed’ options represents a barrier, making it more challenging 
for a donor to locate themselves. The participant even struggles with the idea that 
somebody would need to select their ancestors’ origins. They explain that asking for 
somebody’s grandparents’ place of birth is ‘just not feasible’ because recruitment 
events do not allow for the team to spend their time explaining this in detail. From 
the researcher side (if we follow the path of the previous account which describes 
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recruiters and researchers in opposition) there is a similar amount of dissatisfaction 
with the manner in which the data is collected.  
…it’s very hard to actually be sure that people know what 
ethnicities – in genetic ways – they actually belong to. You 
sometimes have the case that you have a great grandfather that 
was Chinese and due to that fact the whole family regards itself as 
being Chinese which is not necessarily true when all the other guys 
are basically some other race because after two generations, the 
racial indicator is gone … then when people answer and say ‘ok, I 
belong to that ethnicity’ due to some cultural feeling which is not 
really reflected in their genes you get answers for the genetic way 
that do not necessarily really reflect the true ethnicity. (Participant 
17) 
A person might struggle to ‘know’ their ethnicity ‘in genetic ways’. A great 
grandfather’s ethnicity is ‘not necessarily true’ for the generations that follow him 
because the ‘indicator is gone.’ There are threads of biological reductionism that 
might be picked up from this statement – particularly the idea that ‘some cultural 
feeling’ cannot be ‘reflected in their genes’ which equates to their ‘true ethnicity’. 
But more pertinently, this quote speaks to Lee’s claim that even if self-identifications 
do not stray far from ‘good approximations of ancestral origin’ (2009: 1184) there 
remain concerns over reproducibility and consistency using the methodology. Along 
with this, scientists in individual projects producing their own taxonomies may be 
‘reducing biomedical rigor’ (Bliss, 2011: 1024) which consequently could hamper 
comparability between different projects (see Bradby, 2003). Order, then, is not 
easily achieved. What one participant views as ‘feasible’ in the interaction with a 
potential stem cell donor, might not be the classification framework deemed most 
useful by the scientists enrolled to produce these frameworks. Order, which is needed 
to be able to determine the archive’s current state and its future direction (‘what we 
need to do more of’), is not quite as easy to produce in this archival endeavour. 
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4.4 ‘Everybody Records It Differently’ 
We have seen so far how having ethnicity data on donors is framed as something that 
would be strategically useful in determining what should be included in these 
collections of umbilical cord blood. For that reason, donors are asked to identify their 
ethnicity when they donate. Having this information about the collection as it exists 
is seen as something that can help those working with the collection to decide the 
direction they need to take as they move forward and develop the bank. But if those 
working with the collection do not know the ethnicity of the patients – the 
constituency that we can think of here as the archive user – then is the usefulness of 
donor information limited? In what follows, I want to develop the discussion of how 
order is brought into this particular archive, by thinking specifically about how those 
working in this collection try to understand the patients who will receive the material 
stored there. The following quote below comes from an interview with a practitioner 
who participates in the APPG. 
 So … if we had this all beautifully recorded you could say we 
searched for 100 Afro-Caribbean patients and found this many 
donors. So that sort of information would be useful. (Participant 1) 
In this account, the ‘beautifully recorded’ patient data are viewed as a tool to make 
determinations about likelihoods of finding matches. In the example here, by 
knowing that 100 patients who could be defined as ‘Afro-Caribbean’ found a 
hypothetical number of matches, a determination of chance could be produced. That 
data would be ‘useful,’ we infer, because without it such claims cannot be evidenced. 
In this context, it makes sense to ask how patient data is collected. To begin 
exploring this question, I want to consider a quote, reproduced below, from an 
interview with a senior immunologist. 
…the whole collection of ethnicity data has not been easy. But 
we’re lucky we can collect it. In France they cannot by law. It’s 
illegal! … So we managed to start collecting data. And the NHS 
approved that, and we have been collecting data on the donors for 
the past – I think – 10 years? But not on patients. … in the forms 
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for Search we ask for the ethnic origin of the patient. But it’s only 
this year we started collecting it. A big achievement because it’s 
the only way we can actually see the unmet need. The only 
scientific way of doing it. Before, we suspected. (Participant 9) 
That collecting user data had been a struggle speaks to a concern of archival theorist 
Sundqvist who states that the users of archives ‘are often defined in a deductive and 
perhaps speculative way, not explicitly underpinned with empirical data’ (2007: 
635). Capturing this data is difficult, and the scientist vocalises their feeling of luck 
that they can collect it at all. In their example, France, it is illegal to collect ethnicity 
data at all. To the extent that data are still limited, ‘speculation’ (in Sundqvist’s 
terms) or ‘suspecting’ (in the above participant’s) is necessary. One APPG 
contributor reflected on their work as a practitioner, showing me a tissue request 
form their clinical nursing team uses for patients. On it, ethnicity was an open field 
entitled ‘Ethnic Origin. Be Specific.’  
…ethnicity’s a big problem, because everybody records it 
differently … so this is what we fill in when we take the blood tests. 
But as you can see here: “Ethnic Origin. Be Specific.” … there’s 
no doubt it would be useful information … So, it would be very 
useful to have an accurate ethnicity. I asked the girls and they said 
they virtually never fill it in. (Participant 1) 
In the quote preceding the one above, the scientist laments that ethnicity data 
collection ‘has not been easy’. Similarly, in the account directly above, the 
practitioner sees it as ‘a big problem.’ For the participant, this is because ‘everybody 
records it differently.’ They offer an example from their own practice. When faced 
with a form that requests ethnicity data, ‘the girls’ (revealing something of the 
gendered dynamic of the nursing team) ‘virtually never fill it in.’ Inconsistency (or, 
perhaps, disorder) lies at the heart of the issue in this account. The ‘Ethnic Origin. 
Be Specific.’ is an open field that could as easily demand a narrative answer or some 
kind of patient genealogy instead of a singular word of identification. Nonetheless, it 
exists to bring the possibility of some semblance of order. It is by their omission that 
these clinical nurses do not advance the cause of order. Nonetheless, the 
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classificatory imagination (Beer, 2013) is apparent in the extract below where the 
practitioner advances another possibility for data collection. 
From the minute they come into hospital as the patient, we need to 
have a drop-down box of ethnicity categories. Whatever it may be, 
and it shouldn’t be too complicated. It should be what’s 
scientifically useful … I’m sure the scientists could group these for 
us. And have a tick box that we use that ticks the same tick box the 
donor people use, and the same tick box that the government 
members use, so we’re all talking about the same thing. So we 
know exactly where we have donors, and where we don’t have 
donors. (Participant 1) 
The practitioner is clear that ‘we need to have a drop-down box.’ One of the caveats 
of this is that it ‘shouldn’t be too complicated’ which echoes the concerns of the 
APPG presenter who describes a situation in which the scientists offered a 
classificatory scheme with too many ethnicity options. And yet, whilst the avoidance 
of complexity is important, a balance must be struck. The drop-down box options 
must still be ‘scientifically useful.’ Here, the clinician defers to the ‘scientists’ who 
could do the labour of grouping. The ideal classification system would be used by all 
stakeholders (the patient care team, the stem cell donor). Ideally, it would tally with 
what the government uses, ‘so we’re all talking about the same thing’. However, this 
account reveals that the participant equates the ‘scientifically useful’ classification 
scheme with one that would be meaningful beyond that sphere – for example, in 
government ethnicity classifications. Yet the interviewee quoted earlier expresses a 
fundamental fissure between ‘cultural feelings’ and scientific or ‘true’ ethnicity. As 
such, the balance of usefulness and accessibility is a difficult one to strike. But the 
commensurability of language, consistency and order, are constructed here as the 
ideal. This is a point that I will return to shortly. Briefly, though, it is interesting to 
note that as the practitioner continues in their imagined scenario of data capture 
(exercising their classificatory imagination, as Beer might say) they run up against 
the confounding problem of mixed race-ness. 
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Participant 1: And then, of course, you’ve got mixed race and it 
gets even more complicated.  
RW: Would a drop-down box suffice for that? 
Participant 1: Well you’d have to tick two probably. Mum and dad. 
And I guess, yeah … well it has to be clever doesn’t it? Yes… it’s a 
tricky one. How you’d actually do that. 
Here, the participant highlights the issue of ‘mixed race.’ They do not specify 
patients or donors, thus implying that it is the broad identity category of ‘mixed 
raced’ which is so ‘complicated’. As archival theorists Cook and Schwartz note, 
systems of record management that appear rational and stable are ‘inherently chaotic’ 
(2002: 176). Within the framework of maternal and paternal antigens, it makes sense 
to the participant that one would actually need to capture both parents’ ethnicities. 
Suddenly, a drop-down box that would capture data of scientific use becomes 
perhaps too complex. This is the quandary of mixed raced data capture and the logic 
of having to regress to predecessors to meaningfully make sense of one’s molecular 
individuality (Anderson and MacKay, 2014). It speaks to the inflexibility of ethnicity 
classifications that, by way of their rigidity, make no space for the restive bodies that 
refuse to fit into one category.  
The practitioner struggles to picture a means of data capture that would account for 
such instances. The classification would have ‘to be clever’, but it is ‘tricky’ in 
practice to answer ‘how you’d actually do that’. The challenge of order is complex 
and problematic given that the data of interest are patient and donor ethnicities. This 
point is particularly pronounced when we zoom out a little. Referring back to the 
practitioner, even if one collection is nicely ordered, how do we know that ‘we’re all 
talking about the same thing’? We have considered the complexity inherent in donor 
and patient data collection, but what happens when that data is put to work, or when 
classifications and their attendant classificatory imaginations clash?  
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4.5 Translating Classifications 
Donors and patients are important constituencies to know in terms of their ethnic 
identities. We have seen this point emerge out of the accounts of those involved in 
trying to collect such information. The data would be useful, having some role to 
play in determining the strategic direction of the collection. But we have also seen 
how challenging it can be to collect such data. From the design of a classificatory 
framework, through to the point where data might be collected, there are divergent 
purposes (encouraging registration versus collecting specific and useable data) and 
barriers to collection (the omission of data, or the practice of not collecting at all). 
Importantly, though, the UK’s UCB banks, as we have seen, exist in part to address a 
lack of adult volunteer donors of minority ethnicities. As such, it makes sense to ask 
if the system of order that determined this lack in adult donor registries is the same 
system of order than UCB banks use to determine whether they are successfully 
addressing it. The quote below, from an interview with a scientist working in one of 
the cord blood banks, demonstrates the complexity of order in this context. 
And to be funnier … between labs, recruitment, cord blood, we 
didn’t have the same ethnicity codes … It was crazy. We were 
uploading our units in [our central database], in our register and 
we were trying to translate our ethnicities to the ethnicity codes 
that we had already in the register. It was like, “excuse me, we are 
not specialists in ethnicity!” I cannot ask my lab scientists to figure 
out what this means! So, we talked together. We agreed to ethnicity 
codes. We were working with the different maternities we have in 
the program. Because NHS – at the different trusts – they had 
ethnicity codes as well. We found them really interesting to use. We 
agreed with one of them, we worked with H&I people…. and we 
agreed an ethnicity code. And now we wish to have the same 
ethnicity codes with NHSBT… (Participant 6) 
As the quote above explains, even within a singular institution’s interrelated 
operations (UCB collection, adult donor recruitment and laboratory diagnostics 
work), the ethnicity classifications are different. This is far from the ‘edenic order’ 
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that selective collections strive for (Brothman, 1991). The suggestion on the part of 
the participant that this situation was ‘funny’ or ‘crazy’ speaks to the nonsensical 
collection of data that, by way of its initial collection design, has limited use for the 
people who work with it. Expanding on this, the participant notes the practical 
challenge of having to make sense of often contradictory, and always variable, 
ethnicity classification systems. Across the different British UCB banks and adult 
registries, ethnicity data were being captured differently. In the same quote, the 
respondent describes how their laboratory staff had been given the job of trying to 
input data from one classification system into another, so that all tissue and donor 
data could be searched for on their central database. The suggestion that being a 
‘specialist in ethnicity’ is a requirement for this task is telling. It speaks to how 
challenging (both practically and, it might even be said, epistemologically) bringing 
different classification schemes together stands to be. According to the scientist, this 
is an expertise that none of their staff had. A charity spokesperson summarises the 
quandary differently. 
Transplant centres, even registries, aren’t using the same ethnicity 
codes. If you’re not using the same codes, how are you – one’s an 
apple, one’s an orange but you think they’re both the same. 
They’re not the same … [Registries and hospitals should be] 
getting their acts together, and being consistent. In terms of using 
the right codes to decipher what racial aspects of people you use. 
(Participant 4) 
The interviewee gives a similar account to the scientist. ‘Transplant centres, even 
registries’ are seen to employ inconsistent ethnicity codes. In referring to the well-
known ‘apples and oranges’ idiom, the participant implies that these different 
ethnicity codes are incommensurable. Thus, no aggregation or comparison of data 
sets in terms of ethnic composition can be made whilst, as the same participant 
explained during an APPG presentation, the parties are not all… 
…talking the same language about what is ‘black’, what is defined 
as ‘white’, what is defined as ‘mixed race’. (APPG notes, 
September 2013) 
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This speaks to what Brubaker calls the ‘ever-recommencing definitional casuistry’ of 
ethnicity (2002: 167). It demonstrates the challenge of trying to pin down sufficiently 
durable ethnicity classifications which are scientifically and culturally meaningful 
across time. Expressing the need to align different data collection practices across 
British institutions, one participant briefly described a discussion with their 
counterpart in a different institution, explaining why it would be useful. 
Every time I see [them], it’s like “we need to do this ethnicity code 
together” … WMDA [World Marrow Donor Association] ask us 
for ethnicities, and sometimes we don’t have the ethnicities from 
the patients. So when we need to do the reports for stats, we cannot 
provide these data … If we had all the ethnicities recorded, we 
could do also analysis ... Information is power. And HLA is totally 
related with ethnicity so why not have it if it is not difficult. If 
NHSBT is working together with Anthony Nolan, let’s agree the 
same ethnicity codes, then move on to the transplant centres to 
agree the same ethnicity codes. (Participant 6) 
Even between institutions, there is a recognition that they ‘need to do this ethnicity 
code together’ so both are using the same classificatory imagination (Beer, 2013). In 
the account above, the participant also makes reference to international pressure to 
provide relevant data when the ‘WMDA ask us for ethnicities.’ If both the NHSBT 
and Anthony Nolan could ‘agree’ (a word that could as easily evoke the sentiment of 
compromise as it does harmony), the field would be in a position to provide a more 
comprehensive set of statistics to the World Marrow Donor Association which 
attempts to produce a global picture of current stem cells stocks. The participant does 
not mention whether this would then rely on the UK’s stem cell inventories (if they 
somehow compromise/harmonise) employing the same classificatory imagination as 
the WMDA. Since 2011, the WMDA has provided ethnicity codes to advise for 
global registries (World Marrow Donor Association, 2011 - see Appendix E). The 
organisation’s quality and regulation working group website explains its codes, 
reproduced below, in the following terms: 
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‘Race/ethnic information is increasingly relevant to unrelated donor 
search strategies … Global registries are enhancing communications 
using electronic systems to exchange information. As a result, it is 
increasingly important to achieve a common standard of ethnic 
definitions. [WMDA] worked towards a WMDA Dictionary … to 
allow stem cell donor registries that capture race/ethnicity data on 
donors and/or cord blood units to incorporate these into their 
[electronic messages to WMDA]’ (World Marrow Donor 
Association, 2015) 
The ‘common language’ they were aiming for, which relies on consensus between 
the WMDA and the array of registries they work with, has yet to be matched in the 
UK. This is clear simply by comparing Anthony Nolan’s current classification 
scheme (reproduced earlier in the chapter) with WMDA’s directly above. The lack of 
consensus over classification and categories is commonplace across archives. The 
taxonomies used to manage archival matter are always potential ‘sites of 
disagreement’ (Beer, 2013: 43). They are, as Derrida evocatively notes, ever at risk 
from being ‘shaken by an earthquake from which no classificational concept … can 
be sheltered’ (1996: 5).  
Bowker asks an interesting question in this respect. ‘Why does the best standard not 
always win?’ The answer he posits speaks to the issue at hand here, that ‘no node is 
an island’ (2005: 112). In other words, it is difficult to make one classificatory 
standard win no matter how good it is if it is being put to work in a wider context in 
which everybody else is already using their own classificatory standards in their own 
context. This issue, I would argue, is compounded by the contingency of a socially 
salient, spatially, temporally transient notion such as ethnicity. Interestingly, the 
suggestion in the WMDA codes’ very existence is that ethnicity is a language of 
some kind which has the capacity to be translatable in different geographic contexts. 
In this case, everybody needs to speak the same ethnicity language, or at least use 
different languages that exist in the same epistemological family so they can be 
‘translated’ across frameworks.  
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The ability to translate the meaning of different ethnicity languages across such 
frameworks is held as a holy grail, but seems almost impossible given the importance 
of the locality in which classifications are defined. The WMDA, being an American 
organisation, includes in its classification framework a North American ‘broad race’ 
code, which is absent from Anthony Nolan’s classification. Its ‘Europe’ section is 
much briefer than the more in-depth Anthony Nolan classifications. The context 
from which classification emerges explains these differences. These classifications 
articulate geographically specific ways of knowing bodies, but also the different 
interests served which may include expediency at the point of donation or, on the 
other hand, durable scientific usefulness. For this reason making sense of different 
classifications, particularly internationally, potentially moves beyond translational 
challenge to translational impossibility. 
4.6 Molar and Molecular Differentiation 
So far, we have explored the view that ethnicity data are useful for ordering the UCB 
collection, but that these data must be collected so that they are either directly 
applicable to, or translatable to, other collections. Given this, it is tempting to ask 
how the practice of HSC transplantation happens at all if the collection of such a 
seemingly useful sort of data is so erratic. With that in mind, it is worth considering 
how practitioners do their work with such inconsistent – perhaps even inexistent – 
data. To explore this, it is useful to remind ourselves of that link between ethnicity 
and tissue type that was touched upon in chapter one, and to consider how the 
strange, congealed relationship between these ostensibly molar (ethnicity) and 
molecular (genetic) bodily distinctions works in practice. The quote below comes 
from a policy maker involved in the APPG. 
But Asians are much more susceptible to diabetes. I went to one of 
the meetings … I said to one of the doctors, why is this? He said, 
there’s something in the genes, they think. So genes, you see ... 
Different people … I wonder how different Caribbean blood is to 
blood in the Orkney Islands? ... They found years ago with spina 
bifida, that it’s more prevalent in South Wales and the Orkney 
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Islands in the north of Scotland. Why? It’s probably because they 
were short of something in their make-up. (Participant 12) 
In this quote the policy maker gives an account of how a person’s ethnicity can 
determine their susceptibility to different kinds of illness. Importantly, an Asian 
person might be more vulnerable to developing diabetes because ‘it’s in the genes.’ 
Similarly, the participant claims there is higher prevalence of spina bifida, a 
gestational spinal development disorder, in South Wales and in the Orkney Islands. 
‘Probably,’ the participant suggests, this is due them being ‘short of something in 
their make-up’, by which the participant infers the notion of genetic make-up (or 
composition). They describe blood as ‘Caribbean’, positing its difference to blood 
‘from the Orkney Islands’. In this account we witness the reduction of ethnic 
identity, and illness experience, to the nebulous notions of ‘genes’, ‘blood’, and 
‘make-up’. This quote demonstrates how this prevalent model of the relationship 
between genetic composition and experience of health, mobilises ethnicity as the 
intermediary in the causal chain. Somebody has diabetes so, because they are Asian, 
they must have something ‘in their genes.’ Spina bifida is prevalent in North Wales 
which is populated with people of a particular descent or ancestry, so they are ‘short 
of something in their make-up.’ To the extent that the molar category of ethnicity is 
invoked simply as an indicator of a deeper molecular state, its use is necessarily 
limited. For example, the quote below is from an interviewee responding to a 
question about whether clinicians would ever use donors’ ethnicity data when 
making a selection for their patient. 
No, because the ethnicity tends to be the thing that determines the 
HLA type … the importance of ethnicity is only in the HLA type. So 
your HLA types are inherited, obviously, so certain populations 
have certain HLA combinations. So that’s why it’s so important. 
Um, but yeah, as soon as you – I’m not aware of any data, but as 
soon as you’ve the HLA match, it’s quite likely that they’re from 
the same ethnic group anyway. (Participant 5) 
In this account, the reason given for clinicians not using donor ethnicity data is 
‘because the ethnicity tends to be the thing that determines the HLA type’. Again, 
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ethnicity becomes a causal intermediary. This time, not between the event of illness 
and molecular composition, but between the event of the match and the molecular 
composition. If ‘you’ve the HLA match’ then you are ‘likely’ to be part of ‘the same 
ethnic group.’ The participant notes that there are no data confirming this, but 
conveys a surety that a match within an ‘ethnic group’ ‘tends’ or is ‘likely’ to be the 
case. I asked a practitioner involved with the APPG the same question. They 
reflected on their own experience in response: 
Participant 1: So we would take it [ethnicity] into account, but 
there are other things that matter before. So we’d match for HLA 
type ... We match for viruses they may have seen. We match for 
blood group. There’s all sorts of things we come down. So ethnicity 
could be in there if we had the information. I have never had 
information, I don’t think, on the ethnicity. 
RW: Ok, but if ethnicity is something that matters–  
Participant 1: Well it’s already there. 
RW: in the HLA? 
Participant 1: Yeah, exactly.  
In a similar account, this practitioner notes that they ‘have never had information’ 
about donor ethnicity. If they did, they ‘would take it into account’ but this would be 
lower on the list of criteria considered in the process. I will consider this list of ‘all 
sorts of things we come down’ in depth in chapter six. But importantly, this account 
suggests that ethnicity (a datum that the practitioner never has) is not as important as 
HLA typology. How the clinician chooses to describe this is telling. Ethnicity is 
‘already there’ in the donor’s HLA type. In the preceding quote ethnicity 
‘determines’ HLA. In this one, ethnicity is folded into HLA. HLA is crucial, and 
ethnicity takes on what I have described elsewhere (Williams, 2015) as an almost 
metonymic position as HLA’s less specific, molar stand-in. A clinician would not 
select a donor for their patient based on ethnicity alone. Ethnicity sits somewhere in 
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the list of useful information of those working with and in these collections, but 
contends with other data for priority. As an example, the participant below is a 
scientist who presented at the WMDA annual conference, working to analyse the 
prevalence of different HLA types in registries across the world. I asked them 
whether they would find it useful to have ethnicity data in HSC collections around 
the world. 
Participant 17: You might think “okay this data could be better for 
scientific evaluation,” … but I think this is a very luxurious 
demand in the context that we’re working in … It would be nice to 
have them all always HLA typed at the best level … which we try to 
do but of course it's timely and a costly process. 
RW: That’s a priority over having everyone’s ethnicity data? 
Participant 17: Yeah, of course. I mean the ethnicity data is nice to 
have and if you could get it then it’s alright. But it’s not anything 
that I could imagine we would phone up someone and ask people 
for that. 
Having ethnicity data is a secondary ‘luxury’ compared to other factors such as HLA 
typology which have more utility. In this context, improving the consistency of racial 
and ethnic categories, prioritised by respondents above, instead starts to look like an 
unnecessary luxury compared to having tissues ‘always HLA typed at the best level.’ 
The molecular composition of available HSC cells is information that is useful to 
have. Talking about a new working group established in their workplace, one 
participant explained the use of doing analysis not with donors’ ethnicity data but 
with their HLA data. 
Participant 17: We have all this wonderful, beautiful data about 
HLA and you can do an analysis like “what is the matching 
probability of an international exchange” and that kind of thing 
and, since we have the data, we’re doing it.  
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RW: And this makes the registry more efficient? 
Participant 17: That’s the offspring of course.  
Here, the scientist describes the work they are involved in using HLA data taken 
from international collections of HSCs. In this account, they describe the kind of 
question they might calculate an answer to. These are questions of ‘matching 
probability.’ By collating all the information on the HLA combinations of each donor 
in one collection, and doing this with all the collections they have data for, the 
interviewee can then see whether a potential patient HLA type would correspond to a 
match. If a person has x combination of HLA alleles, they stand y chance of finding a 
match. HLA, then, is now being used to give a sense of the chances of making 
matches internationally. This work is done by collating data of present registry 
donors to construct a sense of what the international system of HSCs is able to 
provide. This work is being done without comprehensive ethnicity data. 
This prompts an important question. If ethnicity is not useful in the quotidian 
practice of using banked HSCs, why is it so central to strategic planning? Or, to refer 
to Brubaker, for what purpose is racial ‘groupness’ enrolled here? The beginning of 
the answer is embedded in the consensus on a relationship between one’s ethnicity 
and one’s genetic composition. But this understanding does not fully explain why 
ethnicity is enrolled. Why talk about something like a donor’s ethnicity (which is 
thought to be scientifically less useful or truthful, as we have seen) when we could 
simply talk about a donor’s tissue type? The rest of the answer can be found by 
referring back to the archival paradigm. The beginning of this chapter opened with 
Kaplan’s argument that all ‘archivists do what they do so that others … now or in the 
distant future, can do what they do’ (2002: 217). As a conceptual ‘proxy’ for genetic 
composition, ethnicity offers a socially salient and – importantly – molar point of 
reference for those working to make the UCB collection as useful as it can be by 
being able to guide collectors to the bodies perceived as most relevant to the 
collection. 
The ethnicity/genetic relationship claim has cache in this space and there is an 
understanding that minority ethnicity individuals are less likely to find a tissue match 
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(although this is a claim, as we saw, based on assumption). As such, ethnicity can be 
enrolled in the strategic efforts of the collection managers. You cannot encourage 
donation by asking people of a particular tissue type to come forward (because none 
of us off the top of our heads would know what our tissue type is!). However you 
can collect umbilical cord blood in the maternity wards that serve more Asian and 
Black women. Ethnicity is thus the focal point around which practical strategic work 
coalesces. This work is undertaken by everybody in the chain. This includes the 
scientists constructing the infrastructures of their ethnicity data collection, the 
donation drive organisers collecting donor ethnicity data and the volunteers who 
offer it. Ethnicity can also be seen as central when the clinical nursing teams find 
time to ‘be specific’ about their patients’ ‘ethnic origin,’ or when the women who 
consent to donate their umbilical cords are requested to tick the box that would ‘give 
the best description of [her] ancestor’s origin.’ The quote below comes from a public 
bank administrator. 
…going out to a population going ‘we need more of you to join the 
register because we have – well we don’t know how many patients 
we have.’ … When we’re trying to do quite accurate modelling of 
what our bank needs to look like, it’s really difficult when you’re 
not 100% clear – you’re doing it a bit by, almost, instinct. 
(Participant 8) 
The administrator uses adult donation as an example of the need for ethnicity data, 
suggesting that encouraging donation in a particular group or ‘population’ by saying 
‘we need more of you’ is a difficult claim to uphold if the number of patients is 
unknown. Likewise, it is challenging to know what the UCB bank ‘needs to look 
like’ if those managing it aren’t ‘100% clear’ about the requirement, and thus have to 
rely on ‘instinct.’ To this extent, being able to make claims about the ethnic 
composition of the bank goes some way towards knowing the limits of the bank’s 
capacity for provision. Ethnicity data may not be useful in the clinical practice of 
trying to match a patient and donor molecularly. Yet not having the data can be 
equally perilous to the telos of managing the UCB collection in the first place (that 
is, making it representative). The chart below, from Anthony Nolan and NHSBT’s 
annual inventory report (2014: 21), demonstrates this. 
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Figure 7: UK cord inventory ordered by ethnicity reproduced from the 2014 annual 
inventory report 
 
This chart depicts the ethnicity data of all cords available in the UK’s two main UCB 
banks. They are broken down by donor ethnicity. Donor ethnicity data collection 
allows those managing the bank to know what it looks like and – within the 
framework in which ethnicity is connected to genetic composition – what it needs to 
look like as it develops. This information does not have utility in the clinical 
decision-making process of the practitioner because they do not receive this 
information about the donor. But it has utility as a means of demonstrating the bank’s 
current position in terms of what is deemed to be an important referent (ethnicity) 
and as a tool through which those working in the collection can make decisions about 
moving forward. Ethnicity, then, means little in the practice of using this archive, 
whilst having a great deal of resonance in terms of how archival inclusion is 
conceptualised and planned out. 
An important point to make at the end of this chapter, though, is that the molecular 
individual as she is understood today is only a product of the most recent consensus 
of what constitutes the self. My point here is that HLA as a standard nomenclature is 
itself constantly under review, being challenged to absorb new alleles into its 
ontological paradigm of what constitutes the self. This is, of course, hardly a surprise 
given, as Mackenzie et al. (2013: 703) point out, ‘the essential thing that a standard 
needs – an unchanging attribute – is, it seems, precisely what the biological 
essentially lacks’. This is to say that even HLA typing standards change. Even in not 
bothering with a messy register like race, fixed standards like HLA must be updated 
regularly to keep up with the pace of change in what constitutes the molecular 
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individual from year to year. I will unpack this more in chapter seven, but the point 
here is that we should be wary in suggesting that the exclusive use of a molecular 
register in ordering any archive could ever be a final act of ‘consigning chaos to 
oblivion’ (Bowker, 2005: 70). 
4.7 Conclusion 
This chapter explored how those working with UCB collections in the UK decide 
what will be included in these collections. I began this chapter, then, by plotting out 
the purpose and the order of the collection. This revealed much about the difficulty 
of trying to gather data about individuals’ racial or ethnic identities. So too did it 
begin to reveal how inclusion in this collection hinges on ethnicity. Speaking broadly 
to the difficulty of trying to capture socially salient but formidably transient 
categories like ethnicity (Bliss, 2011), the chapter demonstrates how order in this 
collection is something desperately strived for but not so easily come by. This, I 
suggested, prompts important questions about how ethnicity is translated across 
different collections that are drawn together as a wider pool of HSC resources for the 
UK’s public. If they do not order their collections in the same way, what use can the 
order have overall? This concern steered the chapter towards exploring what use – in 
clinical practice – ethnicity has. As we see, in quotidian clinical selection of tissue, 
the answer is clear. Here, ethnicity has no use at all. Put differently, clinicians 
receive no information regarding the tissue donor’s ethnicity. Ethnicity has use only 
so far as those managing the collection can conceptualise where their collection 
stands, and what they need to do (in accordance with immunological understandings 
of ethnicity as a genetically meaningful category) to ensure the continuing usefulness 
of their collection. 
I suggested that ethnicity is a tangible means of strategising – more so than invisible, 
molecular markers of difference. You can focus collections in maternity units where 
there are more Black and minority ethnicity women. But as soon as a person donates, 
their ethnicity matters little in the specific task of matching a donor and a recipient 
together. As such, whilst this archive must focus its wider strategy on a broad 
concept like ethnicity, the day-to-day small-scale matching of tissues requires no less 
than the intensely molecular HLA typing that negates the need for ethnicity. This 
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relationship between the molar and molecular registers of ethnicity and HLA type, 
then, highlights the importance of understanding not only how but why we are asked 
to situate ourselves and our bodies (as well as our identities and potential clinical 
usefulness) within a broader, ‘genetically diverse’ population.  
This, perhaps, is what Nikolas Rose was pointing towards in his discussion of how, 
in the contemporary moment, race has come to signify ‘an unstable space of 
ambivalence between the molecular level of the genome and the cell, and the molar 
level of classifications in terms of population group, country of origin, cultural 
diversity, and self-perception’ (Rose, 2007: 161). As a tool of individuation, a 
person’s HLA type will discern them from everybody else. Placed side by side, two 
HLA types can be compared for similarity or “compatibility”. But in the archival 
space, where tissues are stored so that this comparison may one day take place, 
ethnicity (which this chapter has demonstrated remains an indeterminate register) is 
thought to be a more useful ‘ascertainment strategy’ for locating the potentially 
useful stem cells in the first place (Kittles and Weiss, cited in Rose, 2007: 159). 
As a pivotal centrepiece of the inventory’s strategy, ethnicity means everything. As a 
contingent and context-specific social category in a world of molecular allogeneic 
tissue matching, ethnicity begins to lose all meaning. The decision of what to include 
in the collection orbits around a category that paradoxically, means everything and 
nothing at once. We can, I would conclude, be assured that the purpose of using 
ethnicity to encourage donation has an emancipatory biopolitic at its core that 
demonstrates a clear departure from historical uses of ethnicity in a medical setting 
(Rose, 2007). And yet the inability to “pin” ethnicity down in durable and universal 
classificatory frameworks, or to make race meaningful beyond ordering this archive 
tells us something. Ethnicity in a biomedical setting – even if used with the most 
beneficent intentions – offers a jarring molar indeterminacy as compared to the 
extremely specific forms of molecular information now available to us. It is 
important to trace if, how, and why ethnicity persists in such settings as the capacity 
of tissue typing technology inevitably develops and the molecular dimensions of 
individuation proliferate and deepen. 
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Chapter Five: Exclusion from the Archive 
5.1 Introduction 
In the last chapter we explored the notion of order as it relates to the context of 
umbilical cord blood banks. Moving on from this, and drawing on the exclusion of 
archival practice that I highlighted in chapter two, I want to explore the extent to 
which can we understand UCB collections as exclusionary spaces. The fact that 
traditionally, UCB banks are dualistically posited as either public or private, adds 
another vector this discussion. As such, the idea of the public, the universal, or the 
national resource, is one that this chapter engages with in some depth. In doing so, it 
moves towards a considered critique that though titularly public, these systems are 
anything but inclusive and universal. Indeed, private – in terms of the privation of 
access – seems to make sense as a way of thinking of such ostensibly ‘public’ 
selective collections. 
With this in mind, the chapter begins by considering how archives are always 
limited, if only by the fact that they rely on ‘resources’ to be sustained and 
developed. By considering empirical data from interviews, and analysis of policy 
documentation, I first plot out the incredibly limited state of provision of donation 
opportunities for UCB across the UK. Out of this come several threads of discussion, 
focusing around the different limitations of resources (where there are either 
stipulated criteria of how resources might be used, or there is simply not enough 
money). This practical arrangement exists alongside the enrolment of the claim that 
undonated UCB is waste. What is to be done with this moral indictment of 
irresponsibility, if somebody cannot donate even if willing? For this, and the broader 
notion that donation is a communitarian act, I turn to the work of Roberto Esposito 
(2011), which opens the chapter discussion out to consider how even in hospitals that 
allow public donation, not all women will qualify to do so. As it transpires in the 
chapter, then, a universal resource is not universal in terms of its donation, which 
allows us to reconsider briefly the role of the ‘private’ banking system in this 
context. 
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But beyond this, I am also keen to explore the fallout of the desire for the archive to 
be representative – to give, as Achille Mbembe writes – an ‘illusion of totality’ 
(2002: 21) which, as Derrida provocatively argues ‘is never without violence’ (1996: 
3). The chapter, then, looks to consider in detail how the demand for HSCs donated 
by minority ethnicity mothers translates into focused collection practices that 
concentrate on maximising such donation. This produces particular kinds of 
exclusion of its own. Enfolded into this is a question that has to be asked. What 
happens, I begin to explore here, when groupness is invoked (Brubaker, 2004). If 
particular ethnicity groups are responsibilised to donate for the good of their own 
community, what becomes of the universal tenet that holds up this system?  
5.2 Limited Resources 
To begin this chapter, it is apposite to think about the notion of resources as it relates 
to the archival space. ‘Many archivists,’ writes Jimerson, ‘remain constrained by 
external forces, including … resource allocators’ (2009: 297). ‘Resources’ here is a 
handy euphemism. It congeals various issues enfolded into the notion of having 
enough money. Here, I want to unpick how resources in the context of UCB 
collection are indeed limited. Consider, for example, notes below from an All Party 
Parliamentary Group (APPG) meeting, where a policy maker asked a question at the 
end of the group session. The question was directed at those present involved with 
the Stem Cell Strategic Forum (SCSF). The policy maker asked if there was an 
optimum number of UCB collection sites. The response came from an administrator 
of one of the umbilical cord blood banks: 
… that boils down to simple resource issues … we had identified 
the need for 50 million pounds of resources ... to put all of the 
recommendations into place … we've been looking at an annual 
figure of the last three years of four million. (APPG notes, 
September 2013) 
The number of UCB collection sites ‘boils down to simple resource issues.’ Though 
a grand figure of £50m would have been useful, the SCSF secured only £4m. A lack 
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of capital, put simply, puts limits on the number of UCB collection sites. In this 
context, consider the quote below, from an interview with a policy maker. 
…providing funding to NHS Blood and Transplant and to the 
Anthony Nolan directly to implement specifically the 
recommendations around aligning the stem cell registry … about 
half the funding has gone to the cord blood side of it if you wanted 
to put a figure on it. We've provided 12 million over the last three 
years. So that's our role… we obviously work closely with [the 
institutions] in determining the best way for allocating the funding 
to get the best results… [They] are obviously under pressure as 
well to make sure that they use funding they get in the most 
appropriate way as well. (Participant 10) 
In this account, the policy maker describes a situation in which the institutions in 
receipt of this funding must determine the ‘best way for allocating’ it ‘to get the best 
results.’ The funding is not unlimited, and so the managers of the UCB collections 
must give considerable consideration, and ‘are obviously under pressure’ that the 
funding they receive be used ‘in the most appropriate way.’ This raises interesting 
questions around what constitutes appropriateness in this context of limited 
resources. What, here, is the ‘best result?’ It is not, I will preface the rest of the 
chapter by stating, a scenario in which any pregnant woman in the UK is able to 
donate her HSCs when she gives birth. According to Redshaw et al. (2011), as of 
2010 there were 289 maternity units.4 Out of these, only fifteen offer the option of 
donation to women giving birth in the unit. Eight of these sites exist in London. The 
remaining seven are dotted in different cities across England. Of the eight collection 
sites in London, six are run by the NHSBT (the other two are managed by AN). An 
                                                 
4 The figure of 289 maternity units comes from Redshaw et al.’s report focusing on 
maternity provision in England in 2010. This number included Obstetric units, and Adjacent 
and Freestanding Midwifery Units (next to, and separate from, hospitals respectively). This 
number has likely changed slightly though no more recent audit exists. 
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immunologist who has worked on professional guidelines for tissue selection 
explained the situation in an interview. 
We could move to some other places. It’s easier for us to have all 
our collection centres in London because [of] resourcing, staffing 
... All the units are assessed [in London] ... If they fulfil certain 
criteria they are then sent to Filton [in Bristol] where they are 
processed and stored. (Participant 9) 
In this account, the interviewee concedes there could be NHSBT-led collection 
centres in ‘some other places’ but due to ‘resources, staffing,’ it is ‘easier’ to have all 
the facilities (from collection through to assessment) in London. The suggestion that 
‘resources’ demand this concentration of collection centres is important. It reveals 
that practical exigencies preclude expansion and, thus, inclusion. This was an issue 
that was recognised in the SCSF report. 
Logistically, maternity units collecting cord blood are best 
managed in clusters, allowing staff to move from hospital to 
hospital to ensure 24/7 attendance to maximise the number of units 
collected. (UK Stem Cell Strategic Forum, 2010b: 35) 
The policy document can be seen here to rationalise the concentration of collection 
centres within a single city (in this case, London) by framing it ‘logistically.’ Such 
language connotes an almost militaristic operation of efficient procurement and 
supply with the thought-out movement of personnel. Collection sites are ‘best 
managed’ by being selected as ‘clusters.’ Such planning permits the movement of 
staff which can allow their constant (‘24/7’) presence. The intention of all this is to 
‘maximise’ collection. What this suggests, of course, is that maximisation is not the 
same as expanding collection sites, but encouraging a selective focus on a 
concentration of collection centres. A similar account was provided by a speaker 
answering questions at an APPG regarding the state of Anthony Nolan’s decision to 
extend staffing provision across existing collection sites rather than open new ones. 
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There wasn't that much money in the pot … the best way was to 
sweat, for want of a better word, our existing assets to 24/7 
collection centres. (APPG notes, September 2013) 
Instead of the euphemistic limited resources, this account quite directly notes that 
there was not ‘that much money in the pot.’ This APPG speaker explains that with 
the limitations as they stood, it made sense to ‘sweat’ their ‘assets’ to day-and-night 
provision in individual wards where shift-worker collectors take over from one 
another so that there is always a qualified collector at hand for any delivery. They 
are, then, deriving as much value as they could out of their investment and paying 
collectors to stay in participating maternity units all day, every day of the week. As 
such the speaker’s account explains how Anthony Nolan, like the NHSBT, 
rationalises its choice not to widen the scope of collection by placing staff in 
different maternity units, instead focusing their staff in maternity units in which they 
are already based. Both institutions can thus be seen to work within a logic where 
efficiency is equated with focus and selectivity. Any other state of matters, for 
example opening up in a number of units dotted across the country, and with less 
than constant staffing, would seem inefficient. This is an issue that the SCSF picks 
up in its 2010 policy document. 
‘A ‘postcode lottery’ exists for prospective cord blood donors 
outside London who are currently unable to donate.’ (UK Stem Cell 
Strategic Forum, 2010b: 84) 
The notion of a ‘postcode lottery’ enrolled here implies a sense of randomness to a 
woman’s (or a ‘prospective’ donor’s) likelihood of giving birth in a maternity unit 
where somebody works to collect the UCB tissue. The sense that this is 
determined by chance belies a complexity of reasons that have produced and closed 
off opportunities to donate UCB in UK maternity wards. Those managing the UCB 
collections, then, are limited by their resources, which resonates with Jimerson’s 
(2009) point that all archivists face the decision of making the best of what resource 
allocators allow them. More than this, though, what begins to emerge here is that 
selectivity inevitably begets exclusion. Who, in other words, are the losers of the 
postcode lottery?  
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5.3 ‘The Kind of Funding We Have’ 
There can be too little funding for the managers of these UCB collections to fulfil 
every goal they may wish to fill. They have to work with what they have and ‘sweat’ 
their assets (to borrow from one participant, above). Resources, then, can be limited. 
But beyond this, resources can also be delimited, a word I use here to convey funding 
that states quite specifically how the money is to be used. Here, I want to consider 
how the kind of funding that the institutions secure can limit the spread of staffing for 
collection in maternity wards. This speaks to our broader concern in this chapter, 
which is to develop some understanding of how UCB banks, as selective collections, 
might be necessarily exclusionary. Delimited, rather than limited funding, is a 
particularly acute issue for Anthony Nolan. The charity had to secure government 
funding to expand its collection units across areas other than London. As well as the 
funding from the Department of Health, Anthony Nolan’s available resources for 
collecting UCB are boosted from the government’s Regional Growth Fund. The 
quote below comes from an interview with a scientist. Here, the scientist explains 
which maternity ward they are selecting to staff with UCB collectors. 
Hopefully it will be Nottingham … QMC [Queen’s Medical 
Centre] and City Hospital, and hopefully Newcastle … And then, if 
Newcastle doesn’t want, or it’s too difficult to open it, we will go to 
Manchester, because we need to do it in the North because of the 
kind of funding we have. (Participant 6) 
The funding that the scientist refers to in this account is the governmental Regional 
Growth Fund (RGF) which the charity bid for and was awarded in 2013. The growth 
fund, awarded by the Department for Business, Innovation and Skills (2013) under 
the auspices of ‘UK Stem Cell Provision’, to an extent dictates which maternity units 
in which geographical areas the charity is permitted work with. As the scientist notes, 
the caveat of the funding is that they ‘need to do it in the North’. As the Department 
for Business, Innovation & Skills’ annual RGF report explains, the fund is designed 
to ease the transition of areas ‘dependent on the public sector … to sustainable 
private sector-led growth’. The report notes that bids from those areas ‘where there is 
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a vibrant private sector’ may struggle to be successful for this kind of funding (2014: 
8).  
By using this source of funding, the charity precludes itself from operating in 
particular spaces deemed unsuitable within the government’s normative neoliberal 
framework of prudent investment (see Bentley and Pugalis, 2013). In the map below, 
reproduced from the same annual report (2014: 9), public sector-reliant areas (dark 
blue) and private sector-reliant areas (light blue) are mapped out.  
Figure 8: The UK’s public sector- and private sector-reliant areas reproduced from 
the 2014 RFG annual report. 
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Segments of low public sector employment (thus, less eligible for the use of RGF 
funding) are not on Anthony Nolan’s list of collection site options. But the cities of 
Nottingham and Manchester, 80 miles apart, are. Swathes of pale blue, private 
sector-led England once again miss the cut because of the resource limitations of the 
institutions providing UCB collection, which are compelled to stay in the 
concentrated cluster of London hospitals or focus their energies on particular cities. 
Practical limitations like funding, staffing and proximity are central to the limited 
number of maternity units that collect UCB, and thus the limited opportunity for 
women to donate their umbilical cords. The institutions cannot collect at every 
maternity unit, and choosing where to invest funding is based on determinations of 
what is both practicable and efficient. The point of this is that those managing how 
UCB is collected must be selective in their broader strategic decisions. This speaks to 
the point made by archival theorist Terry Cook. He writes that those working in 
archives will choose, ‘in eras of limited resources … which systems, which functions 
… and which related records, will get full, partial, or no archival attention in all 
archival processes, from system design requirements to appraisal and acquisition’ 
(2013: 102). When an archive is purported to exist in the national interest whilst its 
staff practices selective acquisition of matter, a tension must inevitably arise. With 
government funding, the public UCB banks operating in the UK are collections of 
matter that exist primarily for the UK’s public health, to save the faceless lives of the 
unnamed patients past, and the imagined patients future. What tensions arise between 
this required exclusivity, and the enrolment of national interest and community? The 
quote below comes from a public bank administrator. 
It’s not a right. It’s not a right! We do play on this a little bit 
because when we’re persuading the hospitals to let us do cord 
collection we do sort of say, “This is a service that you’re offering 
your mum. Your mum, given a choice, if she is quite passionate 
about this, and she’s completely ambivalent between two hospitals 
she wants to go and have her baby in, she might choose to go.” 
There’s plenty of evidence and examples of women who’ve said, 
“I’m going to have my baby in that hospital because I can donate 
my cord” … So it’s like a service but really it shouldn’t be looked 
121 
 
at as a service because we’re not offering it as a universal service. 
(Participant 8) 
In this account, the administrator describes a situation in which hospitals are 
approached to be collection sites. The interviewee explains that convincing a hospital 
can require the bank workers to ‘play on’ the idea that donating cord is ‘a right.’ 
They are offering ‘a service’ to mothers who are ‘passionate about’ donating, and 
who might make their choice of hospital based upon the availability of an 
opportunity to do so. Crucially, though, the administrator states the UK UCB banks 
do not offer a ‘universal service,’ a service available to all, equally. Even within a 
collection site, as I will touch up shortly, some women are favoured over others. 
There is no guarantee that because you deliver in one of the 15 collecting maternity 
units, that you will actually have your cord collected. Donation, therefore, is 
sometimes made to look like ‘a right,’ an adherence to some kind of moral principle, 
though it is not. In this context, it would be useful to explore this disparity between 
the invocations of universalist rhetoric of everybody’s right to donate, versus the 
actuality of selective practice. 
The discussion resonates with Roberto Esposito’s work on the notion of community. 
The originary Latin communitas, he argues, is rooted in the notion of the munus. This 
can mean a gift, or an office. Importantly for Esposito, it can also refer to an 
obligation. Communitas expresses not a common wealth or interest, but the common 
obligations of the community bond. Consequently, community can imply a 
‘diminishment of one’s own goods and … of oneself’ (2006: 50). Thus, when the 
notion of community is used, it is suggestive of a duty of the individuals that 
comprise it to give of themselves to fulfil the duty of the bond. Community is an 
unsettled indebtedness, an absence that must be filled or recompensed. The 
invocation of community might be seen to produce the sense that people have ‘a 
right,’ or a moral compulsion, to give of themselves.  
It is worth noting that this account confounds sociological understandings of 
community as ‘a valorized alternative, antidote or even cure to the ills that the social 
had not been able to address’ (Rose, 1996: 332). Such a community furnishes 
individuals with affective attachments to a shared identity. Community here is 
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something to which we might belong, but which also belongs to us as an entitlement. 
Esposito contends otherwise. Community is actually driven by this perpetual deficit 
of obligation and so is a source of constant tension. The decision to focus cord blood 
collection has outcomes that do not necessarily speak to the perhaps illusory 
sentiments of community that prop up ‘public’ donation systems. Take, for example, 
the quote below from an administrator working with one of the adult donor registries. 
Here, they reflect on their organisation’s trouble with would-be UCB donors. 
People get so offended when told they can’t give blood … they look 
at this sort of donation like it’s a right. Same with cord blood 
donation … people say, “Well I couldn’t do it at my local hospital” 
... Sometimes altruism completely overrides the need of the patient 
… there’s a fine line between altruism and selfishness. (Participant 
2) 
Healy argues that ‘the gift of life, the dignity of donation and the rhetoric of 
community sit uneasily with the bureaucratic administration of procurement’ (2006: 
112). Here, he is writing about the donation of blood, to which the administrator 
quoted above draws a comparison with UCB donation. People, the administrator 
asserts, ‘get offended’ by the inability to donate, as if donation were ‘a right’. In the 
account, this ‘altruism’ which implies a sense of selflessness, of giving out of 
concern for the welfare of others is not far away from ‘selfishness’.  
This resonates with a point made by Brown who notes that UCB banking in its public 
valence is promoted in reference to the ‘solidaristic moral economy of gift and 
altruistic participation in imagined community and nationhood’ (2013: 98). Brown 
goes on to note a particular discursive emphasis on the wastefulness of not donating. 
The system of procurement is propped up by an altruistic tenor that  
‘…succeeds only if the discursive framework of waste is accepted by 
donors or depositors and works on the basis that UCB has limited 
value outside its clinical usefulness in UCB banking. Waste, as a 
classificatory status, imposes a moral injunction not to squander 
something potentially precious’ (ibid.) 
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With Brown’s point in mind, it might be suggested that it is as though the concern of 
communitas, reciprocating their indebtedness to the community, folds over on itself 
in a harmful way when women feel a compulsion to donate that cannot, in actuality, 
be fulfilled. This highlights the problematic construction of the UCB bank within a 
framework of universal donation, where the moral admonishment of waste is 
invoked to encourage the act of donation. 
The bank instead is built and developed on the platform not of creating access to 
donation but actually closing access off. By appealing to the spirit of communitas and 
the obligation to give of oneself, archivists construct a debt which all in the 
community should feel a responsibility to repay, but which very few actually can. In 
this context, recall the requirement of banks to ‘cluster’ their collecting, rather than 
expand it. The quote below comes from an administrator who oversees the collectors 
of UCB. Here, they reflect on the situation in the collection site in Leicester, run by 
Anthony Nolan. 
There are women who are unhappy if they can’t donate because 
they’re not delivering in the right place. We have women who are 
having home births … we have a stand-alone centre in Melton 
Mowbray. If they deliver there then we can’t do it [collect the 
cord]. We explain that we’re a finite service and we can’t be 
everywhere, we have to concentrate where most babies are being 
born, which is here. (Participant 11) 
The interviewee above describes a situation where the city centre maternity ward 
does not host all the births in the area. If a woman has a home birth, they are not 
‘delivering in the right place’ to permit collection. 14 miles out of the city limits is a 
small rural town called Melton Mowbray, and it is a similar story there. The town is 
famous to most of us for its eponymous pork pies, but probably not so well known 
for its rate of umbilical cord blood donation, which is zero. ‘If they deliver there’, 
explains this participant, ‘we can’t do it’. Again, people are ‘unhappy if they can’t 
donate,’ which echoes preceding quotes. But the implication here is that there is no 
rationality to this unhappiness because the collection site is a ‘finite service’. The 
notion that the collectors cannot be everywhere is suggestive of the selectivity of the 
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practice of collecting and banking UCB tissue. This theme is explicit in the quote 
below from another administrator. 
You get a lot of women who hear about cord blood banking in the 
UK and think “Yes, I want to do that” … Ours is a focused 
collection model … Based on the targets, we don’t really need to 
expand into huge amounts of collection sites. (Participant 8) 
In this account, the ‘focused collection model’ does not allow for the women ‘who 
hear about cord blood banking’ and decide they would like to participate. The 
foundation of this model of collection is the targets. ‘Based on’ these, there is no 
‘need’ for expansion to allow the many women of the UK to donate their cords. To 
refer back to Esposito, there is no requirement for these members of the community 
to fulfil their munus, or duty, even though they ‘hear about’ the possibility of 
contributing to a life-saving resource for their community, and decide they want to 
participate in it. Importantly, though, even if a woman did deliver in one of the 
eligible maternity wards, with staff employed to collect cords to send onwards, there 
is still no guarantee that their cords would be collected for the bank.  
5.4 ‘We Wouldn’t Collect from Them’ 
As we have seen so far, funding, limited and delimited as it can be, forces those 
working with these collections to make decisions about where they will collect UCB. 
As a consequence, they are also making decisions about where not to collect. Whilst 
‘playing off’ the claim that the bank offers a service to donors, this is (as Healy 
(2006) notes of large scale tissue collecting projects) not so much a donation system 
as a procurement system. We can learn more about UCB collection and its 
exclusivity by recourse to literature on blood donation systems where questions of 
exclusivity through selectivity are central. Valentine (2005) notes the propensity to 
morally valorise the selfless blood donor whilst some are ineligible to donate even 
though they have the capacity to. The particularly old and young, the anaemic, those 
who have engaged in sex work or who have ever injected a non-prescription drug, 
any man who has had sex with another man in the last year, anybody who might have 
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recently travelled to a malarial zone. All of these people are ineligible to partake in 
blood donation, the vital act of citizenship.  
We can thus see how the private existences of people (their sexual partners, a lack of 
iron-rich food in their diet, their last summer holiday) are transposed onto their 
(in)eligibility for participation in the vital public. By extension, they are also denied 
access to an avenue for addressing their debt to the community through the act of 
giving. The onerousness of sustaining one’s relation to the community in this way 
demands ascetic self-denial (Copeman, 2009). The policing of eligibility therefore 
problematises an understanding of blood donation as a ‘participatory space of 
belonging’ (Valentine, 2005: 115). We are challenged to rethink public blood 
donation beyond an act both of, and for, community because it is ‘a public practice 
… that certain kinds of public are precluded from’ (ibid.: 116). It is institutional 
safety regulations in blood donation that produce these ‘categories of people’ who 
risk the safety of the national supply of blood (Busby et al., 2014: 89).  
These frameworks of value are also applied in the realm of blood stem cell donation, 
and they become clear when considering UCB banking through an archival lens. All 
archives, suggests Mbembe, are ‘primarily a product of a judgment’ (2002: 20). The 
archival reason (Osborne, 1999) in this instance can be found in trying to gauge the 
safety of the cord blood unit. Tests are undertaken once the cord blood unit has been 
retrieved and sent to the laboratory, but the judgment inherent in archival practice is 
present even earlier on in the process of collection. Whilst all women in a maternity 
unit with collectors could donate their UCB and then have tests completed on all, 
resources get in the way of this too. The quote below comes from an interview with 
the individual who co-ordinates the regional collections of cord blood units for one 
of the public banks. 
Participant 11: We have to give verbal information about the 
program, and this reviews it. They have to tick all the boxes to 
agree. There’s a screening form. If they say ‘yes’ to any of the 
things above that line then we don’t accept. This is our exclusion 
criteria basically, that we work with. And anything else - if they’ve 
got any sort of formulating infection, or if the placenta’s smelly, we 
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wouldn’t collect from them because we wouldn’t want to put 
anybody in danger. 
RW: A lot of that looks like the blood donation– 
Participant 11: It is. Almost word-for-word, it’s the same thing…  
According to Richard Titmuss, successful blood donation systems rely on consistent 
donations from regular donors. In turn, blood safety relies on knowing ‘the state of 
health, the health history, and the social habits of the donor’ (1970: 162). The 
personal integrity of a donor was so important, according to Titmuss, because ‘one 
man’s untruthfulness can reduce another man’s welfare’ (ibid.: 163). The conception 
of ‘safety’ provokes a logic of surveillance, of policing the boundaries of donation. 
In the UCB context, the archival reason embedded in the early stages of the 
individual unit collection process is brought into sharp relief. The archival reasoning 
can be found in these checklists, verbal scripts, and even smell checks. The cord 
blood collector employs a ‘discriminating gaze’ (Featherstone, 2006: 594) from the 
point of procurement. In the account below, the same participant guides me through 
the pages of a cord blood collectors’ advisory guide. 
…So if someone has got Oral Herpes – fresh lesions they must not 
donate. “If lesions are healing, accept”… They might have a 
condition such as diabetes, which lots of women have. If they’re a 
Type-1 diabetic or some other autoimmune condition then they 
won’t be considered as being clinical in the future, so that would 
be one you wouldn’t go for first. You’d go for your straightforward 
woman with no medical conditions. So there are some choices you 
can make... (Participant 11) 
The guidelines of eligibility state that if a woman has oral herpes, she is ineligible. 
But if the contusions in the mouth are in the healing process, the collectors may 
‘accept’ the donor. Similarly, ‘lots of women have’ diabetes, one of the autoimmune 
conditions that render them ineligible to donate a cord that will be ‘clinical in the 
future.’ The implication of this is that the cord would be suitable for research 
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purposes, but that this donor is one that the collector ‘wouldn’t go for first’. The 
‘straightforward’ woman who does not present any of these conditions is the one 
‘you’d go for’ first. ‘Choices’ can, and must, be made. As Beer (2013) argues, the 
archive’s politics live in the processes of such decision-making. This is particularly 
evident in the account below. Here, the same participant describes how having IVF 
prevents women from being able to participate in donation and, importantly, the 
women’s reactions. 
…we have to say no maybe because they’ve had IVF … If they’ve 
had a human product such as a hormone which women will 
generally have had in their treatment then we’re not able to 
collect. It’s like having a blood transfusion. CJD. That’s the 
problem really. So they get upset, they can be very upset. We just 
try and thank them very much, you can help in all sorts of different 
ways. You can tell all your friends, spread the word. That’s what 
we need people to do. It doesn’t, you know, they’re disappointed… 
(Participant 11) 
The comparison of the situation of IVF users coming into contact with ‘human 
products’ with Creutzfeldt-Jakob disease (CJD) is telling. Variant CJD (vCJD) is a 
fatal neurodegenerative disease caused, it is believed, by consuming the meat of 
cows contaminated with Bovine Spongiform Encephalopathy (BSE). As a 2013 
report commissioned by the Department of Health explains, it is thought that up to 1 
in 2,000 people in the UK present an indicator of vCJD because of the presence of 
BSE in the UK food chain in the early nineties. From 1999, all blood donations have 
had the white cells removed ‘in order to reduce any vCJD infectivity present’ 
(Bennet and Daraktchiev, 2013: 2). The paper also describes how from 2004, 
anybody who had received blood components would thereby be ‘excluded from 
donating blood, in order to prevent vCJD … being “recycled” within the population’ 
(ibid.).  
In the UCB domain, collectors must similarly ‘say no’ to the women who have 
received IVF treatment. These women who are rejected become pregnant using new 
reproductive technologies. These are the ‘happy’ rather than ‘hopeless’ narrative 
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category of IVF treatment stories (Franklin, 1990). As Throsby puts it, ‘the desperate 
infertile woman … functions as a cautionary tale’ in the pursuit of IVF success 
where the divorcing of female existence from motherhood is anathema (2004: 64). 
And yet, IVF treatment precludes UCB donation. The successful entry into the 
feminine injunction of motherhood by way of IVF blocks the path to successfully 
complying with the moral injunction not to waste the precious stem cells within 
one’s umbilical cord (Brown, 2013).  
Questions over the quality of donations, then, lie at the heart of exclusionary blood 
donation practices. In a similar way, the exclusion of men who sleep with men is 
directly related to HIV infection via blood transfusions in the United States, where, 
between 1982 and 2001, 14,262 people have been diagnosed with HIV or AIDS 
because of their use of blood products donated in the US (Donegan, 2003). As a 
social group thought more likely to have HIV, closing access to donation for the 
constituency becomes a method of quality assurance. As Titmuss argues, it is 
because of the risk to safety that blood collection services ‘have stressed the great 
importance of maintaining the most rigourous standards in the selection of donors’ 
(1970: 162).  
This rigour, enrolled by collectors of UCB as they employ their archival reason, 
amplifies the exclusionary tenor of the system of procurement. The women excluded 
because of the discriminating gaze of archival practice ‘can be very upset’ or 
‘disappointed’ if archival reason dictated that they were not donors considered to be 
eligible. Their would-be donation is thus rendered one of the ‘unimportant, 
irrelevant, worthless things [that] remain in the profane realm, beyond the archive’ 
(Groys, 2003: 179). This clashes, as we will see, with the expectations of individuals 
who might have hoped they could donate. One participant suggested that would-be 
donors’ concerns might be assuaged by a better understanding of who could benefit 
from the donation.  
Basically donating cord blood in a hospital down the road, it goes 
to a bank that’s available to everyone and that’s something we 
have to make sure the message gets out. That the bank doesn’t 
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serve them, the hospitals they came from; it’s a national resource. 
(Participant 10) 
The act of donating in a hospital ‘down the road’ (we might infer, a hospital local to 
the donor) is not the purpose of the bank which ‘doesn’t serve’ the donor, or their 
hospital. Rather, the bank is a ‘national resource’ ‘available to everyone’ to use. 
Trying to disentangle the notion of a public cord blood initiative from a universal 
donation structure would rely on a reconstruction of cord blood donation away from 
the moral language of waste avoidance (Brown, 2013). Instead, accounts would need 
to be redirected towards a frank assertion about the reality of the initiative. That is, 
most women cannot donate. In this light, might we also need to reconsider the idea of 
the private banking model? Accounts given by interviewees, all connected with the 
public sector of cord blood banking, aired concerns over the quality of the product 
offered by private banks, but not necessarily the notion of the product itself. Below 
are quotes from two different interviewees. 
The private banks have this sort of network of collection, so if you 
think about the national banks are only in certain hospitals, so you 
have to give birth there otherwise you can’t store them, whereas 
private banking accesses women who give birth anywhere in the 
country. (Participant 5) 
So from her point of view, she’s thinking “well this is unfair!” and 
the private banks will say, “well, yes. But we offer it everywhere.” 
… Private banking is something else ... It’s a different offering. 
(Participant 8) 
The first account asserts that private banks are seen to offer a ‘network of collection’. 
If you wish to donate publically, you can only do so ‘in certain hospitals’ whilst the 
private network allows women wishing to preserve their cord to ‘give birth anywhere 
in the country’. The reflections in the second quote resonate with this point. The 
interviewee suggests that, from the potential donor’s point of view, the inability to 
donate is ‘unfair’. In this way, private banks can be more universal, because they are 
able to offer the service ‘everywhere.’ The private bank can be conceptualised as an 
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avenue for those women who cannot donate to participate in the act of stem cell 
storage which stands to challenge the private/public binary offered by sociological 
accounts that pitch, as Brown et al. put it, ‘a solidaristic ethos of community 
inclusion against the atomistic seclusion of the self’ (2011: 1116). The capitalistic 
motivations of private banks overshadow individuals’ motivations to bank privately, 
which stand to be produced out of the exclusionary practices of public banking. 
5.5 Ethnic Exclusivity 
The practice of collecting UCB into banks for public use is, as we are beginning to 
see, clearly exclusionary. A lack of funding might stop expansion into more 
hospitals. Particular kinds of funding might demand certain qualities of the area in 
which the collection site is to be placed. The pregnant women who wish to donate, 
but are not able to attend the chosen maternity unit, are excluded. We also see 
resonances with other kinds of tissue collection practices, particularly blood 
donation, in that even if a woman does attend a chosen maternity unit, she might not 
be a safe enough donor. There is even more to be considered in terms of 
understanding the UCB collection as an exclusionary space. As we saw in the last 
chapter, adult donor registry data come mainly from volunteers who self-identify as 
white. Briefly, I mentioned that the focus on ethnic minorities has been employed to 
try and augment their donations in UCB banks. Here, I want to consider how that 
focus plays out in practice, and how it produces another vector of archival exclusion. 
Take, for example, the quote below from a participant involved in the APPG.  
We want to focus on hospitals which have a high birth rate. 
Preferably a high birth rate of diverse ethnic mothers and that’s 
what we’re focused on. So Mrs Jones out in little Bollock-on-the-
Wold going into her local maternity hospital? She doesn’t have 
access to that. (Participant 8) 
Here, the administrator offers an example which alludes to how donors’ ethnicities 
enfold into decisions about which maternity units are to be selected as collection 
sites. The hypothetical Mrs Jones resides in the coarsely-named, fictional Bollock-
on-the-Wold which is reminiscent of the similarly hyphenated Cotswolds town of 
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Stow-on-the-Wold. Mrs Jones, her whiteness duly inferred by a traditional rural 
residence and one of the most common British surnames in the UK census (McElduff 
et al., 2008) is not in the scope of ‘focus’. Instead, this is placed on hospitals where 
there are ‘diverse ethnic mothers’. It is not too much of a stretch here to see the 
inference. The participant seems conscious of the fact that selecting urban hospitals 
with high concentrations of minority ethnicity women closes off access to white 
women in rural areas. Whilst whiteness is only implied here, rural areas in Britain 
traditionally have a much smaller concentration of ethnic minorities than do urban 
centres (Garner and Bhattacharyya, 2011; Parkinson et al., 2006).5 
To make sense of this, it is worth returning to our archival lens. Featherstone notes 
the tensions at work in archival decision-making, writing that ‘the archive should be 
as exhaustive as possible’ (2006: 593). By and large, archivists believe that they 
should incorporate a diverse breadth of matter into the archive, thus readying 
themselves for the unknown future. Groys calls this a ‘mandate for completeness’ 
(2003: 182), in that there is an onus on archivists to ensure that they offer a 
comprehensive and representative range of matter to users. Why spend one’s 
resources on banking what are believed to be common, ‘white’ stem cells when there 
is a lack of rare, ‘minority’ stem cells that could be addressed through focused 
collection? 
This is, I would argue, not unlike Bowker’s point that in the effort to produce 
biodiversity databases, a spread of diversity across the archive is preferable to 
‘preserving a large number of species within a spread of genetic difference’ (2005: 
                                                 
5 Parkinson et al. assert that the dimensions of Black and minority ethnicity (BAME) 
geography has ‘a clear urban-rural gradient’ (2006: 52). They also note that the distribution 
is heavily weighted towards London, but that other large and small cities across England saw 
an increase in BAME residents and a decrease in white residents between the 1991 and 2001 
censuses. This is, as Garner and Bhattacharyya assert, because ‘of original settlement 
patterns around London and the larger industrial bases throughout the Midlands and the 
North of England’ (2011: 5) 
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207, my italics). Maximising diversity is key in the database. Accordingly, an 
understanding of HLA diversity as linked to ethnicity (see Williams, 2015), for 
instance, is instructive in where UCB is collected. Collection sites not only need to 
meet funding criteria, but must fit within this logic where ethnicity is seen to be 
important. The quote below comes from interviews with two individuals involved in 
the APPG. 
A petition went on in Manchester by the MP … to have a collection 
site opened there and that’s why we’ve ended up in Manchester. 
Again, another place with lots of babies and good diversity. 
(Participant 11) 
…we collect at King’s … because King’s has a huge number of 
ethnic minorities … You basically target the region because that’s 
where there are lots of mothers of ethnic minority groups. 
(Participant 1) 
In the first quote, the interviewee explains that a collection site in Manchester is a 
rational choice not only because of the density of births – ‘lots of babies’ – but also 
the high numbers of women coming from ‘ethnic minority groups.’ Echoing this, the 
second quote notes that King’s College Hospital (one of the London collection sites) 
is a similarly attractive collection site. The hospital has a ‘huge number of ethnic 
minorities’. Ethnicity, and the consensus on its connection to tissue-type rarity, is 
pivotal in how the archival mandate for completeness is understood. 
It is worth noting that the construction of rarity in minority ethnicity tissue might be 
seen as rooted in a particular and problematic history. Titmuss was attuned to it, 
cautioning his readers to remember the ‘contemporary world-wide phenomena of 
racial prejudice and its association with concepts of blood impurities, ‘good’ blood 
and ‘bad’ blood, untouchability and contamination’ (1970: 20). I would argue, 
though, that what we see here is a kind of inversion of this. Black UCB and Asian 
UCB (the most useful, molar categorisation for otherwise molecular distinctions) is 
imbued with a kind of value because of its rarity. It becomes vital that such tissue be 
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collected and stored away. How, then, is this understanding put into practice at a 
policy level? Consider this extract from the Stem Cell Strategic Forum, below. 
‘Since 45% of ethnic minority individuals live in and around London 
… it follows that an ethnically diverse cord blood inventory may 
best be achieved by collecting cord blood units primarily from 
London hospitals with maternity units with over 5000 births per 
annum.’ (UK Stem Cell Strategic Forum, 2010b: 35) 
As the extract explains, nearly half the ethnic minority population of England lives in 
London and its surrounding areas. To evidence this claim, it refers to a visualisation 
of the spread of ethnic minority people (and their inherent bodily resources) by 
mapping census data from the 2001 census (UK Stem Cell Strategic Forum, 2010b: 
35), reproduced below. In the map, darker areas represent a higher presence of 
minority ethnicities 
Figure 9: The distribution of minority ethnicity people across the UK reproduced 
from Stem Cell Strategic Forum report (2014b) 
 
134 
 
Through the use of census data, a means of measuring the population, the collection 
managers attempt to combat the underrepresentation of minorities. They do this by 
focusing more intensely on those excluded bodies. By focusing in this way, their 
work actively excludes particular locations and the people in them. Mrs Jones over in 
the Cotswolds has no place in this plan (because she is already represented in the 
adult registry), whilst minority ethnicity status is enrolled as a target for the bank. To 
use Achille Mbembe’s words, this is an archival ‘montage of fragments’. The 
archivists wish to mirror the country’s population, but they can only do so in a 
fragmented and partial way. And yet, as Mbembe goes on to say, this effort creates 
an ‘illusion of totality and continuity’ (Mbembe, 2002: 21). This perceived need to 
focus gives imprimatur to the geographic exclusion of large parts of the country, and 
speaks directly to Stoler’s suggestion that the work of the archivist tends more 
toward ‘an extractive enterprise than an ethnographic one’ (2002: 84).  
Discussing blood donation systems, Titmuss recognises the possibility ‘that because 
one’s blood is rare or unique,’ an individual might be made to feel a ‘particular 
responsibility to make it available to others who may need it’ (1970: 263). This onus 
to make their vitality available can manifest in what Titmuss calls the ‘captive 
voluntary donor’ who, if they choose not to donate, risks the shame of ‘the relevant 
social group’ applying moral pressure (1970: 96). Although Titmuss is talking about 
blood donation rather than stem cell donation, the point is echoed in a quote from an 
individual involved in an organisation that encourages adult volunteer, organ, and 
cord blood stem cell donation amongst ethnic minorities. 
…whether it be bone marrow, cord blood, organ donation [our 
organisation is] highlighting … how race is important in terms of 
matching … we are the vanguard of this movement of getting 
ethnic minorities, especially Black and mixed raced people to 
realise: take your health seriously, especially when it comes to 
cancers and especially when it relates directly to race. You need to 
be ready to try and help someone else because you never know 
when you might need it yourself … That’s a very specialised 
message that’s got to be … couched in a way that will resonate 
with families and mothers-to-be when they hear it. (Participant 4) 
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In this account, the interviewee positions their movement as a ‘vanguard’. The 
militaristic inference is suggestive of being on the frontline of a battle in bringing 
ethnic minorities to a realisation. The military tactic could be seen as an invocation 
of the munus. The participant puts this quite bluntly, stating that one must be ‘ready 
to try and help someone else because you never know when you might need it 
yourself’. This network of munus, the insatiable obligation to others in the group, 
must be ‘couched’ so that it will ‘resonate’ with the potential cord blood donors. This 
affective resonance is a central element in the augmentation of donation. Awareness 
raising is therefore not simply about highlighting the illness and the statistical 
probabilities, but of highlighting potential donors’ responsibilities to the community.  
This sentiment is explored by Kierans and Cooper (2011), who consider the manner 
in which organ transplant policy reproduces notions of racialised genetic difference. 
They argue that this discourse of difference constructs the issue of organ donation as 
a cultural one that falls beyond the remit of medicine, and which thereby racialises 
the responsibility to donate by placing the onus onto these ‘different’ communities 
themselves. Tensions emerging from community-led campaigns to promote adult 
donor registration speak to the same concerns that Kierans and Cooper have of 
similar organ donation campaigns which ‘amplify the idea that donation is the 
collective responsibility of biologically, socially and culturally distinct and 
distinguishable communities’ (2011: 14). In this context, consider the quote below 
from the same patient activist as above. 
Because we’re talking about life and death. We don’t take any 
prisoners on this, we are hard hitting. We won’t compromise – 
especially with the black community – on pussyfooting around 
these subject matters … For many years, our motto was a 
quotation from Malcolm X. Our motto was “by any means 
necessary” … And we are probably now as hard on our community 
…than ever before. So we don’t compromise at all on this. 
(Participant 4) 
This language – ‘We don’t take any prisoners’, and a motto from the Muslim 
minister and Black luminary Malcolm X – indicates a sober resolve to highlight both 
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the community’s difference. It also indicates a consciousness of some obligation to 
itself that, remaining unfulfilled, amounts to what Ruha Benjamin has elsewhere 
called a kind of ‘civic defection’ (2013: 44). 
This racialised difference-making lies at the centre of Kierans and Cooper’s 
argument. They argue that by highlighting difference, one risks the ‘further 
entrenchment of such difference’ (2011: 14). This entrenchment becomes 
problematic when, as Kierans and Cooper explain, the microcosmic reproduction of 
Titmuss’s original advocation of intercorporeal generosity along ethnic lines actually 
comes to ‘contradict the wider communitarian and inclusive vision of society upon 
which this view was originally built’ (2011: 11). Communitas is perversely inverted. 
Communities within the larger population are indebted to one another inside the 
same reified ethnic circle. This risks challenging, at least in spirit, the notion that 
donors should not be given the option to prescribe their potential recipient’s 
characteristics (Titmuss, 1970). One interviewer touched upon this when they 
reflected on the state of adult donor registries in the nineties. 
So I was involved in the very early days, when we just didn’t have 
any Afro-Caribbean patients. And it’s quite interesting because 
they used to do, even in those days, some early drives. And you 
quite often got Afro-Caribbean donors coming forward saying 
“we’ll donate but only to an Afro-Caribbean child” … sort of very 
ethnically driven … quite frequently people would say that. 
(Participant 1) 
In this account, the participant points out that minority donors would come forward 
with a caveat that their stem cells only be used by another person with the same 
ethnicity as them. The idea that donation was ‘ethnically driven’ is interesting, but 
perhaps not so surprising with the kind of messages enrolled in encouraging the 
donation in the first place. By reproducing a racialised difference in encouraging 
donation, accounts of the munus or indebtedness coalesce around this same ethnic 
line. The onus to help then becomes sealed within the differentiated community itself. 
If donation systems enforce an image of a sealed ethnic community that must help 
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itself, as Kierans and Cooper suggest, then indebtedness and the drive to give only 
within said community makes sense.  
But with this in mind, it is perhaps worth remembering that as well as having the 
ability to reify categories of difference, transplant technologies can effectively 
transcend them. In Beck’s account of the unified stem cell donation system of 
Cyprus, he describes the biopolitical unification of Turkish- and Greek-Cypriot 
bodies that come to embody a ‘vital public’ distinguishable from the ‘political public 
in the classical sense’ (2011: 113). This highlights the need to consider how both 
group-specific and nation-wide appeals to give belie ‘the complex layering of myriad 
networks of individual association, action, and intention that animate the social and 
moral worlds in which people actually live and die’ (Simpson, 2014: 6). 
5.6 Conclusion 
In response to the last chapter’s concern with inclusion, this chapter has picked up 
the threads of exclusion produced out of a demand for the UCB bank managers to 
ensure their collections are representative. This empirical chapter, then, has been 
broadly concerned with what kinds of conditions preclude the act of UCB donation. 
The limitations (and delimitations) of resources decide to an extent how many 
collection centres there are and where they should be. The ethnic composition of the 
area served by a maternity unit also has some bearing on this, whilst the choice over 
which units will be collected within that already lessened pool of potential donors is 
made in reference to other selection criteria that further filter the access to donation.  
What do we learn from having critically explored the state of play regarding access 
to UCB donation? Firstly, we get a sense of who is excluded, along with why they 
are excluded, which gives us some sense that the jussive force of this archive is at 
work. This force, as Bowker writes, ‘operates through being invisibly exclusionary. 
The invisibility is an important feature here: the archive presents itself as being the 
set of all possible statements, rather than the law of what can be said’ (2005: 14). To 
my mind, what Bowker is saying here speaks to what we see happening in the UK 
context of public UCB donation. It works in the system’s interest for those involved 
in the management of UCB collection and collections to portray what they provide as 
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a universal service. At its visible level, public UCB collection is surely a great thing, 
a communitarian giving of self to fulfil the insatiable debt of the commons. Every 
woman’s donation awaits its entry to the ‘set of all possible statements’. At the 
invisible level, public UCB donation is not something just any woman can do. If one 
is lucky enough to live in the right city (eligible for funding, sufficiently composed 
of minority ethnicities, and therefore chosen to have a collection site), there’s scope 
(though, as we have seen, no guarantee of) donation. The various vectors of 
exclusion that make up archival practice in this instance are thus Bowker’s ‘law of 
what can be said’.  
Secondly, what we see here despite all the donors and all the donation, is a system of 
procurement (to use Healy’s (2006) phrasing). Indeed, my own use of such terms 
(and the challenge I have found it to employ any other word than ‘donor’) bespeaks 
the prevalence of the framing of these systems as ones of donation. As irritated, 
upset, or guilty as anybody might be made by what we see here, the scenario is borne 
out of the fact that those in charge neither want nor require every unit that could 
potentially be collected in the UK. It is the discriminatory gaze and the exclusion it 
produces that defines the practices here. In our context, producing a useful collection 
for the public’s use ironically requires preclusion of public contribution to it.  
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Chapter Six: Using the Archive 
6.1 Introduction 
In the last two chapters, we have explored the roles of order and selectivity within 
the UK’s public UCB collections. Here, I want to explore how these collections 
come to be used. In the spirit of the archival lens, it might be said that this chapter 
offers a contribution to the literature on archival ‘user studies’, an area that those 
writing about archives often lament as remaining fairly underexplored (Conway, 
2010; Johnson, 2008; Sundqvist, 2007). What I want to plot out in the following 
discussion is the way in which the umbilical cord blood banks in question stand to be 
used (or indeed overlooked) in users’ efforts to find what they are looking for. How, 
put simply, is use made of these archives? 
To begin exploring this question, this chapter considers what might be thought of as 
the standards of medical practice that have been produced to guide clinicians in 
making their selection of HSCs. The British donor selection algorithm (Shaw et al., 
2009) is a professional, published consensus statement designed to recommend 
particular treatment paths in a given scenario. In what follows, I consider how this 
tool that guides potential users to the archive, requires regular updating itself to keep 
in step with technological advances in tissue matching, before looking at the 
important local, idiosyncratic (Knorr, 1979) iterations of such standards. What 
emerges here is that, alongside the more rational register of decision-making in the 
scenario of HSC selection, is a considerably more affective layer in which particular 
clinicians are comfortable using particular kinds of HSCs, something which I 
conceptualise as ‘clinical comfort’. 
Throughout the chapter, I tackle how those working with these selective collections 
operate in light of these changing standards and subjective preferences. How, I 
consider in what follows, does their desire to encourage archival use (Kaplan, 2002) 
actually manifest in a space governed to an extent by both an experiential layer of 
affect and a stratum of continually transforming standardisation. With this in mind, I 
look at how clinicians are drawn to the archive, or are compelled to take the risk with 
UCB which is, to them, a new and risky technology. As I demonstrate, subjective 
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preference governs interactions well beyond opting to search for cord. This 
preference also emerges when it comes to the task of selecting which cord to use. To 
anchor the exploration, I focus on the issue of a unit’s Total Nucleated Cell (TNC) 
count. Recent data suggest that larger TNC counts, or cell doses, are a feature of 
more successfully engrafted units. Clinicians’ preference for these units has changed 
the kind of demand the UCB archive is experiencing and, thus, what matter the 
archivists are collecting and putting into the collections for future use. The chapter 
concludes by making a case for appreciating that UCB collections, like all useful 
archives, can only be understood in reference to the demands of their users.  
6.2 Professional Standards and Local Idiosyncrasies 
To preface the discussion that follows in this chapter, it is worth plotting out the 
process of how a UCB unit travels from the freezer to the clinic. Figure 10, below, 
taken from the publically accessible Anthony Nolan Operation Guide (2012: 5), plots 
out a sort of UCB unit search process ideal type. The image divides transplant 
centres (TCs) and the charity that performs the tissue search, Anthony Nolan (AN). It 
represents the manner in which a UCB unit is requested, located, chosen and 
dispatched. It is a representation used to visually describe the process of search and 
selection to anybody interested enough to read it – perhaps clinicians, charity 
workers, or policy makers. Unsurprisingly, it does not (and, I would argue, can not) 
convey the complexity of the actuality of unit selection. Its use lies simply in 
demonstrating the key moments in any instance of a search.  
This is a fairly straightforward process in which a ‘SEARCH REQUEST’ prompts 
those at the bank to undergo three blue boxes’ worth of archival searches. All 
pertinent units are located (LISTING). The archivists then produce a list (REPORT) 
then filter that list based on the relevant figures (set out next to the blue boxes). The 
archive workers then produce a set of results (SHORT LIST) sent to the clinician to 
be ranked (RANKING). This colourful image is suggestive of a rational, processual 
task of archival use, guided in the main by the archivist (in the case of Figure 10, 
‘AN’) who does most of the work then gives the final choice to those at the 
transplant centre. 
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Figure 10: Anthony Nolan’s cord blood ‘search algorithm’ flow chart reproduced by 
Anthony Nolan Operation Guide (2012). 
 
The process of a search is succinctly laid out and demonstrates how the ‘archivist, as 
digitizer, system builder, and interface architect, plays a fundamental mediating role’ 
(Conway, 2010: 427) in how their selective collection will be used. Indeed, we could 
leave the chapter at that and have a fairly clear sense of the basic way in which use is 
currently made of these umbilical cord blood banks. That is, a search, a list, a choice, 
and a delivery. However, to end the account there would be to omit important 
elements enfolded into whether use is made of this archive at all.  
Readers will recall the first sentences of the introductory chapter, where I posited a 
scenario in which your clinician suggested you had a chance of surviving your 
illness. This chance was some stem cells in a freezer. How, though, did your 
clinician know they were there? Why did they even think to look? To refer back to 
the colourful flow chart (Figure 10), why was that burgundy ‘SEARCH REQUEST’ 
made in the first place? The answers to these questions seem fairly obvious. UCB is 
an HSC source that clinicians know about and use to treat their patients. But, as I 
explore here, HSC was not always a source, not all clinicians are familiar with it, and 
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certainly not all of them will use HSCs from UCB in the course of care for patients 
who might benefit from them. As this chapter unpacks, it cannot be assumed that 
these collections will be used. As Conway notes in his study of those using 
photographic archives, different expert users of archives all have their own ways of 
choosing which archives to use and how to navigate them. There are different 
‘modes of seeing’ archives that are informed by the highly variegated ‘distribution of 
user expectations’ (2010: 459). I want, then, to spend some time thinking about what 
user expectations might be black-boxed (or burgundy-boxed) in the first phase of 
archival use, the ‘RESEARCH REQUEST’. Put differently, to understand how use is 
made of these archival spaces requires us to think about why a clinician would even 
think to use one of them in the first place.  
A good place to start looking for answers to this is the professional standards created 
to guide clinicians in their decision-making processes. Berg and Timmermans argue 
that such standards are an attempt to ‘rationalize medical work’, thus making clinical 
practice ‘more “scientific” by invoking formal technologies and by erasing 
unwarranted local variations’ (2000: 36). The British Cord Blood Working Group 
was developed by a group of scientists and clinicians interested in setting a protocol 
based on the knowledge produced in the course of their own practice, to offer 
guidance and a reference point for UK clinicians working with cord. A means of 
doing this was the production of a consensus statement and a ‘donor selection 
algorithm’, which I have reproduced below. This was published by Shaw et al. 
(2009: 10) and the algorithm was reproduced in the Stem Cell Strategic Forum’s 
report (2010b: 12), testament to its relevance as perceived by those planning out the 
future of clinical HSC provision. ‘We recommend,’ says the text accompanying the 
algorithm in the original journal article, ‘that the nationally agreed donor selection 
algorithms should be used’ (Shaw et al., 2009: 10), in lieu – we might infer – of a 
non-nationally agreed, personal choice on the part of the individual practitioner. 
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Figure 11: Shaw et al.’s ‘donor selection algorithm’, reproduced from 2009 working 
group consensus statement. 
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Before laying out the relevance of the table, it is worth briefly explaining how to read 
it. This table posits what we might think of as four illness scenarios. The first (a) is a 
childhood malignant disease. The second (b) is the same kind of disease in an adult. 
The presentation of metabolic disease is the third (c) scenario, and marrow failure (d) 
is posited as the fourth. The ranking of treatment options (1st, 2nd, 3rd, and 4th) make 
reference to the column headings, which represent the clinician’s choices of source. 
The first choice is a ‘family donor’. This comprises HSCs from a related donor, via 
either bone marrow or peripheral blood or by UCB taken during a sibling’s birth. The 
second choice is a ‘volunteer unrelated donor’. This would be HSCs taken from an 
adult donor via their bone marrow or from their peripheral blood and would be 
located via a volunteer adult donor registry. Finally, the ‘unrelated cord’ describes 
any anonymous UCB unit from an umbilical cord blood bank.  
Positing an instance in which a patient presents with marrow failure (scenario d), we 
can see how the Cord Blood Working Group recommends we move forward. In the 
1st instance, a matched family donor or cord is preferable. If this is not possible, the 
table then advises that the 2nd best option is to use HSCs from a volunteer unrelated 
donor. Simple so far, but if the ideal 10/10 unrelated donor match cannot be located, 
the 3rd option offers three choices: 
 an unrelated, volunteer adult donor who can offer a 9/10 match, or 
 an unrelated UCB unit with a 6/6 match, or  
 an unrelated UCB unit with a 5/6 match, but with a Total Nucleated Cell 
(TNC) dose greater than 3 x 107/kg. 
 
These three are equivalents in this table. We could choose any of these three. Indeed, 
these are only recommendations so we could choose to disregard the table altogether. 
In the scenario that a practitioner has all of these options available to them, they then 
have to choose. Choice, or selectivity within these collections, as we saw in the last 
two empirical chapters, is met with selectivity beforehand on the part of the 
collections’ users. Clinical standards, in this way, can be seen as part of the selective 
prelude to archival use.  
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Choice permeates this archive. But what does the Cord Blood Working Group’s 
attempt to order preference tell us? In understanding the pertinence of this table, it is 
perhaps useful to consider Harry Collins’ discussion of scientific knowledge 
transmission. Exploring the ways through which knowledge is thought to be 
transmitted between individuals and groups, he posits the notion of algorithmic 
learning. This is the transmission of knowledge ‘through information channels, such 
as scientific journals’. In this model, there is the implicit assumption that ‘what there 
is to be known can be constrained in a set of discrete bits of information and logical 
instructions’ (2012: 323). The table from Shaw et al., it might be argued, represents 
the algorithmic model. It assumes that knowledge is best conveyed through logical 
instructions and so treatment options are ranked (1st, 2nd, 3rd, 4th) for a number of 
illness scenarios (a, b, c and d). Importantly the information is conveyed through a 
leading professional journal, Bone Marrow Transplantation. 
In addition to this, the table can be seen as an attempt to bring order to the practice of 
tissue selection. This speaks to a point raised by Berg and Timmermans in their 
discussion of clinical decision-making devices. The logic that produces these models, 
they argue, necessarily posits existing practices as ones defined by disorder. Messy, 
non-rational practices are thus in need of replacement with ‘scientifically established, 
rational, and universal modes of working and understanding’ (2000: 31) that can be 
referred to so that practitioners can achieve optimal outcomes for their patients. In 
reality, however, these reference tools are prone to adaptation. Embodied in these 
tools is ‘the never-ending need to tinker, to work around, to articulate loose ends’ 
(ibid.: 51). Indeed, this point is made in the very publication in which the national 
consensus algorithm appears. 
‘It is unclear at this stage how the use of double UCB units may 
affect selection criteria. It was noted that data in cord blood 
transplantation were becoming available on outcomes when 
selection was based on other parameters (for example, CD34 counts) 
and that, therefore, these selection algorithms will need regular 
review and updating’ (Shaw et al., 2009: 10) 
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The potential increase in use of two smaller matching cords (‘double UCB units), 
instead of one larger one, may change the algorithm down the line. New parameters 
– for example, different kinds of stem cells with the unit (CD34 cells in this instance) 
– may eventually be seen as more important than they appeared in 2009 and again 
cause the algorithm to change. This excerpt is an acknowledgement that selection 
criteria are likely to change in ways that are, in the present, ‘unclear.’ As such, 
written into the algorithmic transmission of knowledge is the inevitability of ‘review’ 
and of change, or ‘updating’. As was noted in the first chapter, the field of HSC 
transplantation has always been something of an unknown terrain developed in 
research studies and small scale trials. The technology has, since its instantiation, 
been predicated on the understanding that there was more to uncover and know about 
how the treatment works. The quote below comes from a scientist analysing data of 
current international stem cell stocks. 
We’re basically curing because it works, not because we 
understand … how the illness works … since we don’t have this 
global knowledge, well you have research that advances every year 
and thus introduces new aspects that you have been disregarding 
thus far. (Participant 17) 
In this account, the scientist asserts that ‘we don’t have this global knowledge,’ a 
knowledge perhaps presumed by the existence of donor selection algorithms like the 
one above. Indeed, practitioners operate with a limited understanding of ‘how the 
illness works’ and it is an area that comes to be defined by the gradual emergence of 
‘new aspects’ so far not recognised as important in the field. These thoughts echo the 
reflections of Donnall Thomas, the transplantation scientist awarded a Nobel Price 
discussed in the first chapter. Reflecting on the sporadic successes with the early 
animal models that his team was experimenting on, he noted that ‘evidently it could 
be done - we just had to find out how’ (1994: 341).  
Transplantation can be thought of a domain defined by scientific research, by 
‘finding out how’. Patients treated with HSCs from a UCB unit may become a datum 
in a research publication whilst, say, a patient treated for a broken arm probably 
would not be. Practitioners are still learning about the immunological illnesses and 
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the technologies they can use to cure them. With this in mind, consider the interview 
quote from a member of the Cord Blood Working Group that published the selection 
algorithm. They explained how part of the group’s function now was to update that 
consensus algorithm.  
So part of the thing [we are] thrashing out is, if you have a patient, 
what order you should pick your donors in. And where cords fit 
into that … even amongst cord experts there’s differences of 
opinion. (Participant 5) 
The notion of ‘thrashing out’ – exhaustive, vigorous discussion – resonates with the 
point made by Berg and Timmermans that ‘messy, real-time work’ (2000: 52) is 
required to sustain such decision making tools. Repair and refreshment are necessary 
to make standards work (Lampland and Star, 2009), as they are always at risk of 
‘falling apart under changing circumstances’ (Timmermans, 2015: 80). Building on 
this, it is hardly surprising that it is not an easy task to produce the selection 
algorithm. Another quote from the same interviewee as above exemplifies this well. 
As soon as I can get our experts to finally agree, because although 
everyone agreed in the room. The fine print – there’s emails 
coming forwards and backwards, and then it needs approval for 
various things. But I would hope that that would be submitted for 
publication before the end of the year. (Participant 5) 
The selection algorithm is essentially a composite of the preferences of a number of 
experts. The production of consensus and the consensus itself look nothing alike. The 
table above, for example, reveals nothing of the ‘forwards and backwards’ of emails. 
Its rational lists of ranks and ailments belie the effort of getting ‘our experts to finally 
agree.’ This quote echoes a point made by Bowker and Star. They argue that 
professional classifications, which are central in the management of many 
enterprises, are ‘a contested site of great political significance’ (Bowker and Star, 
1999: 229). Perhaps tellingly, I interviewed the founder of the working group in 
November 2013. As of September 2015, the consensus statement has not yet been 
published. The inevitable review and updating of standards raises questions about 
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how archivists are supposed to respond. If recommendations are regularly changing 
what clinicians are advised to select, then these archivists must also have to adapt 
what matter they have to retain. Without doing so, they surely risk their inventories 
becoming obsolete – collections full of units that have lost their usefulness in 
reference to criteria that have changed around them. This is a point I want to return to 
in more depth in the next chapter, but for now I want to remain with the issue of use. 
The quote below comes from an administrator at a UK cord blood bank. 
They’re refining the consensus statement. The cord blood working 
group meeting has moved cord up the algorithm. So I think they’re, 
we’re making progress, but it’s not just about us sitting in the bank 
saying “this is what they should be using.” (Participant 8) 
Those working at the bank, then, see important ‘progress’ in cord’s movement ‘up 
the algorithm’. This suggests an archival awareness of the importance of these kinds 
of standards in the use of these collections. Importantly, though, the administrator’s 
account also implies an amount of exasperation as to the capacity of archivists to 
affect the decision of clinicians to become archive users. Harris, for example, 
suggests that those managing archives ‘must go beyond merely servers of record 
users. They must become creators of users’ (2002: 148). But in the actuality of 
collections administration in the bank as described in the account above, it is ‘not just 
about us’ telling clinicians that their collection is ‘what they should be using’. So 
what else, or who else, might it be about? 
The account bespeaks a complexity behind the changing clinical standards that 
cannot be addressed by simply creating users, to use Harris’ term. Perhaps it would 
be this simple if there were profession-wide consensus about what is important or 
relevant to the process of tissue selection. However, Knorr argues that relevance and 
importance are never stably defined and never ‘standardized throughout’ scientific 
communities (1979: 361). Behind her argument is the notion of idiosyncrasy. 
‘Choice and interpretations,’ she clarifies, ‘are crystallizations of order in a local 
contingency space’. Her argument, developed in reference to scientific laboratory 
work, resonates in our context.  
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Figure 12: (below) A transplant centre’s ‘donor hierarchy’ for paediatric leukaemia 
reproduced from APPG presentation 
 
 
Figure 13: (below) A transplant centre’s ‘donor hierarchy’ for metabolic disease 
reproduced from APPG presentation 
 
 
For example, take the above images (Figure 12 and Figure 13) which are reproduced 
from the slides of a presentation at an APPG. During the APPG meeting, Participant 
1 who presented these ‘hierarchies’ explained that they could be referred to in their 
transplant centre when a clinician was faced with a choice of clinical options, a 
situation they claimed was becoming more common. Importantly, these hierarchies 
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exist in addition to the national consensus algorithm discussed earlier in the chapter. 
By the simple fact of their co-existence we can see how, as Knorr puts it, ‘research 
sites develop local interpretations of methodical rules, a know how referring to what 
is meant and how to best make things work in the face of a codified literature’ (1979: 
359, original italics), the codified literature being the guidance provided via the 
algorithmic transmission of a published donor selection algorithm. The practitioner 
described how they and colleagues at the transplant centre will ‘go through the 
boxes’ (observation notes, APPG September 2013), starting at the top and working 
downwards. They explained that the decision must take into consideration issues of 
availability, access and cost. I asked the participant to expand on this point in their 
presentation during an interview. 
If you have a good matched adult or a good cord that’s fine. When 
you get to the mismatches, you see on the hierarchies you’ve got 
these choices … you can use a mismatched unrelated … you can 
use a mismatched cord. They’re all on the same band. (Participant 
1) 
Here, they describe the hierarchy. ‘A matched adult or a good cord’ is the ideal 
situation. But ‘when you get the mismatches’, that is – if you cannot find a matching 
family donor (an MFD, as the tables refer to it), the practitioner has ‘got these 
choices.’ Referring back to the hierarchies reproduced above, we can see how the 
clinician is talking about the 1st choice, an MFD or a matched UCB unit. If neither of 
these options from the family is available, the next most preferable choice could then 
be considered. In this scenario, there are other options ‘on the same band’. Thus, the 
practitioners working in this hospital refer to this hierarchy and may still have to 
make a choice between an 8/8 matched unrelated adult donor or a 6/6 matched 
unrelated UCB unit. These hierarchies, like the algorithm, are tools of clinical 
decision making. Importantly, though, the quote reveals the centrality of choice 
within these seemingly rational tools. Berg and Timmermans similarly argue that the 
seeming order imposed by a tool like a transplant centre hierarchy actually compels 
judgement. They write that ‘logic has to be complemented with judgments devoid of 
rigorous calculation,’ (2000: 53) as if the more rational register of selection must run 
parallel to a different, perhaps more affective, repertoire. 
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6.3 Clinical Comfort 
Given the contingency of archival use as it is so far emerging, the challenge of what 
Harris calls ‘archival outreach’ wherein collections workers ‘reach out to users and 
create new users’ (2002: 150) comes into sharp relief. Alongside tables of 
recommendations – both nationally and in hospitals – are the people who are using 
them. Each practitioner is a person, each having to make a decision for their patient 
in the face of circumstances peculiar to the given situation. In an interview, the 
practitioner who presented the transplant centre hierarchy at the APPG reflected on 
why, as is noted in the SCSF report (2010b: 73), some transplant centres are less 
likely to use UCB in HSC treatments.  
We were quite slow to use cord. We used different sources. We 
used mismatched adults and parents, but just lately we’ve got much 
more into cord … we’ve found new properties of cord that actually 
we think give us advantage over adult cells … we have a lot of 
research going on around that as well. … 2010 we did more cord 
transplants than adult, from unrelated donors. So that was very 
unusual for us … different centres like doing different – and 
they’re better at doing – different [HSC sources]. (Participant 1) 
In this quote, the interviewee attests that using a lot of cords was very ‘unusual’ for 
their transplant centre. But the shift in practice that they describe demonstrates that 
the status quo can change. In this account, we see how knowledge transfer thus need 
not be algorithmic, occurring through the traditional channels of output (Collins, 
2012). To ‘think’ there is an advantage is, according to this practitioner’s reflection, 
sufficient for practices to transform. In the local setting, there has been a gradual 
‘slow’ shift in practice in which UCB begins to be more frequently chosen and used. 
The research does not have to be published, but can be ‘going on.’ Indeed, Knorr 
(1979) argues that standard procedures such as publication are too slow for scientific 
practice. As Collins and Evans put it, ‘scientific knowledge takes a long time to 
make and therefore scientists are often pressed to make authoritative decisions on 
technical matters before there is an consensual knowledge on which to base them’ 
(2007: 8).  
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In addition to this, though, the different transplant centres will ‘like’ and be ‘better’ 
at using different HSC sources. The practitioner notes that at their transplant centre, 
clinicians have ‘got much more into cord,’ a phrase usually reserved for developing 
an interest in a new topic or hobby. It implies an almost Bourdieusian sense of taste 
in which one might get into hip-hop, get into yoga, get into the history of the 
Plantagenet kings. The account of this practitioner where they explain that one might 
get into cord bespeaks how preference works its way into a seemingly objective 
hierarchy. Broadly speaking, the archive itself is a noted space for the expression of 
taste (Good, 2013; Liu, 2007). But what we see here is slightly different. There is an 
affective register of ‘liking’ and ‘getting into’ that runs parallel to the rational 
register of standards and hierarchies that determine whether use is made of these 
selective collections. In this context, it is important to consider some of the 
consequences of the ‘parasite’ of locale-specific decision-making (Berg and 
Timmermans, 2000: 55) which, as we are beginning to see, incorporates elements of 
preference that sit uneasily with the move towards standardisation. The quote below 
comes from an adult donor registry administrator. 
[A practitioner’s] experience will in some cases determine your 
outcome … if you’re not a centre that does cord, or that has 
experience in doing cord, and if you’re not willing to gain the 
experience that you need or whatever – should you be sending your 
patients to other places to have their treatment done? …people use 
terms like “postcode lottery”, but there is an element of that. You 
know, you’ve been doing this, you’re working on this, and I’m sure 
in your head, if I were to get leukaemia, where would I want to go? 
(Participant 2) 
In this participant’s account, transplant centres are bounded spaces in which only 
certain options are available. One hospital might not be ‘a centre that does cord’. The 
practitioners there may not ‘do’ cord. In this administrator’s view, the choice to do 
cord or not necessarily delimits the options available to patients receiving treatment 
at the centre. This produces, suggests the participant, a ‘postcode lottery’ in which 
some patients are referred to a centre that ‘does’ cord whilst other patients are not. 
This censure on particular options could, according to the same interviewee, have 
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quite remarkable material effects on the conclusion of your treatment. This is a point 
taken up in the 2010 inventory strategy report, where a graphical representation of 
the concentration of transplantations across the UK is mapped out for adult and 
paediatric recipients (UK Stem Cell Strategic Forum, 2010b: 73-74). These are 
reproduced immediately below. 
Figure 14: (below) Adult transplant activity in the UK in 2009 reproduced from Stem 
Cell Strategic Forum report (2010b) 
 
Figure 15: (below) Paediatric transplant activity in the UK in 2009 reproduced from 
Stem Cell Strategic Forum report (2010b) 
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A transplant centre’s willingness to perform particular procedures could conceivably 
‘determine your outcome’, as can be seen in these images that demonstrate how 
certain hospitals (equipped with the personnel and facilities to undertake transplants) 
appear to be less likely to undertaken UCB transplantations than others. The same 
administrator described how a transplant centre’s preference for one treatment could 
affect patients in other ways. 
We should be careful how we message that to patients … You want 
people to think, to be like, “this is an option!” … I’ve had people 
say to me, [despondently] “yeah, they found me a cord” … people 
are disappointed by it! Because the message that’s out there from 
the transplant centres is a little bit negative about cord. 
(Participant 2) 
In the account above, the interviewee explains how the preference of the transplant 
centre clinicians filters into patients’ views on their own treatment paths. Rather than 
an excitement that an option has been chosen and an HSC source secured, the 
interviewee has had contact with patients who ‘are disappointed’ by the fact that a 
cord has been found for them. They explicitly link this disappointment with the 
transplant centres being ‘negative’ about cord. This disappointment in having to 
resort to cord as a clinician and receive one as a patient speaks to the inherently 
affective dimensions of healthcare provision as well as healthcare receipt (see 
Mattingly, 2010) and is lamented by this registry administrator.  
When, at the beginning of this thesis, I asked you to imagine you had been told you 
were about die, I did not ask you to consider what your emotional response might be 
when told that your chance at life was stem cells from umbilical cord blood rather 
than an adult donor. But if your clinician was disappointed, it is feasible that by way 
what feminist theorists have described as a kind of affective contagion (Gibbs, 2002; 
Gorton, 2007) you would have been disappointed too. Given the recognised need for 
archivists to encourage the use of their archival materials (Daines and Nimer, 2011; 
Harris, 2002), the challenge of doing so extends well beyond trying to encourage the 
movement of UCB up a selection algorithm. Encouragement might even include 
trying to influence the affective domain of the ‘negative’ and ‘disappointed’ 
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sentiments of clinicians who must somehow transition into ‘getting into’ and ‘liking’ 
cord.  
As was explored in the introductory chapter, data from the first clinical intervention 
using UCB in 1988 were written up and published the next year (Gluckman et al., 
1989). The episode is used, as I am doing now, to preface most social scientific 
discussions of the use of UCB. This tends to done with little acknowledgement that 
the 1988 transplant was what might be called the thin end of the wedge. 27 years 
later and many practitioners who have the option of using UCB still do not. The 1988 
transplant was only one clinical intervention. Though it is obvious, it is worth noting 
that just because one clinical team in one transplant centre was able to achieve a 
successful transplant in their local context, it did not then follow that every transplant 
centre in the world would immediately undertake UCB transplantation. The quotes 
below are from a scientist working in a public UCB bank in the UK and a patient 
activist working to explore gene therapy options for patients with a particular blood 
disorder. I had asked for their view on why some clinicians did not use UCB. 
From the clinician point of view I think the risk was to try an 
alternative source of HSCs that was unknown, because bone 
marrow was the classic, the benchmark. (Participant 9) 
Bone marrow transplant is still the preferred option because if 
you’ve got a sibling donor, it’s a 90/95% success rate now. If it’s 
unrelated donor, it’s 80/90%. So at the moment that’s far less risky 
than anything else. (Participant 14) 
In the first quote, the scientist constructs UCB as an ‘unknown’, contrasting it against 
the ‘classic’ source of bone marrow. Given the existence of the ‘classic’, to step onto 
the terra incognita of a new technology would be a ‘risk’, a behaviour that one 
typically tries to avoid. The avoidance of risks, as we will later see, is magnified if 
the wager is one of life or death as it potentially could be in a clinical situation. In the 
second quote, we see a similar sentiment where ‘anything else’ that is not the 
‘preferred option of’ bone marrow is ‘risky’. We might imagine, following on from 
this, that cord blood has emerged as – at best – an innovative and exciting new 
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technology in the blood malignancy treatment arsenal. At worst, though, cord blood 
stands to be viewed as an unnecessary risk given the prevalence and success rates of 
bone marrow technology. The accounts above demonstrate how the latter view has 
been prevalent. 
This is not to say that cord will always be posited in this way. To demonstrate this it 
is useful to look back at the activist and the scientist’s reflections above. Both of 
them use the term ‘bone marrow’. Technically, this is a misnomer. As I touched upon 
in the introduction, adult stem cells are now considerably more frequently sourced 
not from bone marrow, but from peripheral blood. In 2009, out of the 812 stem cell 
donations sourced in the UK, only 13% were directly drawn from bone marrow, 
whilst 74% came from peripheral blood (UK Stem Cell Strategic Forum, 2010b: 15). 
Peripheral blood is often embedded in the term ‘bone marrow’, its own story of 
establishment black boxed in the process. The quote below comes from a policy 
maker with whom I had been discussing the willingness to invest state funds in a 
technology that might not be used. 
The perfect example … bone marrow kicked off in the seventies, 
then peripheral blood stem cells were available where the blood is 
collected from the donor’s peripheral blood and that is the 
preferred option for clinicians who are looking for a stem cell 
source. So that transition happened. And then you’ve got cord 
blood, which is certainly not as established as either of those … the 
same discussions were ongoing when peripheral blood stem cells 
started as well. Some clinicians wanted to stick with bone marrow, 
stick with a process they are familiar with and comfortable with. 
(Participant 10) 
The interviewee reflects on how there was a ‘transition’ from directly sourcing HSCs 
from an adult’s bone marrow (a needle drawing tissue during a single procedure), to 
the use of peripheral blood where an extracorporeal aphaeresis machine removes 
stem cells from the adult donor’s blood over a period of hours after the donor has 
taken a regimen of drugs understood to “draw out” stem cells from the bone marrow 
into regular circulation. Now, peripheral blood is the ‘preferred option for clinicians’ 
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according to this account (not ‘risky’, to use the term employed by the patient 
activist). However, as the participant points out, the ‘transition’ was marked by 
‘discussions’. Try a new source (peripheral blood extraction)? Or continue to use a 
‘familiar’ source they were ‘comfortable with’ (bone marrow extraction)? The 
interviewee suggests a similarity between that ‘discussion’ then and a cord 
blood/adult donor discussion now. Importantly, this policy maker states 
unequivocally that UCB is ‘certainly not as established’ as the adult donor sourcing 
techniques. The quote suggests that UCB, unlike peripheral blood, has not had its 
‘transition’ yet, if ever it will. 
There is something else important in this quote though that brings to life the 
importance of the various dimensions of clinical decision making that have been 
central to the chapter so far. This policy maker says that a clinician can be more 
‘familiar’ or ‘comfortable’ with one technique over another. It is, they note, the 
‘perfect example’ of what is happening currently with UCB technology. Clinicians 
want to ‘stick with’ a particularly technology (a term we might normally use for 
remaining faithful to a friend, or persevering with a carbohydrate-free diet), ‘stick 
with’ something they are ‘comfortable with’. Sticking to comfort, or – to use a 
different idiom – remaining in the comfort zone, is thus seen as an important element 
in the transition to a new technology and, more specifically, using the cord blood 
bank to engage with the technology. This obviously has implications for the use of 
the UCB collections in question here. Like a horse to water, you can ‘take the 
archives to the people’ (Harris, 2002: 148), but you cannot make the people use 
them. Tell every clinician in the UK that there is a well-stocked cord blood bank and, 
unless, they are comfortable with the technology, the bank will still not be used.  
The affective repertoire enrolled in the above interview quote (the intimacy of 
familiarity and, in particular, the satisfaction of comfort) speaks to the ‘corporeal 
dimension of experience and sensation, response and reaction’ (Brown, 2015: 2) that 
has more recently come to the attention of those interested in the sociologies of affect 
and emotion. It is here, in this notion of comfort, that I suggest that we can really 
begin to understand use in the archival spaces in question here. There are different 
ways of understanding comfort. It is generally defined as a sense of physical ease. A 
person can be comfortable in doing something which also implies a lack of coercion. 
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That is, if you are comfortable with doing something, we can fairly assume your 
willingness to engage in the activity. Importantly, comfort can imply a preference 
too. One can be more comfortable doing x than y. There is also, perhaps, a moral 
dimension to comfort too. Is comfort something we are striving towards, attempt to 
preserve, or trying to move beyond? 
Provided in a clinical setting, care is intended in part to bring comfort to a patient 
through the intimacy of the provider-patient interaction (Dowling, 2006). Indeed, 
much work has been done on the affective labour in such scenarios (Theodosius, 
2008; Twigg, 2000). But in the context of the current study, it is interesting to 
explore how this affective register relates to engagement with, or use of, a clinical 
option. In the quote below, a scientist working in a public cord blood bank explained 
how UCB and bone marrow stem cells are used differently: 
…people knew how to handle bone marrow. Clinically, it’s a 
different way of handling. You need to train people in the clinical 
management of UCB transplantation. You cannot transfer the 
training immediately (Participant 9) 
In this account, the scientist asserts that adult-derived HSCs and those from UCB 
both require ‘a different way of handling,’ highlighting the practitioner’s manual 
labour in the process of transplantation. The practitioner must undertake a manual 
interaction with the cells, ensuring they are correctly managed before, during, and 
after entry into the patient. People ‘knew’ how to ‘handle’ bone marrow, but did not 
necessarily ‘know’ UCB in the same way. Knowledge would need to be acquired 
over time (it would, after all, be impossible to ‘transfer the training immediately’). 
This scientist’s reflections allude to the almost artisanal nature of cell transplantation. 
With this is mind, consider Harry Collins’ discussion of the experiential vector of 
learning that is traditionally associated with craftsmanship but that is also important 
in the development of skills in scientific application: 
‘The transfer of craft knowledge … is a matter of acquiring skill. An 
apprenticeship, or at least a period of interpersonal interaction, is 
thought to be the necessary prelude to the transfer of skill-related 
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knowledge. This process rests on the enculturation model.’ (Collins, 
2012: 323) 
Enculturation is crucial to the transmission of scientific knowledge and complements 
codified, algorithmic transmissions like published guidelines. And yet it is not 
usually associated with scientific practice but with skilled craftsmanship. There is, 
then, some precedent to what I am laying out here about what Brown (2015: 2) calls 
the ‘corporeal dimension of experience’. This is the messy context of tacit 
knowledge and scientific application (Collins, 2012; Collins and Evans, 2007). Like 
the tinkering scientist (Knorr-Cetina, 1981), clinicians must develop knowledge (and, 
perhaps, comfort) through actual experience and practice, a point noted in the 
Sociology of Health and Illness literature, wherein the quotidian practice of clinical 
labour is inflected both by a technical component and the indeterminacy of clinical 
judgement (see Pope, 2002). 
In this context, it makes sense that a practitioner might become more or less 
comfortable depending on the outcome of their use of the clinical option, and begin 
to use the technology more regularly. The adage practice makes perfect rings true 
here. Training with UCB means learning to use it, and use requires a patient. A 
transplant clinician might use UCB for the first time, and an unfavourable outcome 
(lethally acute graft-versus-host-disease, for instance) might put that clinician off 
using the treatment again. For instance, one interviewee connected poor outcomes 
with a clinician’s choice to adopt UCB technology. 
It comes down to “well, I used cord before and we had difficulty. 
These are the difficulties that we had with it.” And that’s not based 
on experience of 50 cords. It’s experience of the one or two that 
they’ve used. And how can it not! They are people after all, 
whether we believe it or not. (Participant 2) 
In this account, we see the participant make a clear case that ‘experience’ is what use 
‘comes down to.’ If a clinician used a cord for the first time and ‘had difficulties’ 
(which we might read as an adverse effect for the patient) it makes sense to this 
participant that the clinician would be reluctant to take up the technology. How, the 
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participant asks, can that experience not have an influence? They make a point of the 
practitioners’ personhood, as if to say that it makes sense for us all to be influenced 
by our experience. Karin Knorr-Cetina reminds us that social reality and sense 
making ‘in no way stops short of the natural sciences’ (1981: 434). Indeed, it is as 
much the internal, personal experience and material engagement with a technology 
as the professional standards that rank, order or otherwise classify it that will 
determine whether the practitioner will be comfortable enough to use it.  
Conversely, a first positive experience might make the clinical option more 
appealing. For example, the quote below comes from an administrator involved in 
developing the SCSF recommendations in 2010, and refreshing them in 2014. 
…subjective clinician preferences … some [clinicians] are very, 
very happy to use cord blood and some that actually would never 
use cord blood… (Participant 18) 
In this quote we see an explicit mention of ‘subjective clinician preferences’. 
Practitioners, as subjects in a social world, have to learn from their personal 
experiences as we all do. Some will be ‘happy’ to use cord, like some of us might be 
‘happy’ to drive a car. Others would ‘never use cord blood’ just like some of us 
would ‘never’ work in the hospitality sector. Just to demonstrate how important 
subjective experience is, we can turn to the archival lens. The clinical practitioners 
are informed by their own experience, just as the archivists are. In the archival 
profession, for instance, there is discussion about whether archivists themselves are 
led by a sort of archival intuition developed through working with archives and 
learning how to operate within them (Duff and Fox, 2006; Treffeisen, 2003). Cook 
calls this the necessarily ‘culturally bound … socially conditioned and subjective’ 
practice of archiving, another physical practice not of learning how to handle stem 
cells but of learning how to select for storage, preserve and then retrieve (2011: 178).  
What emerges is an understanding that a pivotal aspect of the growth of UCB 
technology’s popularity rests with clinicians. Like us all, they have preferences that 
manifest in being more comfortable with certain options and less comfortable with 
others. We can think of this in terms of clinical comfort. An individual’s level of 
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clinical comfort can be seen to have a recursive effect in the use of UCB and, thus, 
the collection that holds it. The account of a UCB scientist, below, speaks to this 
point. 
Yes it’s definitely the clinician view … you can see where people 
are comfortable in using them, and they’ve got experience. They 
get better results. (Participant 7) 
Asked about the uptake of cord in the UK, they equivocally cite ‘the clinician view’ 
as central to the use of UCB. The interviewee draws a relationship between 
experience and success. Those who use cord regularly ‘get better results,’ which 
echoes the sense that the skill is one of enculturation, or slow acquisition. Of course, 
if it requires sustained use to develop those results, it follows that this would render 
uptake of emerging technologies less appealing. This is because, according to this 
interviewee, one has to ‘get comfortable’ to get positive treatment outcomes (and 
negative treatment outcomes equate to patient death or remission). In the 2010 
strategy report for the UK’s stem cell inventory, a similar point is made about the 
complexity of what the authors call a ‘centre effect’ which is explained in the extract 
below: 
‘…a large portion of [2009 allogeneic transplant] activity was 
concentrated in a small number of transplant centres: 27% of 
allografts were performed by the four most active centres. ... There is 
increasing evidence that centres performing a higher number of 
complex transplants achieve superior outcomes when compared to 
centres with low levels of HSCT activity … Recent data identifies 
this effect to be particularly marked in recipients of cord blood 
transplants ...’ (UK Stem Cell Strategic Forum, 2010b: 70) 
The data that they have suggest a relationship between frequency of using a 
particular technique in a centre, and the patient outcomes of that centre. This relation, 
they note, is ‘particularly marked’ in UCB transplantation. Interestingly, though, 
there seems to be less recognition of the individual clinician within the centre and 
their personal experience of using a particular stem cell source in treatment. A 
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different interviewee expanded on this dimension in a discussion about clinician 
preference that again takes up the notion of comfort in the clinic. 
And that’s down to clinician preference… what they think works 
for them best... A lot of it all boils down to expertise. What we do 
know [is] there are 32 transplant centres, of which I would say 
about ten use cord on a reasonably frequent basis. So what are the 
other 20-odd doing? They’re not using cord, so they don’t ever, 
ever have a problem finding an adult donor? It boils down to their 
clinicians aren’t comfortable using cord, are not convinced about 
the case for cord … A maturity of outcome data is going to be 
published this year … once that gets published, we’ll see greater 
infiltration of cord. (Participant 8) 
In this account, the interviewee notes that out of 32 transplant centres in the UK, only 
ten ‘use cord on a reasonably frequent basis.’ They link this uptake of the 
technology, which they imply is quite low, with a singular causal factor. ‘Clinicians,’ 
they maintain, ‘aren’t comfortable using cord.’ The implication of this is that with an 
increase in comfort, UCB might stand to grow in popularity as an HSC source and 
thus, the use of these UCB collections might increase. Importantly though, as this 
administrator points out, it is not the archivists themselves that will produce a 
‘greater infiltration’ of UCB, a word that evokes a sense of very gradual percolation, 
but the release of data. Certainly archives might try to disseminate information about 
their own holdings to encourage use (Eastwood, 2006) but much more weight in this 
account is given to the comfort clinicians have (or, in this case, do not have) with 
UCB. ‘It boils down to’, we might say, a lack of clinical comfort.  
6.4 The Archive Responds 
Clinical comfort might develop through practical, personal experience with a clinical 
option, but it also engenders the recursive effect of the experiences of others, filtered 
through outcome data, that might bring confidence to a clinician taking her first step 
onto the unfamiliar terrain of UCB technology. Of course, until some are willing to 
take up the technology and produce these data, those who rely on the data to choose 
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new clinical options will not be swayed. If the archivists want their collection to be 
used (Kaplan, 2002), then learning how to influence clinical comfort is surely 
integral. One scientist who works in a public UCB bank described a situation in 
which they tried to convince a clinician simply to enter a search request: 
I remember with [UK hospital] with [a transplant clinician], and I 
remember [they] mentioned [they] have a patient, “she needs an 
urgent transplant, I cannot find another donor.” “Look, [same 
clinician], I have 1000 cords waiting there for your patient. 
Probably one of them is there, why don’t you do a search when you 
have an urgent patient. And [they] did, [they] didn’t find a cord 
from us – OK, that’s fine. But since then [they’ve] started doing 
both searches. Adult and cord at the same time. And if [they find] a 
cord, [they do] a cord. (Participant 6) 
In this account, the scientist describes an experience in which a practitioner was 
compelled to search for cords because of the lack of any other source. The scientist 
recounts their conversation, explaining how they encouraged the practitioner to 
search through available cords. They did, and ‘since then’, they have started 
considering the option. Now, the scientist recounts, ‘If they find a cord, they do a 
cord.’ This reflection illustrates how the practitioner’s clinical comfort with UCB 
increased such that they transitioned from never using UCB as an HSC source to 
making it a mainstay in their repertoire of treatment options. In this quote, though, is 
a sort of moral warrant to incorporate UCB and push, we might say, past the clinical 
comfort zone. In asking, ‘why don’t you do a search’ the participant essentially asks 
this clinician to take the risk of doing something they would not – given the existence 
of a more comfortable option – do.  
Unnecessary risk-taking has connotations of foolhardiness, irresponsibility, and an 
inability to regulate the self (see Lupton, 1999). Often, though, risk beyond ‘the 
“comfort zone” and familiar territory’ can be read as an attempt at ‘movement and 
progression’ (Lupton and Tulloch, 2002: 117). Risk taking in the quote above is a 
chance to move beyond the boundaries of convention or standards, to potentially 
save the life of the patient who ‘needs an urgent transplant’ and who has no other 
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avenue. In the earlier quotes where any option that was not bone marrow was ‘risky’, 
this was a scenario where bone marrow was an available option. But what if it is not? 
What if there is only a choice between a UCB unit and nothing? 
It is in posing the new option to a clinician that we can see a kind of challenge to the 
clinician to move beyond their comfort zone. Consequently, they are impelled either 
to try the new option, or make a kind of confessional admission that they are too 
comfortable to move, as if in a kind of techno-stasis. It is at this fork in the road 
where the risk is the choice that use stands to be made of the UK’s UCB collections. 
To refer back to the colourful diagram at the start of the chapter, it really does not 
much matter what the process of a UCB unit search is if the clinician never gets to 
the point where their make a ‘SEARCH REQUEST’. This is, perhaps, what Mbembe 
means when he writes that ‘however we define archives, they have no meaning 
outside the subjective experience of those individuals who, at a given moment, come 
to use them’ (2002: 23). 
One might decide to use UCB, then, but which UCB unit should one use? Perhaps 
unsurprisingly, the same selectively that emerges in reference to picking a treatment 
option is still there when that treatment option has been selected. As I have suggested 
throughout this chapter, the use of its material is central to any archive. It is 
important, however, that the analysis of how the umbilical cord blood bank comes to 
be used is not cast simply as a normative indictment of clinicians to stretch 
themselves beyond their comfort zones. Archival theorist Kaplan argues that many 
working in archives view their work as part of ‘a service industry’ (2001: 3). 
Archivists, she argues, do their work so that others are enabled to use the material 
that the archivists have collected. Given the preceding sections of this chapter it is 
perhaps of little surprise that the same subjective preferences that lead up to a 
clinician choosing to use these collections is still at play once the clinician is 
selecting from them.  
Accordingly, with the remainder of the chapter I want to explore how these archival 
spaces are managed in response to clinician preference. In the quote below, a 
scientist describes how TNC has itself become a kind of point of clinical preference. 
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…it’s complicated because different centres privilege different 
units and have different practices, really. So some think HLA first 
and then TNC, for example, and for others this is a different order. 
They want a big unit! … They have a very, very high cell count and 
a 4/6, [rather] than a 6/6 and a lower cell count. (Participant 3) 
Here we see how some transplant centre clinicians ‘privilege’ different units because 
they ‘have different practices’. Some prioritise the matching level of the 
unit/recipient over the size (or TNC) of the unit. Others, however, have ‘a different 
order’. They ‘want a big unit’ and this takes precedence over the match of the 
unit/recipient who might match at as few as 4 out of 6 loci if the clinician can ensure 
the unit is large enough. The words ‘privilege’ and ‘want’ in this account speak to 
the sense of preference or taste even at the point of unit selection.  
With this in mind, I want to focus specifically on how these collections are managed 
in response to the prevalence of preference as a caveat of archival use. To make this 
point I want to focus specifically on a single element of a UCB unit, its Total 
Nucleated Cell count (TNC) which is also referred to as its size or cell dose. By 
looking at the shifting importance of TNC in how the bank has been managed, we 
are able to see how those managing this collection – though reliant on the clinician to 
try a cord – must make important decisions to sustain the relevance of their 
collection for that clinician to keep returning to it. The below quote briefly sums up 
the connection between preference and use that I want to explore. It comes from a 
participant involved in the SCSF and the British Cord Blood Working Group. 
…so how financially viable your bank is, is dependent on the 
quality of the units you store. So if you store tiny little units … no 
one will buy them, because they’ll buy big, better evaluated units. 
(Participant 5) 
The bank’s financial ‘viability’ – its very capacity to sustain itself – is thrown into 
question if all it stores is ‘tiny little units’ (i.e. units with a low TNC). According to 
this account, the uptake will be minimal because they will instead find a bank where 
they can get larger units. The point here then, is that a bank with larger units will be 
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better at sustaining itself. But this was not always the case. As might be suspected 
from Kaplan’s (2001; 2002) argument that use is central to the archive, as TNC has 
become a more important factor in the mind of clinicians, TNC has equally had to 
become a central point in the practice of UCB banking. However, when scientists 
first began banking UCB in the UK in the mid-1990s, the factor of TNC had much 
less importance. The quote below comes from a scientist who works with the non-
clinically viable units collected by one of the UK’s public UCB banks.  
I think at the beginning of cord blood banking, I think it was just a 
question of banking what you could … everything was banked. 
(Participant 7) 
Whilst nascent banking practices ensured archivists were collecting indiscriminately 
by ‘banking what you could’ or banking ‘everything’, a much more defined kind of 
specific and selective practice of banking has since taken shape. As Featherstone 
(2006) notes, the archival gaze is a discriminating one, where the archivist’s mandate 
is to find something of use to her users within the mass of matter. We have seen that 
usefulness is a central purpose of the archive. Likewise, the UCB collection exists to 
be of use to the practitioners trying to provide healthcare to patients. The archive acts 
as a bypass of sorts, to aid its user in retrieving relevant material more immediately. 
More specifically, when a practitioner does a tissue search and gets back the results, 
they see only what the bank workers made available to them. They are not privy to 
knowledge of which units were regarded as irrelevant, just as all users of archives are 
never privy to ‘what archivists saw before the appraisal decisions were made to give 
researchers what they get’ (Cook, 2001: 35, original italics).  
In the Stem Cell Strategic Forum’s 2010 report, the composition of one of the UK’s 
banks6 as per its units’ TNCs is laid out graphically (UK Stem Cell Strategic Forum, 
                                                 
6 In 2010, the UK’s separate UCB collections were represented with individual data for the 
UK Stem Cell Strategic Forum report. The more recent collaborative alignment of these 
collections now means data is produced across the entire inventory. There are other 
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2010b: 34), then juxtaposed with another graph that demonstrates the pattern of TNC 
distribution across all issued units (i.e. those units that are used). These graphs are 
reproduced below.7 
Figure 16: TNC of units in one UCB collection reproduced from Stem Cell Strategic 
Forum report (2010b) 
 
 
 
                                                                                                                                          
institutionally beneficial reasons for this alignment which, though a digression here, I have 
explored elsewhere (Williams, 2015). 
7 TNC is generally a large number and so is described in the scientific literature using integer 
powers. For example, 9x108 = 900,000,000. I note this because across different publications 
and documents, different scientists and policy makers use different integer powers. For 
example 90x107, rather than 9x108 which are both the same value. For the sake of clarity 
here, I harmonise these different integers in any comparison, as in Table 4 below. However, 
it is interesting to note the move towards 108 in the documents considered here which might 
denote the industry’s own attempt at numerical brevity given the coefficients being 
multiplied are getting larger as the threshold of TNC increases. 
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Figure 17: TNC of units issued from one UCB collection reproduced from Stem Cell 
Strategic Forum report (2010b) 
 
 
As the second graph demonstrates, most units issued from the collection have a 
larger TNC count (greater or equal to 150x107 nucleated cells within the unit) whilst 
most of the units in the bank (to refer back to the first graph) fall below this 
threshold. Thus, the composition is not necessarily synchronous with the pattern of 
use. The report notes here that this pattern of use (‘these data’) should be used to 
transform how units are selected from bank inclusion: 
‘These data suggest that patients’ needs are best met by banking only 
those units containing over 90 x 107 TNC. Additionally, all cord 
blood units containing over this threshold should be typed to high 
resolution for HLA-DR to assist transplant units in selecting the best 
unit for patients. Taken together, these changes should result in 
better overall utilization of cord blood units banked in the UK.’ (UK 
Stem Cell Strategic Forum, 2010b: 34)  
Because more use is made of larger units, those overseeing the collection should 
prioritise larger units. ‘Only those units,’ it is argued here, merit banking and being 
tissue typed at high quality so as to encourage clinicians to pick them and improve 
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the collection’s ‘overall utilization’. I suggest that what we see here is an example of 
the discriminating gaze at work. As in all archives, a decision must be made over 
what is worth archiving. This decision has various vectors, some of which were 
explored in the preceding empirical chapters around where and whom stem cells 
should be sourced from. In addition to this, there are yet more acts of selection that 
correspond more directly to the demands and preferences of clinicians. The 
discriminating gaze is apparent, for instance, in the maternity unit when collectors 
are deciding which, if any, collected cords should be sent on to the bank. This 
process is explained in some depth by a scientist who works with the research units 
that never qualified as ‘clinical’. 
There are steps before it arrives [at the processing laboratory]. 
Usually, we weigh the bag where umbilical cord blood has been 
collected because we know now that the weight is a good 
indication of whether or not that umbilical cord blood will qualify 
… We always weigh it, because we know 120g is about the 
threshold where it’s probably going to be clinical. So let’s say it’s 
100g or 90g – it’s definitely not going to be clinical. It’s not 
possible, so those already, they’re going to be diverted because … 
they’re going to be research units and not clinical units. 
(Participant 3) 
The increasing importance of cell dose (or TNC) is clear in this person’s account. 
Here, they describe how the physical weight of the collected unit is a first point of 
judgement that the matter must pass through on its way from the ‘profane realm’ 
(Groys, 2003: 179) into the selective realm of the collection. Weighing it is now 
something ‘we always do’ because ‘we know now that the weight is a good 
indication’ of the unit’s perceived viability. One might see what Osborne calls the 
‘archival reason’ (1999: 58) in this quote. Some matter is ‘isolated out of the mass of 
detail and accorded significance’ (Featherstone, 2006: 594) whilst the remainder is 
sent to the research scientist. The below quote comes from an interview with a 
collection co-ordinator who manages a group of cord blood collectors. I had asked if 
they recalled any change in the acceptable unit weight threshold since beginning 
their job in 2010. 
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Oh gosh, yes. Several times. When we first started, I have a feeling 
… it was anything over 70 or 75g was considered to be clinical. 
Then it changed to anything over 90g was considered to be 
clinical. Or 100, I can’t remember. Then it went up to 125. So, yes. 
Absolutely. … It’s always changing. (Participant 11) 
In this account, the collection coordinator describes a scene in which collectors must 
be ready to transition their practice in accordance with collection criteria that are 
‘always changing’ (read, always increasing). As the threshold for a UCB unit 
changes, collection practices must respond. There is an implication of increased 
selectivity in the account. They note that early on in the operation, ‘it was anything’. 
The bank was far less discriminating. This is similar to the earlier account from the 
scientist who describes a scenario where ‘everything was banked.’ In what might be 
seen as a move away from an anything/everything mentality, archival practice 
demands that archivists quite literally weigh up their decisions. The threshold of 
weight, as the above account demonstrates, has changed so many times that it was a 
struggle for the interviewee to actually remember what the thresholds have 
previously been. Why, then, has the threshold of TNC risen so much? In the 
exchange below, I had been discussing the TNC threshold with a scientist working in 
a public UCB bank. 
Participant 9: One of the things that is becoming clear is you need 
a really large TNC content…. 
RW: You’ve raised it to 140? 
Participant 9: Yep. 
RW: That decision, how was it made? 
Participant 9: It was made on the basis of what people are actually 
selecting. Transplanters want large units. 
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As the quote suggests, the managers of the collection make their decision on what to 
incorporate (the criteria for admission in this archive, we might say) based on what 
clinicians ‘are actually selecting.’ As such, if the transplant clinicians want higher 
TNCs, it is incumbent on those managing the collection to provide that. They must 
build the collection around user requirement or their units will not be selected. The 
quote below comes from another scientist working with the non-clinical units sent to 
one of the public UCB banks. 
…now there is an incentive to go higher and higher. So for 
example … the threshold was … 120 … then it changed for 150 … 
because now we know that you’ve got a better chance with that cell 
number for the cord blood unit to be picked for transplant. 
(Participant 3) 
The scientist’s reflection reveals their understanding not only that user requirement 
will change, but that it stands to become more fine-grained. The filter of selectivity 
will permit less and less entry, because the weight threshold is increasing. As such, 
those managing the collect of UCB are following practitioner preference (i.e. 
recognising what is more likely to be ‘picked’). In this account, the scientist shapes 
this in terms of an ‘incentive.’ This might be economic, for if a unit is ‘picked,’ the 
unit is also sold. But the notion of incentive speaks broadly to a compulsion to move 
forward, to spur on the project of collection. This resonates with archival theorist 
Kaplan’s assertion to the profession, ‘respond we must, or face irrelevance’ (2002: 
218). Perhaps unsurprisingly, then, the increased centrality of TNC as a point of 
utilisation can be noted in the comparison of the initial Stem cell Strategic Forum 
report (2010b) and its refresh in the 2015 Stem Cell Oversight Committee report 
(2015) 
In the 2015 ‘refresh’ of the UK inventory’s strategy, units in the inventory are 
‘graded’ in terms of their cell dose. These grades, A, B, C and R&D (research and 
development), denote the borders of the quality of a unit as laid out below. The act of 
grading perhaps represents a solidification of the importance of TNC (recall in 2010 
that units were not ‘graded’ but simply grouped by their dose).  
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 Grade A donations: post-processing cell dose >19 x 108 TNC  
 Grade B donations: post-processing cell dose 14-19 x 108 TNC  
 Grade C donations: post-processing cell dose 9-14 x 108 TNC  
 R&D donations: post-processing cell dose <9 x 108 TNC  
(UK Stem Cell Oversight Committee, 2015: 46) 
Quite explicitly, as in the table below, these ‘grades’ are linked to their ‘annual 
utilisation’ (2015: 25). This is not dissimilar to the 2010 report shown earlier in this 
section, where a relationship between unit use and unit size was clearly expressed. 
 
Figure 18: Utilisation of the UK’s UCB according to TNC and ‘grade’ reproduced 
from Stem Cell Oversight Committee report (2015) 
 
 
Here we can see how more use is made of Grade A (3% of this section is used) as 
compared to Grade B or C (1% and 0.2% respectively). The table notes too that 
particular potential units (those below certain TNCs) ‘ceased’ being collected 
between 2010 and 2013, which serves to exemplify how the discriminatory gaze of 
collection practices has transformed since 2010. Notice too that there are more of the 
less desirable units (R&D and Grade C), and fewer of the more desirable ones (Grade 
B and Grade A). As the qualifications of quality increase, a unit is less likely to meet 
them. It is particularly interesting, in this respect, to compare the TNC boundaries 
between the two reports, compiled in a table below.  
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Table 4: A comparison of the 2010 and 2015 brackets of TNC grading 
Stem Cell Strategic Forum report 
(2010a, 2010b) 
Stem Cell Oversight Committee 
report (2015) 
>15 x108 TNC >19 x 108 TNC 
12-15 x108 TNC 14-19 x 108 TNC 
9-12 x108 TNC 9-14 x 108 TNC 
6.5-9 x108 TNC <9 x 108 TNC 
4-6.5x108 TNC 
 
 
These classificatory borders (Beer, 2013) of TNC have shifted considerably since 
2010. The two extremes here are particularly telling. The top selection of cords must 
now meet or exceed the threshold of 19, whilst in 2010 this included anything from 
15 and over. The lowest grade in 2015 would not include any units equalling or 
below 9. Excluded here are many of the units that would have made the cut in 2010 
(4-6.5, and 6.5-9). The comparison of these documents thus demonstrates the shift in 
archival inclusion to accommodate ‘utilisation’ by the constituency of clinicians that 
make up the user group. 
6.5 Conclusion 
Use in these archival spaces, as I have argued in this chapter, cannot be reduced to a 
simple flow chart of forward-moving interactions. Indeed, one of the key things I 
have attempted to point out here is the contingency of the UCB collections in 
question here being used at all. So much goes into the decision of whether a tissue 
search request is issued for a UCB unit, and both clinical standards and personal 
clinical preferences are seen to have their role to play. We saw how standards are 
produced to rationalise clinical use of HSC sources, providing a consensus from 
which all clinicians can move forward. These standards, though, are malleable as the 
people producing them acknowledge that there will always be the need to change 
standards in line with new clinical developments. I suggested that this raises 
important questions for these archives, in that if clinical decision making standards 
are always potentially changing, these collections’ contents are likely to have to 
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change too. This is an issue I take up more fully in the next and final empirical 
chapter. 
Importantly, though, whilst these standards exist, the parasite of locale-specific 
decision making (Berg and Timmermans, 2000) thrives, and different hospitals and 
the clinicians in them stand to circumvent standards. The discussion here centred on 
how the corporeal dimension of clinical application – ‘getting into’ or getting ‘better’ 
at ‘doing’ cord – could lead to a sense of ‘comfort’ with the technology. The other 
side of the coin, as we saw, was that many clinicians are not clinically comfortable 
with using cord, have never trained in the manual application of the cells, and see it 
as an unnecessary risk when more established sources are available. These affective 
and rational registers of decision making are key in how these collections come to be 
used. I offered the example of Total Nucleated Cell (TNC) counts to bring this point 
into relief. The archivists have moved towards larger units expressly because those 
are the archived matter being used more often. The UCB archive, like Mbembe 
(2002) notes of all archives, thus operates (and therefore can only really be defined in 
reference to) the demands, preferences and subjective experiences of those who 
come to use it. 
Critically, though user expectations (Conway, 2010) inform the composition of any 
archive, the complexity of the collections under examination here perhaps exemplify 
a difficulty encountered in maintaining a collection that is to be scientifically useful. 
These transitions in TNC are the by-product of the movement of scientific theory 
(inflected, as we have seen, with clinical comfort). These transitions, inevitable in 
their nature, are inherently problematic for collections managers. Bowker reminds us, 
‘the measurements that are made now are necessarily constrained by current theory’ 
(2005: 177). Theory changes (in our case, the issue of TNC) and a whole array of 
practices must be adapted, meanwhile a whole array of archived matter is jettisoned 
into uselessness because of its meagre hopes of ‘utilisation’.  
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Chapter Seven: Risk and the Archive 
7.1 Introduction 
In this final empirical chapter, I want to move beyond chapters four and five where 
we considered how the UK’s public UCB collections are ordered and exclusionary, 
and beyond chapter six, the previous chapter, where we considered how use comes to 
be made of them. Building on the discussion of the last three chapters, I want to 
focus on how these archival spaces, in a way, are protected from the risks that face 
them. Those risks take different forms, but highlight the importance of the temporal 
dimension of all archives and, indeed, of technologies more generally. The starting 
point of this discussion is the risk of obsolescence. That is, that the archival content 
is at risk of becoming irrelevant as the criteria of value – a unit’s clinical viability – 
change around it.  
Tying in the reflections of STS scholars around the notion of path dependency and 
path creation (Garud and Karnøe, 2001; Kemp et al., 2001) this discussion 
endeavours to highlight the way in which those working with these UCB banks 
actually conceive of the space and attendant practices as generational. What, I 
explore, is the difference between a first- and a second-generation umbilical cord 
blood bank? Furthermore, what does this conceptualisation tell us about the 
recognition of a need to respond to the changing external demands of archive users? 
It is out of this exploration of the very temporal risk – change in user requirements – 
that is inbuilt to any selective collection of material, a risk that also speaks to the 
concern that a technology can potentially become ‘locked in’ (Garud and Karnøe, 
2001) or ‘irrational’ (Rip, 1995) that the chapter moves forward. 
Risk in these archival spaces takes on many forms, not all as potentially abstracted as 
‘obsolescence’. Other more obviously material risks are faced by those working to 
protect its relevance as it moves forwards, inevitably, into the future. Building upon 
Derrida’s description of the archive writ large as a domicile for the selected matter, 
guarded by those in charge against the physical risk of destruction, I think more 
explicitly about how these UCB banks might become spaces of guardianship. How 
are these collections managed to ensure they are protected from, say, a flood? What 
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mechanisms are in place to ensure the archive’s continued resilience? It is important 
to explore this because it highlights the eternal concern held by those working across 
archives about being able to respond to that which is yet to come. As such, the 
chapter ends by demonstrating how the future is central to the archive in the way 
archivists plan strategically through regular review and constant oversight of the 
broader field in which they and their collections exist. We are left, at the end of the 
chapter, with a clear sense that these archival spaces – as selective collections of 
matter deposited and retained in the past and present – are, as Derrida (1996) notes 
more generally of archives, irreducibly experiences of the future. 
7.2 The Risk of Obsolescence 
We have seen so far that the dominant model of understanding UCB transplantation 
technology has undergone regular and significant transformation. As Arie Rip 
reminds us, the development of technology is not a process of continuous, linear 
accumulation of functionality. He contends that it is more akin to a patchwork quilt. 
‘The eventual shape of a technology … can be very different after 5, 10 or more 
years than it looked at the beginning’ (1995: 418). How the developers of 
technologies facilitate development, and how they escape ‘lock-in’, to use Garud and 
Karnøe’s (2001: 31) provocative term, is important here, and is brought into sharp 
relief in the context of umbilical cord blood banking. Relevant factors emerge, and 
preferences and comfort coalesce and then transform in response. The regularity of 
change (but not its direction) can be seen as inbuilt into the standards and practices of 
the field, as we have seen in accounts so far. I want now to consider more explicitly 
what the implications of this might be in terms of the archival practices of collection 
management. The quote below is taken from an interview with an administrator 
working in a public UCB bank in the UK.  
…it seems like every six months something new comes along which 
almost makes you almost redefine your strategy on how you’re 
going to proceed forwards. And because it’s quite a rapidly 
changing landscape it requires you to be on your toes… and a lot 
of assumptions that maybe we had just five years ago have been a 
little bit blown out of the water. (Participant 8) 
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In the participant’s reflection, the field of UCB technology is described as a ‘rapidly 
changing landscape’, not unlike accounts in the last chapter that described it as an 
‘intrinsically dynamic scenario’. Findings can, in the words of the interviewee, blow 
assumptions ‘out of the water,’ suggesting not small changes, but potentially seismic 
recalibrations in the way things have to be done. Indeed, in the account, these new 
discoveries force those overseeing the banks to ‘almost redefine’ their strategy, as 
they move into the future. There is, as Borup et al. note, no ‘neat slope of 
enlightenment’ over time (2006: 291). Given the likelihood that change will come 
rapidly, workers in these archives must remain ‘on their toes’, remaining alert and 
ready to spring up and move at any point. This is particularly telling in the 
environment described here. The archival workers must always be vigilant to change. 
There can be no prescribed path for a technology, as this would not capture the 
unpredictability of users’ and developers’ expectations. What is asked of those 
working in these collections is that they make their collection ever relevant to the 
present, a reflection that Bowker makes more generally of contemporary collations 
of data: ‘What is being demanded of the dataset is precisely something which over 
twenty years of science studies have shown cannot be asked of the scientific paper - 
to stand outside of time’ (Bowker 2005:177). The requirement of heavy maintenance 
is like a regular rewriting of an old journal article to keep it up-to-date.  
This point is echoed when considering the issue of incorporating a new HLA allele 
into the processing of newly collected UCB units. In the account set out below from 
an interview with a scientist working in one of the UK’s public UCB banks, they 
describe the need to incorporate the typing of HLA-C into the measurements taken 
on all new units. 
But every two years cord blood banking is changing, because cord 
blood transplant is changing … [Senior staff] who are not science 
people … I told [them] we need to do this … Why? Because it’s 
changing and we need to change. We need to move with how things 
are going on. … I remember, in 2009 … I heard [leading UCB 
scientist] from the NMDP [the American ‘National Marrow Donor 
Program’] talking about HLC-C and still we don’t have consensus 
about doing it. And in her last talk, 4 years after, she’s still saying 
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HLA–C is important … and still there are banks that aren’t doing 
it. (Participant 6) 
In this reflection, the scientist overtly says bank workers ‘need to move’ – that some 
‘still’ are not transitioning their practices in accordance with the early signs of a shift 
in transplantation practice. Two things in this quote combine to demonstrate an 
interesting point here: firstly, the interviewee had to convince their senior 
management about the value of this anticipatory act of moving ahead of the curve. 
Secondly, many other bank workers have ‘still’ not made their own move. There is 
evidence here of a consonance with Bowker’s findings regarding updating 
biodiversity databases. He argues that the more information about data one provides 
in order to make it useful, the more work is required. And yet, as he notes, ‘people 
will not see it as a good use of their time to preserve information about their data 
beyond what is necessary to guarantee its immediate usefulness’ (Bowker 2005: 
116).  
This interviewee’s reference to a compulsion to move is telling though. Because the 
technology is changing, those working with the collection ‘need to change’. Some 
within the industry (this interviewee included) see these steps for future usefulness as 
a necessary act in the present or, in Rip’s parlance (1995), a currently irrational act 
that will be at some point become rational. The scientist’s account paints a lack of 
movement as anathema. Simultaneously, what Garud and Karnøe might call path 
creation (as opposed to ‘dependency’) becomes the standard. In such configurations, 
those involved in working with the technology over an indefinite period of time may 
‘intentionally deviate from existing artifacts and relevance structures’. Though 
inefficiencies may be the immediate product in the present, such deviations are 
‘required to create new futures’ (Garud and Karnøe, 2001: 6). As we saw in the last 
chapter, standards around the clinical selection of UCB are designed in the 
knowledge that they may need to be ‘refreshed’, or changed in reaction to new data 
and practices. This ‘reflexive’ practice (Timmermans, 2015) can also be located in 
archival practice itself. What we see in the above quotes are descriptions of literally 
reflexive practice, the reflex of being on one’s toes, or needing to ‘move with how 
things are going on’.  
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One might argue, then, that there are resonances here with Bowker’s (2000) 
argument that the notion of a perfect archival system is itself chimeric if only 
because, as he explains elsewhere, ‘the measurements that are made now are 
necessarily constrained by current theory’ (2005: 177). The technology behind this 
archive’s existence is prone to change, and archival workers sense the need to 
redefine, or change their archival practice in response to that. What is evident in 
these two quotes is how much the two participants seem to anticipate the 
requirement of change, as though it were written into their job descriptions. The 
latitude to absorb change, rather than be somehow perfect, seems to be the aim here. 
Capturing system perfection is unrealistic, indeed nonsensical given that change is an 
accepted and central feature of the practice. This is most apparent in the collection 
managers’ requirement to move away from previous iterations of their collection 
practices. For example, the quote below comes from an interview with a scientist 
who played a role in setting up Anthony Nolan’s bank in 2006.  
[Anthony Nolan’s UCB bank] started in 2006 … the NHSBT cord 
blood bank was already in existence. Barcelona cord blood bank 
was also in existence. It was the bank I created in 1995. We said 
second-generation because at that time, all the learning curves of 
the first banks were already there. We knew at that time that the 
cell dose was more important than at the beginning we thought. 
(Participant 16) 
The participant’s description of a ‘learning curve’ speaks to themes that appeared in 
previous chapters where UCB is cast as an emergent technology about which much is 
still to be learned. The notion that a UCB bank could be ‘second generation,’ 
suggests that the practices of collection management today were essentially born of 
the discoveries made in the course of managing the collections in the past. In 
establishing their second-generation bank, those managing the collection were 
equipped with the knowledge that had emerged since ‘the beginning’. This resonates 
with the point that began to open up at the end of the last chapter. That is, the 
practices of managing the UCB collection must respond to the TNC preferences of 
the practitioners who might use the collection. To be a second-generation bank 
obviously infers that there would have been a first-generation of banks preceding it.  
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RW: OK, so what would a first generation cord blood bank be?  
Participant 6: They were doing very low units with very low 
number of TNCs from their units. They were not testing all the 
virology panel diseases that they need to do as we are doing.  
In this exchange, the scientist describes how the practices of first-generation banks 
were incomplete. The manner in which this participant places first-generation 
practices in the past (‘they were not’), as compared to the second generation being 
placed in the present (‘we are doing’), speaks to the idea that practices in the field are 
indeed changeable. The term is also used by another scientist who currently works in 
the bank.  
We are what you would call a second-generation cord blood bank. 
We have learned how to process, how to test the samples, and have 
high quality units. … In the past, they were doing it at 6 and now 
they have realized that HLA-C has an impact on transplant…. We 
have always been doing this for clinical grade… Because we’ve 
started as a second generation cord blood bank, knowing what 
they were doing wrong in the past and learning the lesson and 
thinking ok, “if we do this, if we do that…” (Participant 6) 
In this account the notion of ‘learning’, present in the other scientist’s account above, 
reappears. The scientist’s choice of words is telling of their view that there is a need 
to enrol, and build upon, the knowledge of the past. The scientist explains that ‘we 
have learned how to process’ units, as compared to ‘in the past.’ Similarly, the 
scientist suggests that second generation bank workers are ‘learning the lesson’ from 
what has been done ‘wrong’ in the past. Waterton describes archives as epistemic 
time machines, not because the matter derived at one point is suspended from the 
ravages of time, but in the sense that archival spaces are ‘built on some kind of 
guesswork, some faith, that we are doing this right, that we are entrusting and laying 
things and meanings that will be interpretable and meaningful in times to come’ 
(2010: 649).  
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Waterton’s point comes into relief in the account above. For instance, the scientist 
implies that ‘if we do this, if we do that’ then these collections can almost stave off 
making the errors of the past – of avoiding ‘lock-in’ (Garud and Karnøe, 2001). This 
speaks more broadly to Garud and Karnøe’s point about the criteria which establish a 
technological artefact’s value. In this case, the quality criteria of UCB ‘do not lie in a 
marker that is an overall arbiter of what is good and bad, but instead, become 
endogenized as a pattern of stabilized relationships within an emerging technological 
field’ (2001: 8). Relevance, put simply, is produced alongside the technology. 
In the context of relevance’s contingency, there are implications for archival practice. 
Even if the seemingly correct decisions are made in the present about what the 
collection should preserve, no archival content has guaranteed permanence. The 
relevance of material, along with its worth and its importance, are contingent. As 
Featherstone puts it, archival matter ‘travels backwards and forwards between … 
rubbish, junk and sacred’ (2006: 593). Matter considered of worth at one point might 
transition into worthlessness at another. The salience of this point is not lost in 
collections of UCB. We have seen that collection workers conceptually divide 
temporal shifts of banking practices into different iterations, or ‘generations’ of bank. 
The generation of a UCB bank is, as we shall see, seen to have a direct connection to 
the relevance of the material stored in it. The quote below comes from an interview 
with a scientist involved in setting up one of the UK’s public UCB banks. 
Participant 16: At that time, the international standards of cord 
blood banking including donation and processing were edited ... 
This means that the first generation banks have a lot of units that 
are not useful for transplantation any more.  
RW: But might they become useful again? 
Participant 16: Maybe not, because the regulation also changed ... 
For instance now, we consider mandatory … an integrally 
attached segment to the back in order to verify the identity. There 
are many units at the beginning that don’t have this attached 
segment, so this means that this unit may not be any more useful 
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for clinical transplantation. Just as an example… the Japanese 
cord blood bank has erased 20,000 units of their inventory because 
they don’t fulfil the licensing criteria … approved [by] their 
Department of Health. 
In the above exchange, the scientist explains that many units saved by first 
generation banks are no longer ‘useful for transplantation’. The reason the participant 
gives for this is because standards were ‘edited.’ Because of this change, units can be 
seen to ‘travel’ (using Featherstone’s terminology) from useful to useless. The 
participant offers an example from Japan. Some twenty thousand individual units 
have been ‘erased’ because they no longer ‘fulfil’ particular criteria that have since 
been put in place. This obviously raises interesting questions, explored elsewhere by 
Tupasela and Stephens (2013) about what happens to material in tissue banks when 
the institutional arrangements around it break down or change. Though a worthy 
digression, it is more pertinent to the current discussion to ask what situations such as 
the Japanese cord blood bank can teach us about the practice of UCB banking. One 
of the most crucial elements of this discussion is that it is the criteria rather than the 
UCB units themselves that change. This is an important point, which speaks directly 
to the archival countenance of the umbilical cord blood bank. Archival content is not 
meaningful simply because it is in the archive. It is meaningful in reference to the 
externality that the archive intends to serve. Another scientist working in a public 
cord blood bank refers to a different bank as another example. 
So for instance, in Barcelona. I think they have 17,000 cord blood 
units, but they are working with four- or five thousand, because the 
others are so old that they are totally obsolete. And if someone 
requests … these obsolete units, they’re going to need to re-do tests 
on everything because they don’t meet the current standing. 
(Participant 6) 
In the quote above, the scientist offers an example from Barcelona rather than from 
Japan, but the issue is similar. Less than a third of the bank’s inventory (this bank, it 
is worth point out, is referred to by a participant in an earlier quote as a first 
generation bank) is being ‘worked with’. The remainder is ‘totally obsolete’. Again, 
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the units are ‘so old’ that they can no longer be used. But their age is not an 
intrinsically unattractive element. Rather it is the data that had been initially collected 
about them that will not suffice. The bank would be required to ‘re-do’ tests, because 
though they may once have met a previous version of viability, they do not meet the 
‘current’ one. The temporal dimension (the ‘old’ versus the ‘current’) is central to the 
usability of all archives. Brouwer and Mulder argue that value is determined in how 
archival material can be utilised in the present, ‘in its operationality’ (2003: 5). What 
has been operational once may not always be. In Rip’s words, ‘what were rational 
decisions in the context of the time may become historically irrational’ (1995: 419) 
and the continuing relevance of a technology can hinge on its developers’ capacity to 
move past these temporally contingent irrationalities (that is, to avoid irrational path 
dependence). 
Japan and Barcelona serve as demonstrations of how archival practice must be 
responsive. Even by ensuring the transition of practice, there is no guarantee that 
matter saved in a given archive will move with the practice of the archivists. In the 
case of the Japanese units, it is too late and the units must be ‘erased’. In the 
Barcelona bank, they will have to ‘re-do’ tests on two thirds of the units should they 
ever be called upon. In the quote below, the scientist was expanding on the reality 
that some public banks have had to remove portions of their inventory because the 
units have, for one reason or another, become unusable. 
…the established cord blood banks have a responsibility to 
monitor the quality of their units and also to do a clearance of 
their units that don’t fulfil the criteria of safety and potency. 
(Participant 16) 
For those creating the paths of technology, there are no benchmarks that ‘flag the 
outcomes of an exploratory act as mistakes’ (Garud and Karnøe, 2001: 8). The 
participant in the previous chapter who described how ‘everything was banked’ when 
banking was a nascent practice did not know then what was known now. In the 
account above there is a suggestion here that bank workers have a ‘responsibility to 
monitor’. This is a charge or a burden of their position. Monitoring (and the 
management, guardianship and reflexivity embedded in that sentiment) is the raison 
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d’être of the bank workers. An attempt to monitor the rationality or operationality of 
the collection. As the chapter has already considered, this monitoring can take the 
form of ‘erasing’ sections of an inventory as in Japan. The quote below comes from a 
participant involved in the APPG. They reflect on this issue in the UK context. 
…a lot of the cords that were banked in the early days of cord 
blood banking … are not really suitable now… we’ve already got 
quite a big inventory in the … cord blood bank but the proportion 
of that inventory that is really suitable for transplantation is much 
smaller … what we’re doing now is we’re doing a very careful 
housekeeping exercise of looking at the units… we’ve started off 
with the units which are red cell-replete. They were processed in a 
different style a long time ago and those units are now commonly, 
have been, associated with some serious adverse events in 
transplantation. Cardiac arrests et cetera. So we’re starting out 
looking at those. (Participant 8) 
In this extract, some units are again seen to travel from useful to useless: those 
‘banked in the early days… are not really suitable now’. As we saw earlier in the 
chapter in the example of Barcelona, there is again a description of a ‘proportion’ of 
the banked units being ‘suitable for transplantation’. What was once rational 
(collecting smaller units) is no longer considered to be so. The rest, they explain, 
requires some kind of ‘housekeeping’, which speaks to the idea that the archival 
space is one of domiciliation – a ‘house arrest’, as Derrida (1996) puts it – in which 
the archival workers are essentially managing a space, running a household (i.e., 
allowing it to move forward). The red cell-replete units are the first point of 
consideration in the housekeeping exercise in which they essentially appraise the 
inventory. The issue behind these units, which have gone through a different kind of 
cell reduction during initial processing and thus have a high dose of red blood cells 
came to a head in 2011 (two years before the above interview took place), when two 
leading UCB scientists published a response to an emerging controversy around this 
particular feature which is exhibited in many early UCB units. In their published 
response, the authors note a statistically significant incidence in a study of patients 
who had received a graft with a unit that was red blood cell-replete. 
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‘recipients in whom one unit of a double-unit graft was RBC-replete 
exhibited infusional toxicity that was of clinical concern. 
Subsequently, multiple severe or life-threatening infusion-related 
adverse events occurring at other centers using unwashed RBC-
replete units have been reported to the National Marrow Donor 
Program (NMDP). As patient safety is of paramount importance, this 
prompted a detailed analysis by and subsequent alert from the 
NMDP in 2009 recommending the wash of RBC-replete CB 
products as a prudent safety measure while the investigation of these 
events was conducted.’ (Barker and Scaradavou, 2011: 480) 
Appraisal, as Cook notes, ‘is the theory and methodology for determining the value 
of archives – which records should be kept and which ones should be destroyed’ 
(Cook, 2005: 102) or which units should be left in the freezer and which should be 
‘erased’ as an earlier participant termed it. We can, then, think of housekeeping as a 
form of archival appraisal that aims for the reduction of redundancy through the 
disposal of ‘uninteresting records’ (Bearman, 2002: 328), the records that clinicians 
would have no interest in because they are red blood cell-replete, and thus would be 
thought to cause adverse effects. These kinds of housekeeping or appraisal ensure 
these collections run efficiently. Archival matter might be ‘weeded, reconstructed, or 
even destroyed’ (Cook, 2001: 26) as a direct result of the fact that things once 
perceived to have a potential use value are no longer deemed to. Archives are 
populated in response to users’ ‘information needs’ (Schwartz and Cook, 2002: 3), 
which I explored in the first and second empirical chapters. These needs are heavily 
contingent. If a given archive pivots around them, those in charge of it must be ready 
for change. This means that the whole archival experience is one of flux. The fear of 
obsolescence, of outdatedness or irrelevance is, as we have seen, a key element in the 
rhythm of these collections. 
Appraisal is the articulation of archivists’ power. In appraisal it is decided ‘what will 
be reflected in archives, and, as starkly, and with finality, which will not’ (Cook, 
2005: 103). Discarding is definitive – particularly the UCB unit which cannot be put 
back into the freezer. It must be maintained at that temperature or lose its potency 
and, with that, its regenerative capacity. As such, one must be sure that there is no 
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potential use in the unit. In Japan, they did not fulfil safety legislation and as such 
could not be accepted for transplant because this would be an infraction of the law. 
The red cell-replete units above need to be considered. Workers are ‘looking at’ 
those units, as if to seek out a reason to keep them. In Terry Cook’s analysis of 
appraisal in the archives of the Government of Canada, he notes the view of the 
leading archivist towards appraisal. Archivists ‘must attempt to anticipate needs ... 
must find means to pass judgement on the probable value of source material’ (Lamb, 
cited in Cook, 2005: 111). The general rule underwriting this practice, as Cook 
argues, is that one must be sure that discarding is the only option: ‘If in doubt,’ he 
writes, ‘keep it!’. The exchange below follows on from the quote earlier in this 
section in which the participant explained that they were undertaking a housekeeping 
exercise in which they were ‘looking at’ the red blood cell-replete units. 
RW: Will the cord units with lower TNCs [lower stem cell doses] 
be discarded in this housekeeping exercise? 
Participant 8: They wouldn’t be discarded. We wouldn’t discard 
them because they’ve got HLA characterization and occasionally 
they do get issued … and saying “those units which are under a 
certain cell dose we’ll discard or issue for research” then we’ll 
start looking at other ones where we’ve got a lot of the same but a 
low cell dosage in terms of HLA type if we’ve got a common HLA 
type… We don’t want to get rid of fairly unique HLA types or 
uncommon HLA types and dump those even if the units are fairly 
small because, paediatric transplant, you know.  
In the quote above, the administrator describes a fairly ambivalent relationship 
between these collections and their low-dose units. Units that have a smaller dose of 
stem cells are, as we have seen, less likely to be chosen. But that decrease in chance 
of selection does not mean that definitively they would not be selected. When they 
come to doing this appraisal (‘we’ll start looking’ – it hadn’t begun at the time of 
interview) the judgement about whether to discard these units will partly rely on the 
rarity of the HLA type. This speaks to themes that emerged in the second empirical 
chapter around what Groys (2003) calls the ‘formal dissimilarity’ of archives where 
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rarity is valuable. Importantly, they would not ‘dump those’ units because of the 
possibility of paediatric transplants that do not require the same large doses as adult 
patients who generally have larger body masses.  
As we have seen, archival theorists have claimed that there is an intuitive sense 
called for in the act of appraisal. Archival theorist Booms (1987) calls this 
fingerspitzengefühl - a ‘fingertips feeling’. This notion captures the idea that 
archivists are in general knowledgeable enough about their users’ current 
requirements and, to an extent, future users’ capacities that they can judge the 
potential worth in the archived matter. This echoes the last chapter’s consideration of 
the discriminating gaze (Featherstone, 2006) around making choices in relation to 
current clinical selection criteria for UCB units. This is evocatively summed up by 
Bowker who notes that contemporary archives 
‘require an act of imagination on the part of the record keeper to 
place him- or herself in the position of any possible reader…. In 
essence, the record keeper is being asked to abstract the record set 
out of the historical flow or time – to provide enough information so 
that an limnologist from Mars… can come along and, from the data 
set and a sufficient command of English, interpret the data’ (Bowker 
2005: 177) 
Bowker is speaking directly here to the temporal dimension of judgement, of trying 
to make decisions now that will have relevance in time to come – to a limnologist 
from Mars, or (more likely) a clinician who possibly has not even been born yet. The 
archive’s contents wait for a ‘constituency or public whose limits are of necessity 
unknown’ (Osborne, 1999: 55). The constituency’s technological limits may expand 
significantly beyond the imagining of the archivist who lodges the matter in the 
archive. Old state intelligence documents produced in one political milieu might be 
read through a thoroughly different lens in another (Lynch, 1999). Biological matter 
saved with a particular purpose in mind might be the object of different research 
interventions at some future point. In the quote below, I had asked a participant about 
the future of lower dose units in the UK’s public stem cell inventory: 
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…there’s a point to be made around future technologies allowing 
for stem cell expansion which are quite expensive at the moment, 
but no doubt over time they will become – they will develop them – 
so that they are more affordable. That does bring in to play, then, 
the lower dose units as well. (Participant 10) 
In this interview extract, the policy maker explains that ‘future technologies’ which 
will ‘become’ economically feasible technical options for the low dose units that are 
currently unattractive to clinicians. This technology which currently exists, but which 
is ‘quite expensive’ will become ‘more affordable’ and ‘bring in to play’ the units 
with small TNCs. This point is echoed in the latest strategy report: 
‘It has been predicted that a 4 fold expansion of stem cells in cord 
blood donations would allow the majority of banked donations 
worldwide to be used for adult patient transplantation … candidate 
technologies for ex vivo graft manipulation are emerging. The 
potential to utilise low dose cord blood donations to improve patient 
outcome is significant…’ (UK Stem Cell Oversight Committee, 
2015: 39-40) 
The kinds of words used here in 2015, ‘predicted’, ‘emerging’, ‘potential’, suggest 
that this technology is, though anticipated, still some way off. But it might be 
suggested that what we see here in the interview extract and the policy 
documentation is a recognition, however implicit, of the possibility that there is a 
window of usefulness that stands to be (re)opened for these smaller units that stand 
to travel back out of obsolescence when technology finally permits such a return to 
usefulness. 
Interestingly, this is not only a problem for the UCB bank. The continual risk of 
obsolescence informs the practices of adult donor registries as well. Old archival 
content has to contend with revised standards of practice, new techniques, and 
emergent methodologies. As Cook puts it, the ‘history of the record is a never-
ending, dynamic process … always being reborn, reimagined, reinvented’ (2001: 
35). Take, for example, the idea that units stored in the 1990s might have to have 
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tests re-done if ever they are called upon. Adult donor registries have existed for a 
much longer time, and face a similar risk of obsolescence. The quote below was 
taken from an interview with an administrator at one of the UK’s public adult donor 
registries. 
For a lot of people on our register, the data is quite old. They 
would’ve joined twenty years ago. And obviously tissue typing 
capabilities are better now than they were twenty years ago. 
They’re a lot better now they were five years ago! Or even two 
years ago! ... They get better all the time, and we’re always trying 
to improve the tissue typing that we’re getting from people. 
(Participant 2) 
This administrator describes a similar scenario to the ones set out in the quotes 
above. Like old units, old adult donor data have been collected and managed 
according to the capabilities of the time when they were stored. Those donating 
twenty years ago were tissue typed according to the typing technologies of that era. 
As the administrator says, contemporary tissue typing techniques have changed. That 
is, the quality and specificity of the typing that can be done on a stem cell. ‘They get 
better all the time.’ In response to this perpetual technical advancement, the registry 
workers must also adapt their practice in perpetuity. They are ‘always trying to 
improve the tissue typing’. There is also an equivalent to ‘re-doing’ tests on old UCB 
units in the adult donor archive.  
…there’s a judgement call as to whether you … go back and re-
type older donors … It’s which ones you go back to. You might 
want to do the rarer ones, or the ones maybe you’ve got in contact 
with to make sure they’re still engaged with the process and would 
want to go. (Participant 10) 
This quote describes how registry workers can ‘go back and re-type.’ This 
retrospective typing could mean that the volunteer donor is called in to have further 
tests as a means of updating their data. Once donor samples have been re-typed, they 
are no longer outdated. Of course, as we have seen, it need not take long for a unit or 
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a donor to pass back into obsolescence, travelling ‘between the known and the 
unknown’ (Featherstone, 2006: 593) as techniques further improve. Re-typing 
essentially brings meaning, or context, to older data which otherwise would, to use 
Bowker’s phrase, ‘rot away in some “information silo” for want of providing enough 
context’ (2000: 646). Without this interaction, the data remain unusable ‘legacy data’ 
(ibid.: 662) that speak only to outmoded criteria. Navigating this conundrum in 
which a ‘judgement call’ has to be made about who to re-type is necessary because it 
is expensive to type somebody. The registry workers cannot, with their limited 
resources, re-type everybody. Even if resources were unlimited, it would be a 
Sisyphean task to do so anyway, as typing capacity is in a constant state of change, 
swiftly rendering data outdated.  
The registry workers can exercise judgement about who it might make the most 
sense to re-type. As the policy maker suggests, it might make more sense to approach 
‘rarer’ donors. From this, we might infer minority ethnicity adult donors. Or perhaps 
it would be better to approach those who have already re-asserted their continuing 
desire to remain on the registry after volunteering potentially years ago. Again, this 
speaks not simply to a discriminating gaze in these archival spaces, but to the 
importance of temporality and the drive to avoid lock-in that marks these elements of 
archival judgement. Without these judgements, the adult registry archive could slip 
into obsolescence quickly. It resonates with the discussion of the UCB bank above, 
wherein the managers of these collections of matter and of data must be ready to 
absorb the changes of the technology they are involved in. Derrida’s (1996) point 
that archives are never finished, but always in becoming rings true here. Adult 
volunteer donor registries and umbilical cord blood banks are collections that require 
anticipatory management. Without this constant consideration, their archival 
relevance stands to diminish. 
7.3 Physical Risk 
Protection from the lock-in of obsolescence has been central to our discussion so far. 
Derrida (1996) notes that the etymological underpinnings of the archive refer directly 
to the guardianship of space. Those in charge of the arkheion warded against risk to 
the collection of public records, policing entrance of users as much as the material 
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itself. The role of being a guardian of the archive means protecting the space from 
risk. So far in this chapter we have seen this concern with risk unfold in the umbilical 
cord blood banks in question, where risk might be enfolded into temporality itself. 
Technologies might advance, and matter and data in a given collection might become 
obsolete in reference to that. But the archive faces more material, physical risks too. 
Pickering perhaps did not mean what follows quite as literally as I present it below, 
but consider this quote from his book in which he explains how we must understand 
technology – like all things in the world – as part of a material environment. 
 ‘Think of the weather. Winds, storms, droughts, floods, heat and 
cold … One could not survive for any length of time without 
responding in a very direct way to such material agency … My 
suggestion is that we should see science (and, of course, technology) 
as a continuation and extension of the business of coping with 
material agency.’ (Pickering, 2010: 6-7) 
Pickering’s suggestion that we think about how technologies and their developers 
engaged in ‘the business of coping’ is a good foundation on which to reflect on my 
fieldwork. Between 2012 and 2014, I had cause to visit three different sites where 
UCB is stored. One was a space where UCB units were processed after collection 
before being sent to the bank for storage. The others were cord blood banks proper, 
where clinically viable units are stored until a practitioner calls upon them or until, as 
we have seen, those units ‘travel’ out of viability. As Lynch notes, the archive is a 
guarded space (1999: 79). In my experience, this was literal. In one instance, a tall 
welded mesh fence stood between the building’s car park and me. On the first visit, 
the security guard telephoned the internal building to check that I was expected. On 
the second, I was recognised and permitted entrance through the gate (I was lucky, it 
was incredibly cold outside on that day). At one of the banks, I stood in the rain 
waiting for somebody to answer the intercom that got me to the foyer. Then I had to 
be escorted into a reception area. Suffice to say I received more interrogation at the 
door of the processing buildings than I faced on the several occasions I visited the 
police-guarded Palace of Westminster to meet parliamentarians. 
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I describe these scenes to emphasise the point made by Achille Mbembe. He reminds 
us that we cannot define the archive without acknowledging the building itself as 
well as the documents stored there (2002: 19). The use made of physical spaces is 
indeed key to understanding the way in which creators, workers and users interact 
with archives and the matter inside them (see Losh, 2004). As Derrida notes, ‘the 
very gesture which consists in keeping safe… is always… threatened by the 
possibility of destruction’ (Derrida 2002: 42). Put differently, the very existence of 
the UCB banks looked at here (and, indeed, those across the world) is because the 
units housed in them need to be suspended in particularly freezing temperatures 
without any risk of disruption to their regenerative capacity. Thus, their position in 
the freezer of the bank is always threatened by the possibility of their removal for 
some reason other than use.  
Physical space, then, means everything in the material work of UCB collection 
management. The quote below is demonstrative of this, and comes from an interview 
with an APPG contributor. I had asked them why Anthony Nolan and NHSBT kept 
their banks separate from one another. This question was borne of my interest early 
on in fieldwork about the institutional interests that lay behind the Stem Cell 
Strategic Forum policy documents (UK Stem Cell Strategic Forum, 2010a, 2010b) 
There’s an advantage in not having all your cords in one basket … 
[a public UCB bank] had a flood. If we’d lost all of our cryo-
storage vats – which we didn’t – that would be the UK’s stock of 
cord blood down the Swannee. (Participant 8) 
To an extent, I had anticipated the participant to answer that the institutions had a 
financial interest in keeping their operations and resources separate. But in the 
account, the ‘advantage’ of having the cord blood banks in separate spaces is not 
financial. Here, the phrase having all one’s eggs ‘in one basket’ might suggest a risky 
cash investment but it is used here much more literally. The phrase infers that the 
delicate egg shells could all be destroyed with a single drop. The alternative, sharing 
the eggs (or ‘cords’, as this participant is suggesting) out between ‘baskets’ or banks, 
essentially shares that risk. They draw on the example of a flood that took place in 
2012. One of the UK’s public cord blood banks exists in a larger blood processing 
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facility that ‘had a flood’. In the reflection, the participant ponders the conditional 
risk. ‘If we’d lost’ the cryopreservation facilities, ‘that would be’ the entire national 
stock of UCB ‘down the Swannee,’ a nightmare scenario. The flood prompted the 
institution to write a report about the incident. In it, the authors described the incident 
as a ‘potentially catastrophic event’ (Rackham and Lawson, 2013: 4). Reproduced 
below is an extract from the document. 
‘…all power, data and telephony to the building was lost, resulting 
in the loss of refrigeration, monitoring, air handling and building 
management systems. The building had become unable to function 
as a blood processing centre.’ (ibid.: 5) 
As the document explained, the flood occurred due to maintenance of nearby land 
rather than because it had been built on a flood plain. The document focused on ways 
that the organisation could ‘learn lessons … which will serve to improve and 
enhance resilience,’ (ibid.: 4) with recommendations around chains of command in 
emergencies, and the clarification of outdated and vague protocols. The event, along 
with a similar incident in Australia, would form the basis of a case study article on 
‘business continuity in blood services’ in the international journal Vox Sanguinis 
(Morgan et al., 2015). That this event occurred demonstrates the logic behind the 
existence of the World Marrow Donor Association’s Crisis Response, Business 
Continuity, and Disaster Recovery Guidelines (Pingel et al., 2012), published in the 
international journal Biology of Blood and Marrow Transplantation. The guidelines 
advise on the intricacies of the immediate response that its international member 
registries and banks should undertake in the wake of a crisis. 
‘Here we provide general guidelines to WMDA members for the 
development of a generic emergency response plan to natural, 
human-caused, and technical-caused events that threaten the timely 
delivery of HSC products and essential related operations, as well as 
to raise awareness of the problem in general. These guidelines for 
the development of an organizational resiliency program should be 
viewed as a basic approach intended to assist registries wishing to 
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establish a new organizational resiliency program.’ (Pingel et al., 
2012: 1785) 
‘Resiliency’ is integral in the management of HSC products. This must be resiliency 
to events of various kinds. Flooding cannot necessarily be predicted, but these 
collections must be prepared for it. Spreading out risk in the form of different banks 
can be seen, as the participant above suggested, as a form of resilience. The spatial 
context of banking becomes crucial. Not building near a river, but near enough to 
transport links to issue cells, whilst central enough that collection points can send 
matter in a reasonable time period. 
In Derrida’s terms, choosing where to build the archons will have an impact on 
whether the house arrest of material can be effective. But risk can never be 
completely avoided. After all, once the unit leaves the UCB collection’s confines, it 
must face the same risks as any moving matter. In the quote below with a practitioner 
active in the APPG, we had been discussing the merits of a domestic supply of units. 
Though they suggested that there was an economic case for this, they argued there 
was also a ‘scientific’ case. 
It would be very nice to have our own bank for our own patients. 
Scientifically, that would make life a lot easier as well because 
you’ve got easier access. Volcanoes erupt. You’ve got cords stuck 
in wherever they are… and you can’t ship it out. It takes too long. 
(Participant 1) 
The 2010 Icelandic volcano eruption meant the plane supposed to transport that unit 
was grounded and the cord got ‘stuck’. The other courier option – shipping the unit – 
was unacceptable because ‘it takes too long’. As such, the proximity of the bank to 
the transplant centre becomes a vital aspect. Importantly, this quote demonstrates that 
whilst the ‘guardians of the register’ can care for the data, and whilst the workers in 
the UCB bank ensure the cryogenic freezers retain their temperatures in a flood, they 
can do very little once the HSCs have left the house arrest of their guarded, 
maintained archival spaces. The extent to which collection management can mitigate 
risk is inevitably limited by the unpredictable events that none of us can foresee. 
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Importantly, though, the willingness to foresee is central to the practice of collection 
management. We see this prominently in the discussion so far, but no more so that in 
the underpinning strategy that laid out the political mandate for what is a 
government-funded enterprise. 
7.4 The Stem Cell ‘Refresh’ 
Star asks the question, ‘when is an infrastructure finished?’ (1999: 379). The archival 
infrastructure these chapters have considered is open to judgement, re-evaluation and 
determinations of outdatedness, irrelevance or insufficiency. As Bowker (2005) 
reminds us, the goal instead is an ability to anticipate change as much as can be 
possible. As the introduction and the first empirical chapter touched on, the 
composition of the UK’s cord blood collections has been developed in reference to 
the Stem Cell Strategic Forum’s 2010 report. In that report, it was recommended that 
the UK’s inventory of UCB across its public banks should comprise 50,000 units 
(2010a). As a scientist working with research units collected by one of the public 
banks explains below, the figure was based on an analysis of … 
…how big your cord blood bank needs to be to substantially 
increase the probability to find a cord blood unit … for a patient…. 
It saw that there comes a point where – from zero to 15,000 – it 
really increased exponentially so there is a real benefit in 
increasing the number … when you come from fifteen thousand to 
fifty thousand … you still have a benefit of doing that. But then you 
need to increase so much the number of cord blood units to really 
make an impact on the patient, that it’s hardly viable at all… So 
that number is when it starts to plateau… There comes a point 
when it almost doesn’t matter how big the bank is. (Participant 3) 
The study producing the figure demonstrated how a particular number of figures 
would ‘increase the probability’ of finding a matching unit. The improvement ‘starts 
to plateau’ after the 50,000 mark, and eventually the size of the bank ‘almost doesn’t 
matter’ because there is no longer a ‘real benefit’ – a phrase the participant uses 
twice here. The figure pivots around the notion of benefit. This benefit can be ‘for a 
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patient’ but the figure must be ‘viable’. If it is not, it is not practicable within the 
limitations of the technology. Those limitations might be technical, but they may also 
be economic. The participant below was involved in the initial study that 
recommended that the UK should have 50,000 units. 
…using the matching criteria at that time in 2009, we observed 
that 50,000 donors were needed to offer a proper or a highly 
qualified donor to 80% of the population and that enlarging the 
inventory further has … not returned sufficient new numbers of 
new match to make this project cost-benefit. (Participant 16) 
The study demonstrated that an increase of the inventory to 50,000 donors would 
offer ‘80% of the population’ an adequate match. Further increase would not return 
‘sufficient’ match numbers to justify the project in terms of its ‘cost-benefit’. The 
economic notion of cost benefit casts the judgement less in terms of direct benefits to 
patients, but within the resource limitations touched upon in the second empirical 
chapter. Importantly, though, as the quote above highlights, the study was based on 
the selection criteria ‘at that time in 2009’. As the third empirical chapter explored, 
these criteria are heavily contingent. Regular changes in criteria have rendered the 
2009 selection criteria out of date. An example of how changes in criteria have 
altered the relevance of the study’s findings is the issue of level of match (i.e., how 
many HLA loci a unit and a recipient should be matched at). The quote below comes 
from a public UCB bank administrator who was explaining the limitations of the 
original study: 
It was only considering 6-out-of-6 and 5-out-of-6 matching. We 
know from experience now … that 4-out-of-6 does play a big part 
in this. When you look at the 4-out-of-6 profile, already the 
provision we’ve got in the UK, most of the population almost 
regardless of ethnicity will find a match, some sort of level of 
match. (Participant 8) 
In this quote, the administrator explains that the initial study used recommendations 
that UCB units should be matched to at least five of the six HLA loci. Those units 
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that would have provided a 4/6, now regarded by many as suitable, were not 
included. Because 4/6 units are now considered to ‘play a part’ in meeting the UK’s 
stem cell supply goals, the many people in the UK population considered unmatched 
until the 50,000 unit figure was reached might have actually found a match before 
this goal had been met. As such, the entire basis of the 50,000 figure is now called 
into question. A scientist involved in this original study highlighted other areas 
where the study’s findings are now outdated. 
The criteria basically has changed … this was a study based only 
in HLA matching, not in cell dose. And the criteria is that … 
matching on high resolution provides more chances of better 
outcomes. So this means that probably, this may affect the size [of 
the inventory], but still we have not been able to test that in a 
scientific study. (Participant 16) 
Along with the level of match referred in the administrator’s quote, the scientist 
above notes that the resolution of HLA typing has changed. They assert that ‘high 
resolution provides more chances of better outcomes,’ a view that has emerged since 
2009, along with the importance of cell dose or TNC (an issue explored in the 
previous empirical chapter). At one time, it was the point around which the UK’s 
public UCB banks were developed. Now, the strategy needs to be refreshed. As such, 
the whole archival strategy is one of flux, of repercussive and anticipatory 
movements. This is perhaps what Derrida means when he argues that all archives 
‘take place’ (1996: 2). Archives can be thought of not simply as buildings but as 
spaces of anticipation. This might be anticipating abstract risks of obsolescence, 
material risks such as flooding, or the risk of moving forward with a strategy that has 
lost relevance with respect to professional and technological trends (Cook, 2001: 29). 
How this change is directed has emerged as a contentious point of discussion that 
reveals the diverse political interests of the different people involved. Take as an 
example the quote from an interview with a scientist who works in one of the public 
UCB banks. Below, they describe the purpose of the section of the SCSF that deals 
with the UK’s stem cell supply. 
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We were discussing … the operational cord blood stock that we 
want to have… if we need to recalculate this famous figure that we 
have of 50,000 cord blood units in the UK because it’s not 
sustainable for a cord blood bank to have so many units because 
you need to collect so much to get this figure. Our clinical 
conversion rate is around 25-27% so per 100 units that we collect 
25 are clinical so we’d need to collect loads of them to get this 
50,000. (Participant 6) 
The ‘famous figure,’ one that has found its ways into press releases, parliamentary 
debate and news items, is not considered ‘sustainable’ for a cord blood bank. The 
reason for this, they explain, is because of the amount of units the UK’s public banks 
would need to collect to meet this goal. They describe how only around a quarter of 
collect units ‘are clinical,’ which is to say 75% of units collected could never qualify 
to be considered in amongst the ranks of the 50,000. As such the banks would ‘need 
to collect loads’ to meet this goal, using up the various resources they have to do so. 
The same scientist explained that a smaller figure would be more realistic, but noted 
that others (particularly clinicians) may not agree. 
…we think that probably with 30,000 we will be enough ... 
Clinicians, always they are saying that still we need to collect too 
many, but this is from the clinical point of view. But from the cord 
blood business point of view – if we are funded by the government. 
Well it’s really difficult because to sustain a facility like this with 
so many cords, it’s not sustainable. (Participant 6) 
Rather than 50,000 units, 30,000 ‘will be enough,’ because any more would make a 
bank hard ‘to sustain.’ This viewpoint, the participant notes, is the ‘cord blood 
business point of view.’ By making reference to the source of funding, the 
participant’s implication here is that sustainability refers specifically to economic 
sustainability. The participant notes that there is another point of view held by 
clinicians who ‘are saying that we still need to collect too many.’ The clinical point 
of view is effectively divorced from a business point of view via this participant’s 
juxtaposition of the perspectives. The accounts below from practitioners involved in 
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the APPG and SCSF described their view on the size of the public UCB inventory. 
Their views mirror the ‘clinical point of view,’ which the scientist above is referring 
to. 
Because we’re going to advise more stringent matching, that 
potentially would mean we need more. And so I think those figures 
are being re-looked at… 50,000 units may not be enough so we 
definitely shouldn’t say we need less than that. (Participant 5) 
I think it would be much better if we have much larger public 
collection. Because actually we’re only using a very few percent of 
the cords anyway…. The safest thing to do would just be to have a 
big public bank. (Participant 1) 
The first quote comes from a practitioner who contributes to the APPG and the 
SCSF. According to the first account, the recommendation of higher resolution 
matching at more HLA loci translates to the selection of units for clinical work 
becoming more fine-grained with ‘more stringent matching.’ From their view point, 
fewer existing units will qualify to this standard. Thus, they assert that 50,000 ‘may 
not be enough’ and that more would need to be collected to increase the chances of 
clinicians finding a match for a patient. The second quote, from a different 
practitioner, suggests that ‘much larger’ scope of UCB collecting is required to 
combat the fact that so few cords are clinically viable.  
Ideally, having ‘a big public bank’ (notice, no figures here) would be ‘safest,’ 
presumably ensuring that more matches could be made. This is the perspective of 
somebody who does not work within the limitations of these UCB collections, but 
whose knowledge is clearest regarding the issue of trying to find matches for patients 
in an external capacity as an archival user. This last quote, which highlights the same 
issue as the banker (that most cords are discarded) takes the argument in a very 
different direction from the scientist. The scientist’s solution is to say that collecting 
more to try and combat this trend in which most units are clinically unviable is 
unsustainable because of the amount one would need to collect. This is informed by 
their familiarity with the practicalities of banking.  
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These different logics bespeak similar professional divisions we have seen elsewhere 
in the thesis – the bankers facing the limitations of their technology versus the 
clinicians whose interests revolve around their work with patients. This division 
between the bank and the clinic, as we saw in the previous chapter, reflects the 
different practicalities that the two professions face in their working lives. In the 
bank, collecting 50,000 cords – which was once a conceivable notion - now seems 
anathema given the criteria clinicians are using now that were not being used then. 
Meanwhile, there is a sense in the data that clinicians are invested in the idea of 
collecting as many cords as possible. More HSCs simply means more chances for 
matches for patients. Ultimately, these archive workers must stay a step ahead of 
their users and their current needs. As we saw in the previous chapter, this might be 
in terms of tissue typing the HLA-C loci that clinicians currently have no interest in, 
but may soon have. This can also be in terms of a broader strategy. Clinicians might 
disagree with the workers who manage these collections. However, these workers 
must be ready to serve tomorrow’s clinical need as well as today’s, all whilst 
labouring within the confines of their resource limitations.  
The collection management strategy, which guides the workers’ goals and actions 
must itself be open to change lest it fall into obsolescence like a UCB unit collected 
in the 1990s and then left in a freezer for two decades, untouched and under-typed. In 
this sense, the strategy must essentially be future-proof. This is not to say that it must 
be so perfect that any future that befalls it would be manageable. Rather, it is to say 
that the strategy must have an inherent latitude to absorb the changes the future 
might bring. Future is unknowable, and so to an extent the strategy’s purpose is also 
unknowable, because purpose and use are in the future. It must be speculative. The 
exchange below comes from an interview with a participant involved in the World 
Marrow Donor Association. I had asked them about the shifting nature of strategies 
in stem cell donation and banking. 
RW: Is there any way you could – 
Participant 17: have an eternal strategy? 
RW: Impossible? 
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Participant 17: I would say so! If you had an eternal strategy then 
you would know how the illness actually works. And basically then 
you would be in the position to say this is not the right treatment, 
or this is the correct treatment… [research] advances every year… 
and as a consequence you have to readapt your strategy. 
A strategy that determined a route worth taking has to be ‘readapted’, an evocative 
word that speaks to the idea that archival strategies have to be malleable with the 
upcoming changes to the circumstances of their existence. The archive, then, is 
defined by the temporal dimensions that sustain it. As ‘an irreducible experience of 
the future’ (Derrida, 1996: 68), the archive is a selective collection of matter that is 
itself ‘in an eternal process of becoming’ (Waterton, 2010: 654). The participant 
above speaks to the eternality of becoming by explaining the impossibility of ‘an 
eternal strategy’. Indeed, this recognition is present the account reproduced below, 
where a policy maker describes the necessity of reviewing the SCSF strategy. 
…we’ve asked for a kind of review, a refresh really, of that annex 
that deals with the 50,000 figure, the cord blood figure. Because 
obviously this work’s been ongoing for the last three, four years. 
We need to see what’s changed, because there has been a move 
globally to increase the quality of the cord blood samples that are 
collected. Increasing the cell threshold may mean you don’t need a 
bank as big as that … The oversight committee is basically what 
the stem cell strategic forum became … we’ve asked them to look 
at the data around that work to see what an up-to-date figure 
should be and what targets we should be looking at, and that will 
inform any funding decisions that we make going forward post-
2015. So that’s pretty much under review, I suppose, at the 
moment. (Participant 10) 
The policy maker in the quote above explains that the policy document that 
explicates the 50,000 unit figure is undergoing a ‘review’, or a ‘refresh’. They 
explain that the reasoning behind this is ‘to see what’s changed’ in UCB technology. 
Stasis is not on the table in this account, which resonates with a point made by Selin 
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that ‘technology can only be understood as becoming, as neither solely constructed, 
nor determined, but amid the conceptual territory of the two perspectives’ (2006: 
125). The technology itself cannot be statically defined, as its very purpose and form 
stands to change. The policy maker above notes that the Stem Cell Strategic Forum 
has itself had a change of name. From the forum that produced an initial strategy, it 
is now an ‘Oversight Committee,’ which bespeaks a change in task to the continual 
monitoring of the strategy and the ability to come together and change that strategy. 
As such, in 2014 the Oversight Committee gathered to reconsider the initial strategy. 
The quote below comes from an interview with a senior person involved in the 
refresh after it had been completed, but before the conclusions been clarified in a 
single document (UK Stem Cell Oversight Committee, 2015). In the quote, they 
make reference to haplo-identical transplant where an HSC donation comes from a 
mismatched family donor (effectively, the donor is half a match, and the none-
matched side is ‘deactivated’). The technique, they say, has attracted… 
…a lot of interest but it’s still a very niche procedure. About 3% of 
transplants, I think, are currently haplo-identical with really no 
long-term outcome data. And that which is starting to emerge is 
actually quite worrying. A lot of relapses four to five years out … 
what we’ve said in 2014 is that we’re going to seek continuity of 
central funding to expand the inventory to 30,000 units and then 
we’re going to pause and review. And if haplo-identical 
transplantation is at this point proving safe and effective, it is quite 
likely that the demand for cord blood will diminish significantly 
and we wouldn’t plan to push on to 50,000. If on the other hand a 
different scenario emerges in 2018 and haplo looks a less desirable 
option, then we would use the sales income derived from selling 
UCB predominantly overseas to drive the inventory up to 50,000. 
(Participant 18) 
In this reflection, the participant positions haplo-identical transplantation as a 
technology that, if it gains popularity, could shift focus away from UCB technology 
altogether. However, because haplo-identical transplant has ‘no long-term outcome 
data’ and emergent data are ‘quite worrying,’ the de-seating of UCB is by no means 
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certain. Interestingly, then, the archival strategy is open to its own closure. If it loses 
relevance in a clinical context and they see ‘demand … diminish significantly,’ the 
collection managers are willing to step aside. A similar point is noted in the 2015 
strategy report, where it is mentioned that the committee 
‘…has paid close attention to developments in the field of 
haploidentical stem cell transplantation. These donations, derived 
from partially-matched family donors, have the potential to reduce 
the requirement for stem cells from unrelated donors’ (UK Stem Cell 
Oversight Committee, 2015: 32) 
The awareness of the potential reduction in user requirement for this archive is 
balanced out by a scoping out of different avenues for making the collection useful in 
new ways. For example, in the report, the authors lay out potential new regenerative 
medicine therapies that may eventually be made available to patients. Induced 
pluripotent stem cell therapies taken from adult cells, somatic cell therapies, and 
tissue engineered products were all recognised in the latest strategy report as 
therapies that might require adult stem cells and UCB (of which there is, as we have 
seen in this thesis, a ready supply) in the course of their production (UK Stem Cell 
Oversight Committee, 2015: 37). There is an implied scope here for the future of 
these current registers and collections. But even in its reflection on these future 
additions to the available regenerative medicine repertoire in the UK, the report 
plotted out the continued usefulness of the existing banks and registers in their own 
right:  
‘In some ways the new generation of cellular therapies are likely to 
be the ultimate in stratified medicines in that, like [haematopoietic 
stem cell transplant] HSCT, a degree of immunological matching 
and tailoring of the clinical therapeutic to the condition of the patient 
will be required. It is important therefore that we continue to build 
on the panels of potential voluntary stem donors and cord blood 
donations in order to leverage the widest possible breadth of 
compatible regenerative medicine products for individual patients.’ 
(UK Stem Cell Oversight Committee, 2015: 37) 
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Here we see that, given the specificity required of these new therapies as ‘the 
ultimate in stratified medicines’, the current collections of HSCs through adult donor 
registration and UCB donations would need to continue alongside them to ensure 
that patients have access to at least one of this diverse array of regenerative medicine 
therapies that stands to expand in the future. 
Derrida argues that ‘the archive is never closed,’ but rather ‘opens out into the future’ 
(1996: 68). The continued existence of these collections through the ‘continuity of 
central funding’, but also more generally in its attractiveness to current and future 
clinical users, relies on the collection managers’ willingness to reflect on its current 
state. These archives’ continuation also relies on archivists’ capacities to posit 
different possibilities in which their collections becomes more and less useful, 
anticipate what Deuten and Rip term the ‘contingencies of the innovation journey’ 
(2000: 70). If it is conceivable that the workers can adapt their practices to ensure 
their collection’s continued usefulness, then the practices will be pulled in that 
direction. For instance, electing to type particular loci, adopting new TNC thresholds, 
and removing old units collected when they were ‘rational’ (Rip, 1995) but now held 
in abeyance to make space for new ones. If it is not conceivable then those 
overseeing the collection must be able to admit this.  
7.5 Conclusion 
It seems fair to conclude, in the light of these discussions, that any archive’s 
continuation is at least partially reliant on its archivists’ capacities to mitigate risk in 
the various forms it takes. One of the big risks that the collections in question here 
face is that the technology they rests upon is – as all technologies are – in a constant 
process of becoming (Selin, 2006). One cannot know what an umbilical cord blood 
bank will be used for in ten years’ time. We see here how a rational decision in the 
past can become irrational in the present (Rip, 1995). It is, then, this dimension of 
temporality that comes to define these archives. Along with a temporal risk that can 
manifest materially (17,000 cord blood units, for example, that have travelled out of 
value and lost their status as archive-able matter), this archive faces other risks of a 
more immediately physical nature. The concern with resilience demonstrates the 
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guarded nature of these collections, these frosty domiciles for those valuable tissues 
whose preservation relies on the capacity of their archivists to keep them safe.  
These points can be seen as a broader effort on the part of those managing these 
collections to absorb inevitable and largely unpredictable change (changes in the 
examples here were floods, new HLA alleles, or emerging regenerative therapies). 
This is a recognised need for an inbuilt capacity to create paths, lest the technology 
become dependent upon one path, and lose its archival relevance (Cook and 
Schwartz, 2002) or become locked in (Garud and Karnøe, 2001). This resonates with 
a point made by Bowker that, whilst ‘it is easy enough to develop a potential 
revolutionary technology… it is extremely hard to implement it – and even harder to 
maintain it’ (2005: 115), especially given the speed at which change is felt to occur 
in the accounts of those quoted in this chapter. In the face of the ‘interminable 
turbulences’ (Derrida, 1996: 18) of the scientific context in which these collections 
exist, cord blood may one day no longer serve a purpose, or may have to exist 
alongside a cadre of newly emerging regenerative medicine options 
Risk, then, is not so much an unusual experience, or something negative to be 
avoided. Rather, risk constitutes the normal state of affairs for collections like these. 
It can take many forms, cannot ever be fully predicted, but can be anticipated and 
therefore be prepared for to an extent. Crucially, I would argue that what we see here 
in the UK example of cord blood is an example of the effective strategic 
management of risk. A publically funded initiative as it is, with a mandate to be 
available to that same public, it might be argued that there is a particular imperative 
for regular strategic consideration. Irrespective, perhaps, of this impetus, the case in 
point demonstrates the extreme importance of being aware of and prepared for (as 
much as anybody can ever be) the variegated changes faced by any collection that 
exists in a physical world for use by an unknowable future scientific constituency.  
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Chapter Eight: Conclusion 
8.1 Introduction 
Having engaged heavily in thinking about the future, and stressing its importance in 
how we understand the UK’s UCB collections, it feels strange to now draw together 
the key points into an ‘ending’. The context in which the research for this thesis 
began was dominated by the notion that collections of umbilical cord blood should 
be described as banks. This research has not focused on whether calling these spaces 
‘banks’ is, in and of itself, problematic. Rather, I have suggested that it is useful to 
ask what we might be missing as analysts by using the term ‘banks’ when we come 
to analyse such spaces. More explicitly, I have argued that we would do well to steer 
clear of thinking of these spaces as though they engender some kind of inertia. By 
this, I mean that UCB collections are not simply a gathering of matter that does not 
change, save for the indiscriminate entry of new donations every time a person wants 
to put their UCB unit into the public bank. Yes, matter is aggregated. But its initial 
inclusion is highly mediated. It is variously informed by molecular understandings of 
what features of stem cells make them valuable to keep, or by whether stem cells are 
viable in the context of prevailing clinical preferences. By the same measure, matter 
is also removed when it no longer matches the transient status of viability, no longer 
merits the status, as Achille Mbembe calls it (2002), of the archive. 
There are, then, two dominant points that I have tried to communicate through this 
thesis. One of these is the offering of a kind of inversion of the umbilical cord blood 
collection by highlighting a number of important elements within the UK’s 
collections that have, in other accounts of public UCB initiatives, gone relatively 
untouched. The second point was to offer an in-depth use of the archival paradigm 
and demonstrate how worthwhile a tool it can be for those of us interested in a broad 
array of material and data collections. Below I offer a kind of synthesis of these key 
points, drawing out key critical threads from the preceding empirical chapters, 
highlighting their importance and contextualizing them as contributions to existing 
literature in the fields of Science and Technology Studies and other related areas 
such as the sociologies of health and illness, and of race and ethnicity. In an effort to 
bring coherence to a set of interrelated themes, what follows is ordered much like the 
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thesis – into four sections responding to the four empirical chapters. This exercise 
explicitly unpacks the so what of this thesis. What, I explore here, are the 
implications of what I have laid out in the preceding chapters?  
I move on to reflect on the experiences of the last three years. In this period, I have 
become acutely aware of the contingency of social research. Issues of limited access 
to parliamentary meetings that I could only explore via luckily comprehensive 
minutes, the fortuity of having willing participants give so generously of their own 
time to talk to me when they operate in a field so politically, professionally and 
intellectually demanding of their energies. For this reason, it seems remiss not to 
reflect on what if, the various different directions this thesis might have taken and 
how the eventual turns I did take have limited the findings I can provide here. 
Finally, I am also interested in exploring the new issues brought into view and the 
different questions prompted by the preceding chapters. As such, I am interested in 
thinking about what’s next and laying out explicitly what I view as important 
avenues for further enquiry that have emerged out of the substantive discussions of 
this thesis.  
8.2 A Bank by Any Other Name? 
In drawing heavily on the archival anatomy I proposed in chapter two, this thesis 
constitutes a shift from existing accounts of public UCB collection as defined in 
beneficent opposition to the private model of collection (Dickenson, 2007; Martin et 
al., 2008). I attempted instead to think purely about the complexity of interests, 
knowledge and practices that comprise the black boxing of the ‘public’ UCB bank. I 
am not so interested here in telling everybody to stop using the word ‘bank’. This 
was not the intention of, or conclusion drawn from, using this anatomy. The worth of 
the anatomy and this analysis has been to use that lens to look for features of these 
collections that happen regardless of whether or not we call them banks. It would be 
superficial here to suggest my contribution is an attempt to popularise the term 
“umbilical cord blood archive”. Rather, what I hope to have done is generate a 
number of critical insights via that lens, which I want to unpack here. 
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What I offer here is an exposition of both what I have argued, and why I have argued 
it. A number of the insights hinge on binary tensions. For example, chapter four 
explored the relationship between the molar and the molecular characterisations of 
the individual self (Anderson and MacKay, 2014; Rose, 2007). What does this 
tension mean for the contemporary practice of UCB collection management, but also 
for its future? In its most racialised moment this molar/molecular distinction 
intersects with another binary that came into sharp relief in chapter five, that of 
archival inclusion/exclusion. As I explained in that chapter, these ‘public’ collections 
limit people’s access to donation through selective positioning of collection sites in 
areas chosen by funding delimitation and/or national ethnicity data, and extensive 
eligibility criteria on the part of individual women. I argued in that chapter that this 
challenged, at a very basic level, the communitarian ideal of public donation. In light 
of this, is it time to reconfigure our binary construction of the public/private division 
of stem cell donation? 
Chapter six offered an account of how the UCB collection comes to be used. As well 
as the more rational register of recommendations and published consensus, a layer of 
what I described as ‘clinical comfort’ was also at play. This formed, I argued, an 
affective register of decision making. In the chapter, I argued that we needed to 
recognise that the collection’s usefulness can be managed in reference to how distant 
its matter is from this clinical requirement informed by that binary of the 
rational/affective. What implications, though, might this have for how we view 
clinical decision making more generally? In chapter seven, I described a number of 
issues at play in managing the UK’s UCB collections. These issues, which I argued 
could be viewed as risks, were various. The risk of destruction, the risk of 
obsolescence and the need for strategy to manage both these as the collection moves 
into the future. These vectors of risk and resilience are crucial, I argued, in 
understanding the contemporary UCB collection (and, indeed, collections of tissue 
more generally). As I explore here, this observation offers fertile ground for thinking 
about the focus and direction of future work in this area. 
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8.3 The Molar and the Molecular 
The first empirical chapter, chapter four, focused on the establishment or 
construction of the UK’s umbilical cord blood collections. It considered how they 
were aggregated and ordered, and uncovered an apparent tension between the binary 
division of the bodily, or molar, self, and the immunitary, or molecular, self. The 
findings here echo Nikolas Rose’s (2007) argument that contemporary life is marked 
by an unstable ambivalence between our molar and molecular selves. We sit at a 
juncture where, with sufficient tissue samples from our blood or saliva, and some 
intensive computer-based calculations, you and I could feasibly determine whether 
our tissues constitute “a match”. What this does for our sense of individuality and 
identity remains to be seen, but we can assume that the potential to know ourselves 
molecularly will only increase as the technologies that allow it transform. Might, 
then, one’s awareness of her molecular individuality produce a kind of ‘data double’ 
or ‘data self’ (Lupton, 2012) that recursively inflects on her self-identity and 
behaviour? 
I am prompted here to imagine two worlds. One is molecular, one is molar. In our 
molecular world, a next-door neighbour’s stem cells might kill you, but a person 
living in a town you have never even heard of might offer the cellular similarity that 
makes your bodies compatible. Does one’s molecular persona stand to obviate their 
other markers of differentiation? In our molar world, compatibility takes on a 
different guise. The bodies that can come together at a social level have been, and 
continue to be, policed by our genders, by our skin colour, or even our nationality. 
The occasional union of these different molar and molecular registers might be quite 
jarring. For example, Stefan Beck writes an account of the Greek-Cypriot child who 
received a stem cell donation from a Turkish-Cypriot man. Beck reveals here that the 
two parties live on either side of Cyprus’ demilitarized zone. Their ‘invisible 
“sameness”’ (2011: 95) was made intelligible by HLA typing, and the two were then 
seen to share a kinship that penetrated and confounded the physical buffer zone 
between their respective political administrations. 
Not every example of stem cell donation is quite so poetic in its transgression of the 
molar/molecular divide. But each occasion of an unrelated “match” demonstrates the 
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disjointedness between the molar and molecular registers as they exist today. And 
yet, the disjuncture is made messier still. As we saw in the introduction to this thesis, 
the immunological imaginary that bore the HLA complex and the articulation of 
molecular individuality, was enacted by scientists influenced by race as a molar way 
of knowing bodies. Thus, the development of the nomenclature of HLA happened in 
parallel with scientists’ efforts to bring molar sense to this molecular style of thought 
(Rose, 2007). World maps, isolated indigenous communities, and migratory patterns 
were all brought to bear on how scientists would understand how HLA individuality 
worked in practice.  
The outcome of that has been that the selective collections made possible by 
immunological knowledge are, confusingly, constructed by a molar register, but used 
by a molecular one. To the extent that ethnicity and immunological profile take on 
what I have described elsewhere as a metonymic quality of interchangeability 
(Williams, 2015), these different registers sit ambivalently as tools of order in the 
UK’s UCB collections. Whilst such racialised classifications are seen only as an 
approximation of genetic diversity, they are still seen to be ‘potentially useful’ 
(Kittles and Weiss, cited in Rose, 2007: 159) for helping to order a social world in a 
scientifically salient way. To the extent that ethnicity is useful in the sense of 
encouraging donation amongst certain bodies, it is described as a luxurious, 
secondary datum next to the more specific and scientifically meaningful HLA type 
of the anonymous donor at the point of a tissue request. “Ethnicity data is nice to 
have”, said one participant in chapter four, whilst noting that it is not really 
something they need. 
Racial classification is frequently acknowledged in various archival practices. Why? 
Perhaps because archives are spaces that demand a certain amount of order, as 
Brothman (1991) contends. Archivists will tend to enrol familiar metrics for 
organising things. As Claire Waterton notes, archives seem to ‘build upon deeply 
held, spatially segregated, cultural understandings of knowledge whereby certain 
forms of ‘‘raw data’’ are gathered ‘‘in the field,’’ through experience of life and of 
the world’ (2010: 648). Artifacts can be measured in centimetres, weighed in grams. 
Ethnicity is one such familiar ordering mechanism in these UCB banks. A good 
diversity of HLA types (which is the normative point of representativeness in this 
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context) is best achieved, in the view of those managing these archives, by enrolling 
donors of minority ethnicity. Ethnicity, the ‘racial register’, as David Theo Goldberg 
has called it (2014: 170), represents an intelligible point of reference for encouraging 
donation. As Goldberg reflects: 
‘How easy is it to characterize someone as white or black, describing 
to a person you have never met whom they will be waiting for, what 
look to expect to find each other. The frontier of the skin becomes a 
default reference.’ (Goldberg, 2014: 174) 
It is easy, as Goldberg argues, to characterise someone racially. It should, then, be 
little surprise that such distinctions are enrolled for a selective collection wherein 
some kind of order is required. But there is an issue here that I have not given space 
to in the thesis. The use of race here (at face value, at least) is to combat a supposed 
dearth of stem cells, to ameliorate seeming inequality. But should we not give pause 
to ask why it is that pre-UCB, adult stem cell registers have since the 1970s 
systematically failed to penetrate the communities they are now so intent on 
accessing? How did the practices and understanding that produced those collections 
of data compel the current demand for minority ethnicity tissue? I will return to this 
point, but think it is useful here to posit the possibility of a postracial archive.  
How would collections managers organise stem cells differently if they stopped 
using race and ethnicity as cornerstones of accumulation and order? How would a 
collection’s composition be portrayed in a pie chart, for example, if the most salient 
datum were not a donor’s ethnicity? What if collecting the data were impossible (as 
in the case of France, where it is, as a participant in chapter four notes, illegal), or if 
all people’s HLA types were already known in advance (if, for instance, all people 
were all typed at birth, or if it were an obligation to place one’s data on a register). If 
ethnicity is but a luxurious datum when these collections come to be used, can we 
expect its grip on their ordering practices to loosen? Can we expect the capacity for 
molecular analysis to move the primary distinction of bodies away from racialised 
molarity? It remains vital to follow what continuing work ‘race’ and ‘ethnicity’, the 
obdurate lines of human differentiation, are being put to as these technologies 
transform. 
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8.4 Privation within the ‘Public’ 
The exclusionary dynamic of the UK’s UCB collections was the focus of chapter 
five. In this chapter, I outlined the different ways in which the titularly public bank is 
highly exclusive, allowing donations from only a fraction of the many women who 
give birth in the UK. STS scholarship, as I explained in the first chapter of this thesis, 
tends towards a binary characterisation of UCB collections as one of two “models”. 
They tend to be thought of as public banks (the kind of collections that this thesis has 
focused on) or private banks. The former, in most conceptualisations, is thought of as 
the more communitarian “model”. Women donate their cords altruistically, receiving 
no payment with the donated tissue being placed on a register that might be accessed 
universally by clinicians across the world. Literature interested in this iteration of 
banking focuses on the complexities of international exchange of UCB tissues, and in 
its position as the emancipatory opposition to the atomistic private model (Brown 
and Williams, 2015; Dickenson, 2007; Waldby, 2006). 
In the private model, individual companies provide storage of UCB tissues on behalf 
of the customer who will then pay the company for exclusive future use of the tissue 
should it be required by a family member. As I mentioned earlier, the focus of this 
thesis has been in many ways an opening of the black box of the public UCB bank. 
The argument of this chapter is a challenge to the very notion of the ‘public’ 
collection. Indeed, on reflection I am perhaps more inclined to take issue with the 
word “public” than I am with the word “bank” because calling the collection a bank 
does not confer the same moral weight on the initiative as calling it public. The 
usefulness of the archival lens in this instance is in understanding that archives 
cannot hold everything, and within a mandate to represent (Jimerson, 2009), can only 
ever retain that deemed most relevant in the given archive. We see these points in 
operation in the UK’s UCB collections, which cannot take tissue donations from 
everybody. Though ostensibly public, the system operates, as I argued in the chapter, 
on a privation of access. This matters for a number of reasons, not least because the 
moral injunction to donate what would otherwise be wasted is a mobilised rhetoric of 
the public UCB collection initiative. 
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As a ‘selective collection’ of things (Stoler, 2009: 45), not everything can go into an 
archive. This is what Bowker calls the jussive force of the archive. They operate, as 
he asserts, ‘through being invisibly exclusionary’ (2005: 14). I plotted out some the 
practices of UCB collection in the UK that could be seen as exclusionary (in the 
sense that they literally exclude certain donors from giving their stem cells). These 
practices were necessitated primarily by resource limitations. Resources stretch only 
so far, and data suggested that it made more sense for those involved to concentrate 
resources on ensuring collection at fewer sites 24 hours a day, rather than open more 
collection sites in more maternity units to offer collection for only a portion of the 
day. The kind of funding available also made a difference to where collection sites 
could be placed, with sites outside of London being selected in part by whether they 
qualified to receive the kind of regionally-specific funding the government had 
awarded the initiative. 
One of the most intriguing things to emerge from this chapter was the relevance of 
ethnicity as an exclusionary criterion as well as an ordering one. Ethnicity in the UK 
is recorded by the government census which those planning collections sites used to 
guide which areas would be chosen. As participant 8, a bank administrator explained, 
a good collection site has “preferably a high birth rate of diverse ethnic mothers and 
that’s what we’re focused on”. The encouragement of particular people who are 
racialised as minority bodies (who thereby produce ‘rare’ tissue) to donate takes 
focus away other bodies racialised as white (who thereby produce ‘common’ tissues) 
raises very interesting questions here about the value of particular kinds of bodies. 
Compare the archival demand for high-value minority tissues in the collection, with 
the political struggle to raise awareness of the seemingly low value placed on black 
lives in the public sphere manifest in contemporary political movements like 
#BlackLivesMatter (Day, 2015). 
This inversion, which prompts me again to highlight the disparity between our molar 
and molecular existences, is not simply intriguing, but has a potentially emancipatory 
core in which the molecularisation of race stands to produce equity (Rose 2007), but 
might as equally reify molar difference (Kierans and Cooper, 2011). This archival 
aperture, so intent in its focus on black and brown bodies, might appeal to a 
racialised communitarianism that for the racialised individual to fall short of is 
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tantamount to a kind of ‘civic defection’ (Benjamin, 2013: 44). As Titmuss (1970) 
explored in relation to blood donation, there can be a powerful tenor of shamefulness 
involved in not giving of one’s self to the rest of the community. This can potentially 
invert the communitarian spirit that underwrites the systems of donation that concern 
us here. In what spirit, with which discursive tone of encouragement, are certain 
people asked to donate? How does that shape one’s relationship to the act of 
donation, and how could this efface the communitarian heart of the “public” 
collection model? Does the conferral of archival status reify racial differentiation or 
is there beneficence in race’s invocation here?  
Whilst I have explored the private sector in more theoretical depth elsewhere (Brown 
and Williams, 2015), I feel there is scope here to consider in more depth the possible 
limitations of critical accounts of private banking based on the promissory dimension 
of the product and the attendant implication of capitalistic avarice (Martin et al., 
2008; Waldby, 2006). I argued in chapter five that the private bank might offer an 
outlet for tissue storage for those individuals precluded from donation by the public 
model. With no avenue for universal donation, could self-pay alternatives begin to 
partially reopen that option even if in another limited way given not everybody is in a 
position to pay for such a service? The important distinction here that limits such an 
argument is that the private bank does not offer universal access to stem cells for 
treatment. The public bank stands to be very public in the sense that it does offer 
universal access. The munus of community (Esposito, 2011) remains unfulfilled 
through private banking, though still only partially fulfilled in the public model. 
What I suggest here, then, is that the dualism of private/public cannot be settled 
easily. The motivations of tissue providers/donors are of course revealing (Brown, 
2013) and the management of the collections into which they donate are complex, 
and confound simplistic titular distinction. As Healy notes, to think of these systems 
of donation instead as systems of procurement is helpful. By bringing focus to 
procurement the motivations of donation have less weight as a way of defining and 
understanding such systems. In a more sociological language, the agency of a donor 
means little without an in-depth knowledge of the structure that permits (or excludes) 
the donation.  
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8.5 How an Archive Comes to Be Used 
The focus on imminent/latent future use of data and matter is integral to the 
theoretical invocation of the “archive” and was central in the discussion of chapter 
six. When I first started thinking with the archive, the weight of the future and its 
performative attributes (Waterton, 2010) made very little sense. The archives I had 
been using were full of artifacts from some time long past. The point, though, was 
that I was using them. They were established and maintained because the people in 
charge of such decisions felt their collections might be useful. In chapter six, I 
suggested that to be able to understand the centrality of use in a given archive, one 
had to have a grasp of how that archive comes to be used. I explored how these UCB 
collections come to be used, arguing that there were different elements at play in how 
clinicians come to use these public UCB collections. The argument this built into to 
was that those working in the archival spaces in question here must be responsive to 
these elements to ensure their collections’ continued usefulness. 
I considered professional guidelines, produced by the consensus of senior scientists 
and practitioners, which are published for the consideration of practitioners working 
with the technology of HSC transplantation. In what Harry Collins might call the 
‘algorithmic’ style of knowledge transmission, these guidelines represent a 
rationalising tool (Berg and Timmermans, 2000) designed to bring consistency to 
clinical practice. In the local space of a given transplant centre, though, experience 
with particular technologies inflects the decision to use UCB over different sources 
of HSCs. The subjective experience of the individual practitioner, the data 
demonstrate, has a large impact on whether they will use UCB and, therefore, the 
collection. Through using the technology and developing a manual capacity for 
UCB, clinicians stand to become more comfortable with the source, echoing Collins’ 
notion of ‘enculturation’ as a means of knowledge transmission.  
These findings resonate with discussions had in the Sociology of Health and Illness 
literature on clinical technical preferences, where the issue of practitioners’ 
discretion and their clinical autonomy has been seen to sit uneasily with imposed 
guidance on the specificities of clinical practice, particularly the prescription of drugs 
(Armstrong and Ogden, 2006; Prosser et al., 2003). The broader adoption of new 
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clinical approaches within general practice, for example, has been of interest for 
some time, with findings highlighting that implementation is a fluid and complex 
process, where no single factor could be given causal precedence in whether an 
approach is adopted. As Armstrong and Ogden note in their review of the literature, 
accumulation or a gradual building up of knowledge is perhaps the best way of 
understanding uptake of a new clinical intervention. The importance of practitioners’ 
personal preference, argues Pope, works in tandem with ‘past experiences, sensory 
responses and abilities’ (2002: 379) to determine the path most likely taken in a 
particular clinical intervention.  
In chapter six, I argued that a clinician’s subjective view of (or their ‘clinical 
comfort’ with) a clinical option plays a key role in its uptake at a local level even if 
disseminated professional guidelines exist. This argument came out of data from 
those involved at a senior level who, for the most part, have never been practitioners 
using UCB in a clinical setting. This thesis is not, and was never intended to be, a 
study of practitioners who use HSC transplant technology. To be able to see the 
decision-making at work through other means (for example, ethnography or direct 
observation) would, of course, have added a different vector to these reflections, but 
equally would have removed focus from the broader concern about the organisation 
of these collections and how they might promote use rather than focusing on the use 
itself. This notwithstanding, the consensus-led guideline as well as user preference or 
users’ ‘clinical comfort’ both made a bid in the data for being integral to how these 
collections come to be used. I would agree with the sociological consensus that there 
is a complex interrelation between external guidance and individual clinical 
preference in the uptake of an option. The ensuring of archival use is an important 
element unique to the context of interest in this thesis that perhaps heightens the 
importance of recognising this interrelation. 
These different registers are at play within clinical settings where choices about 
treatment are made. Though I did not spend any time in such settings, it is very 
telling that there was an acknowledgement of these registers beyond the clinic in 
discussion with a diverse array of people involved in the initiative of public UCB 
collection (who had, for the most part, never actually worked in a clinical 
environment making such decisions). I would suggest that there is such a heightened 
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awareness of this because of the importance in ensuring that the collections come to 
be used. These different registers play on the minds of those involved in collection 
management. Regarding the rational register of clinical consensus algorithms, one 
administrator in chapter three noted that because cord is moving “up the algorithm … 
we’re making progress”. Another administrator who lamented a clinician’s 
preference – the affective register – being based on only a few experiences, said 
“they are people after all, whether we believe it or not”. There was a clear resignation 
to the importance of these two elements that work together to bring users to these 
collections and, therefore, make them useful.  
But these are also recursively folded into collection management practices in this 
instance. How do those managing a collection know what is useful (i.e., what matter 
and data to retain)? The answer here, I would suggest, is in learning from the patterns 
of use. Recall the scientist who explained the decision to raise the threshold for the 
total nucleated cell (TNC) count of a unit. How was the decision made? “It was 
made,” they explained “on the basis of what people are actually selecting”. This 
responsiveness is an integral element in understanding the practices that lay behind 
UCB collection in the UK, as it highlights the driving force of users in how an 
archive is constituted. It is important, then, to think about what this means for how 
public UCB collections might be studied in the future. I would argue that a future 
port of call for the research that emerges out of this chapter is for a more in-depth 
consideration of how those managing collections such as these actually get to know 
their users, and what mechanisms are in place to maintain those relationships. 
In light of this, we can see how UCB collections are managed and monitored with 
care. They are intended to exist in synchrony with the potential constituency of users 
whose choices are wrapped up in subjective experience as much as standardised 
recommendations of professional consensus. This argument goes to the heart of 
challenging the simplistic imagining of public banks as large accumulations of matter 
retained prudentially for some future time. The amount of mediation and 
management, and the required awareness of user requirement, means these 
collections are no less than highly contingent. The units within in them will not stay 
relevant forever, and their continued archival status is certainly not guaranteed. 
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8.6 Risk and Resilience 
Chapter seven focused in on some of the risks faced by the UK’s UCB collections, 
but also how those risks are managed. Some risks, like the formless risk of 
obsolescence, are something that all archives are faced with. Such a risk cannot be 
seen, per se, but its presence holds significant purchase in how the UCB collection is 
managed. Obsolescence, as I talk about it in this chapter, suggests the possibility that 
the archived content within any collection might become, at some point, irrelevant to 
those users who in the near or distant future may come to use it. This comes to life in 
the UCB collections as we considered, in chapter seven, what has been seen to 
happen to material collected earlier on in the project of UCB banking which, though 
still preserved in a freezer, no longer retains its relevance in reference to the 
contemporary expectations and standards of users. We can, perhaps, think of the 
desire for a synchrony between collection and user (as I explored in chapter six) as a 
means of mitigating obsolescence in the sense that awareness of the distance between 
archival provision and user need is best kept in check by knowledge of the 
constituency’s requirements.  
User requirements, then, have a powerful influence over what those managing these 
collections put into them, and what they retain of what is already in them. The 
sustainability of a collection has a great deal to do with how user requirement is 
monitored and responded to. Sustainability as a notion, however, tends to refer to 
economic sustainability when discussed in relation to the management of collections 
of human tissue. For example, in the literature on the management of research 
biobanks, there is a sense that, as Vaught et al. (2011) put it, ‘market need’ must be 
met with ‘a high-quality portfolio’. This is clearly the language of economics (or 
‘biobankonomics’, as the authors call it). I am not in a position to disagree with these 
authors whose interests here are in the research-based biobank. Data from this thesis 
relate to the clinical bank – a collection established and aggregated with a very 
different purpose. Accordingly, I suggest that in the clinical context, if not the 
research context, we could afford to think outside of this remit of economic 
sustainability. 
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‘Market need’, for example, may be understood in our context of interest as ‘user 
requirement’, a ‘portfolio’ as a ‘collection’. Quality is maintained over time rather 
than taken for granted and constant. It relates, as I have demonstrated, not to some 
essential characteristic within a UCB unit, in the distance between that unit (stored 
on a given day in reference to the standards in play on that day) and the requirements 
of the practitioner at the time she comes to look for it to use in treating a patient. 
Quality relates, in short to the maintenance of this important link between archive 
and user. The distance between these UCB units and the user’s requirements 
constitutes an ever-present risk in the UK’s UCB collections. By understanding them 
as archives (not as investment portfolios which sits a little awkwardly with the 
practice of the public collection), the risk comes into sharp relief as an inevitable by-
product of establishing and maintaining a clinically useful collection of stem cells. 
Whilst we can have, to use Bowker’s term, ‘empire over the present’ (2005: 227), we 
cannot ever hope to sustain it without conscious and consistent maintenance. 
I am not arguing here that economic factors are irrelevant, but my conviction is that 
just because the stem cells – like other human-derived tissues - are ‘bought’ does not 
mean they are commodities, or the basis of a market (see Hoeyer, 2009). The profit 
motive may play a role in the more research-based biobank but, as I have pointed out 
elsewhere it has relatively little to do with the management of a bank of tissue used 
for public health purposes. Here, collectors’ institutional interests and state funder 
pressures may have their role to play (Williams, 2015) but the ethos of the market is 
hard to locate (Brown and Williams, 2015). A collection may indeed face closure, 
the end of a finite funding stream for example (Tupasela and Stephens, 2013). But to 
focus purely on its economic sustainability risks obscuring those practices that allow 
the units to be saleable in the first place.  
Returning to the focus of chapter seven, I also argued that risk takes on another more 
familiar guise. The risk of physical destruction, decay and deterioration informs the 
spatiality of all archives. This is what Derrida (1996) might call the archontic 
principle that makes archives protective spaces. Resilience becomes a central tenet of 
the management of UCB collections. The loss of electricity to a cryogenic freezer is 
likely to be as harmful as the more abstract slippage of a UCB unit into 
obsolescence. The spatiality of the all archives is crucial. ‘There cannot,’ wrote 
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Mbembe, ‘be a definition of ‘archives’ that does not encompass both the building 
itself and the documents stored there’ (2002: 19). The archival space, which came 
into relief in the data, is ideally sealed off (autos), protected from the other (állos) of 
the flood, the fault, the spectre of failure produced out of the need for material 
existence of the collection.  
A broader issue that overarches these themes is what emerged at the end of chapter 
seven as acute awareness of the need for strategic direction in how the collection is 
managed as it moves forward through time. One of the major points here is that 
(unlike this thesis) there can, by definition, be no end to any useful archive, because 
a useful archive must be transformed alongside changes within its user constituency. 
As we saw in the introduction, these collections are imagined (in this instance, over 
several decades) then they might be constructed. Archival matter might be 
exchanged, developed, or taken out of an archive for some other reason. An archive 
itself might be flooded or it might be moved. The people who manage them, though, 
do not want their collections to ‘end’, but to continue on indefinitely and usefully 
into a future that they are unable to see, for a consistency of users ‘whose limits are 
of necessity unknown’ (Osborne, 1999: 55). 
There is, in these findings, a sense that it is important to discern, in the increasingly 
common practice of archiving matter and data for a number of different pursuits (one 
in the suite of regenerative medicines being our pursuit of interest here), how risks 
are constituted and managed. The destructive core of all archives was recognised by 
Derrida, when he suggested that archives are always ‘a location… You need the 
exteriority of the place in order to get something archived’. He goes on to explain 
that it is ‘because of this exteriority [that] what is kept in the archive can be erased, 
can be lost’. What constitutes exteriority may change. A freezer and the risk that the 
electricity may be lost and the archived matter a long with it, or a datum which risks 
becoming useless, lost in an information silo ‘for want of providing enough context’ 
(Bowker, 2000: 646) in a style appropriate to the mode of thought of the user at the 
time. 
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8.7 Limitations of the Study 
It is apposite in the context of this discussion to reflect on what I have not done in 
this study that I might otherwise have. Here, then, I want to take the opportunity to 
think about the other methodological approaches I might have undertaken. I am also 
keen to think about my focus on the practice rather than economics of the UCB 
collection enterprise, as well as my concentration on one national context. These are, 
I suggest, things that were lost to the periphery through my focused use of an 
archival sensibility that I consider here. Finally, I consider the issue of the study’s 
timing to suggest that this limitation reveals much about the responsive pace of 
collection practices. These reflections give a foundation to a final consideration of 
how these limitations can be addressed through further, future explorations. 
In the earliest stages of this thesis, I could have selected to undertake a hospital-
based ethnography of the specific practices of UCB collection or a lab-based 
ethnography of UCB processing. These different approaches would have taken the 
project in significantly different directions, and the conceptual position and empirical 
findings would doubtless have been very different. The thesis as it exists here, 
though, offers an important starting point as a piece concerned more broadly with 
how the UK’s publically available UCB collections operate from the perspective of 
those involved at a senior level in the production of the strategy and policy that steers 
those collections through a wider and shifting landscape of regenerative medicine 
and related technologies. I would argue that on the basis of what I have laid out in 
this thesis, focused studies on particular areas of collection and process within the 
broader field of practice stand to benefit from the archival sensibility I have proposed 
here. 
Another what if: an element that I have necessarily focused less on in this thesis, 
though have taken up elsewhere (Williams, 2015) are the issues of cost, money 
saving, public funding, and unit pricing. The focus of my data collection did not 
explicitly touch on these themes that I felt, at the time (and still feel, in retrospect), 
risked taking focus from the other rationales that underpin the broader field of 
practice I have been interested in here. However, as the effects of increasing clinical 
commissioning devolution proceed, it will be important to trace how a patient’s 
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geography delimits their clinical treatment choices. This is a slightly different focus 
from the one I have taken in this thesis which has in the main been removed from 
patient experience, excepting the reflections that emerged around how personal 
clinical preferences in a given hospital (rather than local commissioning constraints) 
can have an influence on a particular patient’s experience to the extent that one 
participant asked me, as I outline in chapter six, ‘if I were to get leukaemia, where 
would I want to go?’ 
To that extent, it is important to reflect on what the findings of this UK-based study 
might tell us about situations in other countries. One of the biggest differences 
between the UK context and elsewhere is not only that patients receive treatment 
through a National Health Service but also that the collections I am interested in here 
are publically funded through centralised funding from the UK government, and also 
(as I explained in chapter five) through competitively awarded public money in the 
form of the UK’s Regional Growth Fund. I would suggest, however, that since more 
than 40% of UCB units released globally for clinical treatment travel across state 
borders (Welte et al., 2010), the practices of collection management and the archival 
response to risk are key issues internationally. Indeed, it is telling that examples of 
the management of obsolescence in chapter seven reached across international 
borders into Europe and Asia. 
The notion of an archival anatomy, which I plotted out in chapter two, has been a 
directing force in how this thesis has taken shape. I am cautiously convinced of the 
usefulness of the protean archive, having seen it put to work successfully elsewhere. 
Whilst I think it has given me a lot, it would be remiss of me not to offer some 
reflection on what it might have taken away. What if I had not used an archival lens? 
I did not think to immerse myself in STS writing on data management in the field of 
biodiversity during the first months of the research project. Nor did I happen upon 
Derrida’s Archive Fever until sometime later, in the midst of data collection when 
particular themes around classification, exclusion and so forth started to emerge (as I 
explain towards the end of chapter three). The data probably would have been 
different if I had been more explicitly looking for archival practice from the start, but 
I would argue that the fact that the paths of data collection and theorising converged 
during the process speaks to their consonance. Put in a different way, it was not so 
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much me being invested in an archival lens so much as practices that might described 
be as archival being integral within the context I have been interested in here. 
The analysis would also have been different if I had not used the archive. I could go 
through the entire thesis and remove all references to ‘archive’, ‘archival’, 
‘archiving’ and so forth (an act that would itself rely on the word processing software 
to offer an archival function of a kind). Where would we be then? The themes would 
all be there: the generational thinking, the exclusion, the selection, the classifying, 
and the order. They would not, however, cohere as a set of practices that make sense. 
As a lens, the archive not only helps to bring these practices into relief but also 
imbues them with a kind of teleology. There is purpose behind the decision not to put 
a collection site here and not there, a logic for the choice to make the TNC thresholds 
what they are, a reason for the racialisation. That is to say, they only make sense 
because the collections managers, like all archivists, are trying to protect their 
collection from risk, make it representative, and ensure its usefulness for a future 
constituency. 
There is, though, an important limitation to what I have produced here. The archive 
as a concept in 2015 is different from what it may look like in a century in response 
to shifts in how knowledge, data and matter are retained, measured, ordered, and 
accessed in different ways. This project has lasted for three years, has focused on the 
practices of those involved with producing the policy and strategy behind two inter-
acting UCB collections, in relation to the policy regarding one country’s provision of 
HSCs. Had there been four or five years, three or four collections, two or three 
countries, the findings might have been different, though I do wonder how different. 
In terms of the practices of collection maintenance, of trying to keep ahead of clinical 
practice and demand, I find it hard to imagine that different countries would fair very 
differently from the context of concern here. The more pertinent factor that stands to 
be considered here is not one of the scale of the project, but its timing.  
As chapter seven demonstrated, practices of the current generation of UCB 
collections, is very different to how they have been undertaken in the past (that is, 
practices in the mid-nineties when UCB collections were first being established). 
Remember the brilliant reflection from a participant I quoted in that chapter, that 
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assumptions from then have since been ‘a little bit blown out of the water’. Looking 
forward, then, how might this project have differed if it had been undertaken in ten 
years’ time? We cannot say for sure, but judging by the last chapter, the landscape of 
regenerative medicine might have changed so much (different demands borne of 
different technical capacities; new technologies vying for the attention of clinicians) 
that UCB collections might be unrecognisable. Remember Derrida’s assertion:  
‘the technical structure of the archiving archive also determines the 
structure of the archivable content even in its very coming into 
existence and in its relationship to the future. The archivization 
produces as much as it records the event.’ (1996: 16-17) 
It stands to reason, then, that just as Freudian psychoanalysis would have been a 
different thing if the Austrian neurologist and his contemporaries had all be 
communicating by email (Derrida, 1996), the practice of UCB collection will be 
different in ten years’ time, when new techniques of procurement, new metrics of 
quality, new clinical options, new demands from users, completely transform the 
practice of UCB collection or indeed, as chapter seven pointed out, negate the 
practice altogether. This is, to borrow from Beer on talking about digital archives like 
Facebook and YouTube, a problem of keeping up. ‘Once something that is so 
changeable is written about then we might wonder what use or value is in the text’ 
(Beer, 2013: 5). Does the non-transferability of the context, its very historicity, count 
against it? HLA types may mean nothing in twenty years’ time, for instance. Cord 
blood could be a thing of the past altogether in thirty! I would argue that the 
historicity of this thesis is key. In many ways, I think one of its enduring resonances 
is the very transience of usefulness (of classifications, or data, or matter) in the 
contemporary technoscientific moment. 
8.8 Archival Definitions and Future Directions 
This thesis, then, stands as a contribution to the important scholarship of writers such 
as Geoffrey Bowker whose engagement with the database as a “memory practice” in 
the disciplines of ecology and biology represents perhaps the first example of the 
significance of the archival paradigm for understanding practices of ordering data 
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and matter in the natural sciences. Those who have expanded on Bowker’s work, 
primarily Waterton et al.’s writing on the complexity of constructing meaningful, 
useable databases for biodiversity preservation (2013). I took inspiration from these 
and other scholars whose work directed me to think in particular ways, to keep my 
ears pricked for particular themes. It is important, though, that I am able to give 
something back to this archival lens, to offer a few reflections on what the archive 
has been useful for here, and what its wider potentialities might be for STS 
scholarship.  
As I argued in chapter two, the archive in a conceptual context is not the same as the 
archive as many of us might think of it. The theoretical archive, writes Stoler, ‘leads 
elsewhere’ (2002: 94). Over this thesis, the archive has led us to a particular 
formulation of what an umbilical cord blood collection is, how it is managed, and 
what it can possibly come to be. Archival thinking has fortified analyses of all kinds 
of selective collections of data: the social network Facebook (Beer, 2013), a DNA-
barcoding biodiversity database (Waterton et al., 2013). Here I have applied its 
elasticity (Osborne, 1999) to an ostensibly material collection with attendant data. 
Using the archive as a heuristic has been key to producing the initial lines of enquiry, 
as much as informing the enquiries themselves that formulate the four empirical 
chapters you have just read. Its use lies, as we have seen here, in its ability to sharpen 
focus on the practices of collection, maintenance and use, and the understandings 
that underwrite them. 
Would it make sense, then, to think about producing some useful definition of an 
archive? I am wary on this count, given that because (i) we cannot know what is to 
come, and (ii) the archive is itself an experience of anticipated future, we cannot 
really define any archive. This is a point that Derrida makes when he writes that the 
archive is ‘only a notion’. He goes on: 
‘We only have an impression, an insistent impression through the 
unstable feeling of a shifting figure, of a schema, or of an in-finite or 
indefinite process … I consider it to be the possibility and the very 
future of the concept, to be the very concept of the future, if there is 
such a thing and if, as I believe, the idea of the archive depends on 
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it… a concept in the process of being formed always remains 
inadequate relative to what it ought to be.’ (1996: 29) 
Keeping this in mind, it makes sense here to think about the future of this research. 
What questions now need to be asked? Something that becomes acutely important 
here is that there is a clear need to keep asking what work the classification(s) of 
ethnicity are being put to in the contemporary biotechnologies. We saw in this thesis 
a difficult relationship. Ethnicity was a means of focusing the collection of stem 
cells, but had little use in the actual task of stem cell transplantation. As the 
molecular takes on more precedence over molar categories, it remains important to 
watch what happens with ethnicity because of its potentiality as a powerful tool of 
producing health equity, but also of reifying difference. Tracing race in this way to 
see where it is used and why, stands to be a productive way of exploring the social 
implications of biotechnologies, and contribute further to the growing body of 
literature being produced at the nexus of race/ethnicity and Science and Technology 
Studies (Benjamin, 2013; Bliss, 2011). 
It is also, I have suggested here, important to question what we mean in our 
differentiation of public and private models of umbilical cord blood collection. This 
is another trajectory for the future. My main issue here has been with the notion of 
“public”. What discourses are being put to use in encouraging women to donate their 
stem cells? Whilst avoiding normative suggestions of what discourses of 
encouragement should look like, another thread of future investigation is to think 
about more effective ways of positing the act of donation or the gift (Titmuss, 1970) 
elicited for systems of procurement (Healy, 2006) like UCB, organ and blood 
donation. These systems exist not because of the practice of universal giving, but of a 
fraction of the population donating because of very specific criteria necessitated by 
limited resources and exacting requirement. As a contribution to the emergent 
sociology of donation, this critique stands expansion across systems of procurement, 
perhaps comparing stem cell donation against other ‘public’ systems such as organ 
donation, a practice that has very recently dropped in popularity in the UK (Knapton, 
2015). 
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In a different vein, I would suggest that there is scope for focused exploration of the 
notion of resilience, a term that reveals an awareness of and preparation for the 
variety of risks that face UCB collections. I would suggest that clinical requirement 
and attendant possibilities of obsolescence are more likely in relatively nascent 
technologies like adult donation and UCB. However, there is potential to think more 
broadly across the different collections of tissue about the need for resilience against 
and (vigilance about) risks of disease, flood, time, (lack of) demand. This might be in 
thinking about the guardianship of collections – the importance of spatiality and 
environment. Perhaps the archival lens would again be useful for exploring questions 
about how resilience is ‘built in’ to the physical environment in contemporary 
collection practices. It seems logical to ask how, more generally, risks are constituted 
across collections as well as considering what practices are being enacted in order to 
efface them. 
8.9 Conclusion 
This thesis has explored the UK context of public umbilical cord blood banking. My 
argument, reduced from eight chapters to a sentence, would be to insert inverted 
commas around the words ‘public’ and – in particular – ‘bank’. I have problematised 
them, arguing that these terms fail to capture the complexity of the intentions behind 
them. I have argued that a stronger grasp of UCB banking is achieved by thinking 
archivally. I have suggested that we must recognise the complexity of these 
aggregations of matter from which lifesaving matter is drawn for clinical use but also 
removed because it has travelled out of clinical usefulness. I have proposed here that 
the enrolment of ethnicity as a tool of aggregation must be questioned given its 
limited use beyond this. So too have I argued that we fail to fully comprehend the 
complexity of the public system of UCB banking without understanding that it relies 
not on public donation, but on systematic exclusion for a number of reasons. I have 
also put forward the suggestion that clinical use of UCB stem cells rests on more 
than standards, but a complex nexus of recommendations and personal preference 
that collection managers respond to in their own collection practices. Finally, I have 
argued that we need to think of anticipation and response to variegated risk as central 
to the project of UCB collections. 
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The thesis has therefore demonstrated that an archival lens offers the heuristic 
richness that ‘bank’ thinking cannot provide to highlight these various important 
aspects of establishing, operating and planning the future of a collection of biological 
material. It thus constitutes a novel contribution to the STS literature on regenerative 
medicine and tissue banking (Brown, 2013; Brown et al., 2011; Dickenson, 2007; 
Martin et al., 2008; Waldby, 2006; Waldby and Mitchell, 2006) as well as the 
growing interdisciplinary corpus on the usefulness of the archive in understanding 
the complex aggregations of matter and data facilitated by contemporary 
technologies (Beer, 2013; Bowker, 2000, 2005, 2010; Featherstone, 2000, 2006; 
Waterton, 2010; Waterton et al., 2013). To take the position that we have reached 
some definitional closure in understanding stem cell collection would be untenable, 
not least because it would be out of step with the archival sensibility I have promoted 
in this thesis. As time marches forward around these collections forcing those in 
charge of them to change direction any number of times, our critical analyses will 
doubtless have to change direction too. I am of course in no position to postulate 
what the future of the UK’s UCB banks will be. However, we can be assured that 
those working inside them will be doing just that. They will, as I have demonstrated 
here, be trying to anticipate a future of users and requirements, and respond in the 
present with the hope that the work they do today will one day be useful. 
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Appendix A: Information Sheet  
 
Understanding Emerging Forms of Governance in public Cord Blood Stem Cell 
biobanking in the UK. 
Information Sheet 
You are being invited to take part in an interview for a research study. Before you 
decide, it is important that you understand why the research is being done and what it 
would involve for you. Please take time to read the following information carefully. 
Talk to others about the study if you wish. Take time to decide whether or not you 
wish to take part. 
 
Purpose of the research 
 
This doctoral research project has two main aims: 
 To develop a better understanding of the emerging governance structure of 
umbilical cord blood banking in the United Kingdom 
 
 To explore the views of clinical experts, policy makers and other stakeholders, 
and how these feed into (1) the production of a policy to expand umbilical cord 
blood banking (2) the novel forms of governance that are facilitating this 
expansion 
 
The project is using research interviews with those involved in the public umbilical 
cord blood industry in the UK to address these aims.  
 
Umbilical cord blood banking has enjoyed a growth in popularity among parents, and 
resultant stem cell stocks have become more accessible to clinicians delivering 
therapeutic treatments to their patients. In response, clinical experts, third-sector 
charities and policy makers have sought to develop an infrastructure to increase the 
collection of immunologically diverse domestic stem cells. 
 
The importance of developing an adequate framework of stem cell treatment 
provision in the United Kingdom is clear, and this research looks to develop a more 
intricate social scientific understanding of how an efficient system of public 
biobanking can be developed and sustained. In doing so, it seeks to explore the 
growing importance of experts in the development of policies that aim to expand 
umbilical cord blood banking in England and Wales and investigate the role of third-
sector charities and patient advocacy groups in the production and rolling out of 
policy.  
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I would like to invite you to take part in this research because I feel that your 
expertise in the wider area of stem cell transplantation as either a clinician, policy 
maker other stakeholder, will contribute to an understanding and knowledge of the 
changes which have and will take place.  
 
What would taking part involve? 
 
This research will involve your participation in a short interview that will take about 
thirty minutes to one hour. 
 
Your participation in this research is entirely voluntary. You will not be asked to 
share personal beliefs and you do not have to share any knowledge that you are not 
comfortable sharing. You can end the interview at any time without giving a reason. 
If, after the interview you change your mind about taking part then you can contact 
me to withdraw from the study and I will destroy any data that you have provided. 
You will have three months to change your mind about participation, as beyond this 
point in the time the data will have been analysed and it will not be possible to 
remove your data from the study 
 
The interview involves questions relating to: your professional background, what the 
purpose of the developments in transplant science and policy are and how their 
success is measured, what the barriers to development are, what the problems that 
development aims to address are, how scientific understanding and concerns translate 
into policy, how existing communities of expertise are consulted, and how effective 
these collaborations between experts, third-sector parties and policy makers are.  
The interview will be audio-recorded with your permission. A professional typist 
who has signed a confidentiality agreement will then transcribe the recording. The 
recording will be kept securely and your name will never be used in the analysis of 
the data or in any output from the research. After transcription, the audio recording 
of the interview will be destroyed  
 
Confidentiality 
 
Your participation is confidential and any information that you provide will be stored 
securely. Your name will never be used in connection with this study or its published 
findings. When the findings of the research are published, short excerpts from your 
interview may be used to support the arguments being made. However, these 
excerpts will be given a pseudonym to protect your identity.  
 
While every effort will be made to ensure that your identity remains anonymous, this 
research will identify organisations by name. While you personally will not be 
named, you may be referred to as, for example, “an employee of Anthony Nolan 
Trust” or “a senior immunologist in the field”. This means that there is a risk that 
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others may be able to identify you if there are only a small number of people with the 
same role within your particular organisation. However, it is important to reiterate 
that no names will be used or any other details of your profession, which would 
allow for specific identification.  
 
Benefits 
 
Whilst there is no direct benefit to you, your participation will help provide 
important information about policy-making from the point of view of the 
stakeholders involved. This will help to produce a more intricate social scientific 
understanding of how an efficient system of public biobanking can be developed and 
sustained in the United Kingdom. The research will produce recommendations that 
will have relevance both in the UK and abroad. 
 
Duration 
 
The research is taking place over two years: The project end-date is October 2015.  
 
Sharing the results 
 
Following the completion of the study, a summary of the results will be made 
available to all participants. The research findings will also be written up in the form 
of a doctoral thesis, disseminated in academic journals, at academic conferences and 
in reports to relevant stakeholder organisations.  
 
Who to contact 
 
If you have any questions then you can contact the researcher at the following: Ros 
Williams, 07814406789 or rgw511@york.ac.uk. 
 
The ethical aspects of this research have been reviewed and approved by the 
appropriate University of York ethics committee whose task it is to make sure that 
research participants are protected from harm. If you wish to find about more about 
this please contact: elmps-ethics-group@york.ac.uk. 
 
If you wish to get in contact with the researcher’s supervisor, Professor Nik Brown, 
at nik.brown@york.ac.uk.  
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Appendix B: Consent Form  
Understanding Emerging Forms of Governance in public Cord Blood Stem Cell 
biobanking in the UK. 
Consent Form 
    Please initial 
1. I confirm that I have read and understand the 
Information Sheet for the above study and have had the 
opportunity to ask questions. 
  
 
2. I understand that my participation is voluntary:  I am 
free to withdraw at any time. I do not have to give a 
reason. Also, I am free to refuse to answer any question. 
 
3. I agree that the interview can be audio-recorded and I 
understand that direct quotations from the interview may 
be used in the publication of findings. 
 
4. I agree to take part in the above study. 
  
 
 
  
   Name of Participant               Date                      Signature 
  
   Name of Researcher                          Date                      Signature 
234 
 
Appendix C: Documents Included in Data Analysis 
Year Institution Title 
2009 Technopolis 
Cord Blood Banking in the UK: An International 
Comparison of Policy and Practice 
2010 
UK Stem Cell 
Strategic Forum 
The Future of Unrelated Donor Stem Cell 
Transplantation in the UK: A Report from the UK 
Stem Cell Strategic Forum. Part 1: Findings and 
Recommendations 
2010 
UK Stem Cell 
Strategic Forum 
The Future of Unrelated Donor Stem Cell 
Transplantation in the UK: A Report from the UK 
Stem Cell Strategic Forum. Part 2: Annexes 
2011 
World Marrow 
Donor Association 
Race Codes 
2012 
World Marrow 
Donor Association 
International Emergency Task Force: Operating 
Guidelines 
2012 
World Marrow 
Donor Association 
Crisis Response, Business Continuity, and 
Disaster Recovery Guidelines 
2012 Anthony Nolan 
Search Algorithm for a Basic Cord Blood Unit 
Selection 
2012 Anthony Nolan Operations User Guide 
2012 
NHS Blood and 
Transplant 
Report on the Flooding Incident at Filton in 
September 2012 
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2012 
All-Party 
Parliamentary Group 
on Stem Cell 
Transplantation 
Cord Blood Transplantation: Meeting the Unmet 
Demand 
2014 Anthony Nolan Stem Cell Registry Review 2014 
2015 
UK Stem Cell 
Oversight Committee 
Unrelated Donor Stem Cell Transplantation in the 
UK: Effective, Affordable, Sustainable 
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Appendix D: Indicative Themes and Questions for Semi-Structured Interviews 
Involvement in APPG/SCSF/WMDA  
How did you get involved in the organisation?  
Why was it that you were invited to participate? 
How did you come to contribute to a particular event organised by this institution? 
 
The role of APPG/SCSF/WMDA  
Can you reflect on the purpose behind the establishment of this group? 
How do discussions at one organisation feed into the other? 
What differentiates the particular organisations you’re involved in? 
 
Cell count thresholds  
Can you describe the relevance of cell count to the practice of UCB collection? 
What is the current TNC threshold, since when and why? 
When did it last change, and how did you become aware? 
 
HLA typing resolution  
What is the current consensus on HLA allele typing?  
Has the HLA typing consensus changed since you first became involved? 
Can you describe the production of the consensus in x article you co-authored? 
 
Establishment of participant charities 
Why/how was your charity established?  
How did you find yourself involved with the APPG? 
Is the charity involved in any ongoing projects that might be relevant? 
 
UCB and adult donation  
Are the technologies of adult and UCB HSC different? 
What are the benefits, if any, of UCB over adult donation? 
Can you imagine UCB becoming a more popular HSC source? 
 
Uptake of UCB 
Why has UCB become more popular between the 2010 and 2015 reports? 
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Why are some parts of the UK more likely to undertake UCB transplants? 
When and why did the WMDA set up a UCB working group? 
 
UCB collection sites 
How was the decision made to open up a collection site in a particular city? 
Did ethnicity data play a large part in the decision to select a particular city? 
 
Individual's knowledge of UCB  
When/how did you first hear about UCB technology? 
How did you get involved in one of the first UCB banking operations? 
Why has your charity become interested in UCB? 
 
SCSF recommendations  
How was it decided to have a 50,000 unit target?  
What do you perceive to be the main purposes of an aligned stem cell registry? 
Why has the 50,000 target decreased to 30,000? 
 
Ethnicity data  
Are ethnicity data useful for your purposes?  
Is there international consensus on how ethnicity data should be collected? 
How were you involved in designing this ethnicity classification framework? 
 
HLA and ethnicity 
Why is there such concern about the ethnicity composition of the UK adult register?  
Can you explain what you mean that ethnicity determines HLA? 
Do you provide clinicians with ethnicity data as well as HLA data? 
 
Private banks 
What was the purpose of inviting private banks to comment on the SCSF strategy? 
Are private banks currently involved in meeting the SCSF targets? 
Do you anticipate that private banks will be involved in achieving 50,000 units? 
 
Economics of UCB 
Is there economic motivation behind encouraging domestic UCB utilisation? 
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How much does it cost your charity to collect, process and store one unit? 
Is it more expensive to have two separate storage facilities instead of one? 
 
Individual documents  
Do you recall your involvement in producing this document?  
How did the TNC count recommended in this document get decided? 
Why did you produce this particular document? 
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Appendix E: The WMDA ethnicity code framework 
Broad 
Race/ 
Ethnicity 
Code Geographical Region Code 
African AF 
North Africa AFNA 
Sub-Saharan Africa AFSS 
Asian AS 
Southwest Asia: Middle East, Turkey ASSW 
Southern Asia: India, Pakistan, 
Bangladesh, Sri Lanka, Bhutan, Nepal 
ASSO 
Central Asia: Kazakhstan, Uzbekistan, 
Kyrgyzstan, Tajikistan 
ASCE 
Southeast Asia: China, Mongolia, 
Burma, Laos, Cambodia, Thailand, 
Vietnam, Taiwan 
ASSE 
Northeast Asia: Japan, North Korea, 
South Korea 
ASNE 
Oceania: Pacific islands, excluding 
Japan, Australia, Taiwan, Sakhalin, 
Aleutian Islands 
ASOC 
Caucasian 
CA 
Europe: Mainland Europe, Greenland, 
Iceland, Western Russia 
CAEU 
  Eastern Russia CAER 
  North America: U.S., Canada, Mexico CANA 
  Australia: Australia, New Zealand CAAU 
Hispanic HI 
Central America & Caribbean HICA 
South America HISA 
Multiple/ 
Mixed 
MX     
Other OT Ex. Australian Aborigine   
Unknown UK     
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Glossary 
AIDS Acquired Immune Deficiency Syndrome 
AN Anthony Nolan 
APPG All-Party Parliamentary Group 
BAME Black and Minority Ethnicity 
BSBMT British Society of Blood and Marrow Transplantation 
BSE Bovine Spongiform Encephalopathy 
CCNE Committee Consultatif National d’Ethique (France) 
CJD Creutzfeldt-Jakob Disease 
DNA Deoxyribonucleic Acid 
DoH Department of Health (UK) 
GIAS Graft Identification Advisory Service 
GVHD Graft-Versus-Host Disease 
HIV Human Immune Virus 
HLA Human Leukocyte Antigen 
HSC Haematopoietic Stem Cell 
HSCT Haematopoietic Stem Cell Transplantation 
IVF In-vitro Fertilisation 
MFD Matched Family Donor 
NHS National Health Service (UK) 
NHSBT National Health Service Blood and Transplant (UK) 
NMDP National Marrow Donor Program (US) 
R&D Research and Development 
RBC Red Blood Cell 
RGF Regional Growth Fund (UK) 
SCSF Stem Cell Strategic Forum 
STS Science and Technology Studies 
TC Transplant Centre 
TNC Total Nucleated Cell 
TRM Tissue-Resident Memory 
UCB Umbilical Cord Blood 
vCJD Variant Creutzfeldt-Jakob Disease 
WMDA World Marrow Donor Association 
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